id	sid	tid	token	lemma	pos
aji-155	1	1	_	_	PUNCT
aji-155	2	1	_	_	PUNCT
aji-155	3	1	_	_	PUNCT
aji-155	4	1	_	_	PUNCT
aji-155	5	1	_	_	PUNCT
aji-155	6	1	_	_	PUNCT
aji-155	7	1	_	_	PUNCT
aji-155	8	1	_	_	PUNCT
aji-155	9	1	_	_	PUNCT
aji-155	10	1	_	_	PUNCT
aji-155	11	1	_	_	PUNCT
aji-155	12	1	_	_	PUNCT
aji-155	13	1	_	_	PUNCT
aji-155	14	1	_	_	PUNCT
aji-155	15	1	_	_	PUNCT
aji-155	16	1	_	_	PUNCT
aji-155	17	1	_	_	PUNCT
aji-155	18	1	_	_	PUNCT
aji-155	19	1	_	_	PUNCT
aji-155	20	1	_	_	PUNCT
aji-155	21	1	_	_	PUNCT
aji-155	22	1	_	_	PUNCT
aji-155	23	1	_	_	PUNCT
aji-155	24	1	_	_	PUNCT
aji-155	25	1	_	_	PUNCT
aji-155	26	1	_	_	PUNCT
aji-155	27	1	_	_	PUNCT
aji-155	28	1	_	_	PUNCT
aji-155	29	1	_	_	PUNCT
aji-155	30	1	_	_	PUNCT
aji-155	31	1	_	_	PUNCT
aji-155	32	1	_	_	PUNCT
aji-155	33	1	_	_	PUNCT
aji-155	34	1	_	_	PUNCT
aji-155	35	1	_	_	PUNCT
aji-155	36	1	_	_	PUNCT
aji-155	37	1	_	_	PUNCT
aji-155	38	1	_	_	PUNCT
aji-155	39	1	_	_	PUNCT
aji-155	40	1	_	_	PUNCT
aji-155	41	1	_	_	PUNCT
aji-155	42	1	_	_	PUNCT
aji-155	43	1	_	_	PUNCT
aji-155	44	1	_	_	PUNCT
aji-155	45	1	_	_	PUNCT
aji-155	46	1	_	_	PUNCT
aji-155	47	1	_	_	PUNCT
aji-155	48	1	_	_	PUNCT
aji-155	49	1	_	_	PUNCT
aji-155	50	1	_	_	PUNCT
aji-155	51	1	_	_	PUNCT
aji-155	52	1	_	_	PUNCT
aji-155	53	1	_	_	PUNCT
aji-155	54	1	_	_	PUNCT
aji-155	55	1	_	_	PUNCT
aji-155	56	1	_	_	PUNCT
aji-155	57	1	_	_	PUNCT
aji-155	58	1	_	_	PUNCT
aji-155	59	1	_	_	PUNCT
aji-155	60	1	_	_	PUNCT
aji-155	61	1	_	_	PUNCT
aji-155	62	1	_	_	PUNCT
aji-155	63	1	_	_	PUNCT
aji-155	64	1	_	_	PUNCT
aji-155	65	1	_	_	PUNCT
aji-155	66	1	_	_	PUNCT
aji-155	67	1	_	_	PUNCT
aji-155	68	1	_	_	PUNCT
aji-155	69	1	_	_	PUNCT
aji-155	70	1	_	_	PUNCT
aji-155	71	1	_	_	PUNCT
aji-155	72	1	_	_	PUNCT
aji-155	73	1	_	_	PUNCT
aji-155	74	1	_	_	PUNCT
aji-155	75	1	_	_	PUNCT
aji-155	76	1	_	_	PUNCT
aji-155	77	1	_	_	PUNCT
aji-155	78	1	_	_	PUNCT
aji-155	79	1	_	_	PUNCT
aji-155	80	1	_	_	PUNCT
aji-155	81	1	_	_	PUNCT
aji-155	82	1	_	_	PUNCT
aji-155	83	1	_	_	PUNCT
aji-155	84	1	_	_	PUNCT
aji-155	85	1	_	_	PUNCT
aji-155	86	1	_	_	PUNCT
aji-155	87	1	_	_	PUNCT
aji-155	88	1	_	_	PUNCT
aji-155	89	1	_	_	PUNCT
aji-155	90	1	_	_	PUNCT
aji-155	91	1	_	_	PUNCT
aji-155	92	1	_	_	PUNCT
aji-155	93	1	_	_	PUNCT
aji-155	94	1	_	_	PUNCT
aji-155	95	1	_	_	PUNCT
aji-155	96	1	_	_	PUNCT
aji-155	97	1	_	_	PUNCT
aji-155	98	1	_	_	PUNCT
aji-155	99	1	_	_	PUNCT
aji-155	100	1	_	_	PUNCT
aji-155	101	1	_	_	PUNCT
aji-155	102	1	*	*	PUNCT
aji-155	102	2	corresponding	correspond	VERB
aji-155	102	3	author	author	NOUN
aji-155	102	4	:	:	PUNCT
aji-155	102	5	e	e	NOUN
aji-155	102	6	-	-	NOUN
aji-155	102	7	mail	mail	NOUN
aji-155	102	8	:	:	PUNCT
aji-155	102	9	ibrahimshnawa3@gmail.com	ibrahimshnawa3@gmail.com	X
aji-155	102	10	;	;	PUNCT
aji-155	102	11	cite	cite	VERB
aji-155	102	12	as	as	ADP
aji-155	102	13	:	:	PUNCT
aji-155	102	14	shnawa	shnawa	PROPN
aji-155	102	15	,	,	PUNCT
aji-155	102	16	ibrahim	ibrahim	PROPN
aji-155	102	17	m	m	PROPN
aji-155	102	18	s	s	PROPN
aji-155	102	19	,	,	PUNCT
aji-155	102	20	azhar	azhar	PROPN
aji-155	102	21	o	o	PROPN
aji-155	102	22	al	al	PROPN
aji-155	102	23	-	-	PUNCT
aji-155	102	24	thahab	thahab	PROPN
aji-155	102	25	,	,	PUNCT
aji-155	102	26	and	and	CCONJ
aji-155	102	27	kasim	kasim	PROPN
aji-155	102	28	n	n	PRON
aji-155	102	29	a.thewaini	a.thewaini	NOUN
aji-155	102	30	.	.	PROPN
aji-155	102	31	2025	2025	NUM
aji-155	102	32	.	.	PUNCT
aji-155	103	1	“	"	PUNCT
aji-155	103	2	preclinical	preclinical	ADJ
aji-155	103	3	immunogenicity	immunogenicity	NOUN
aji-155	103	4	of	of	ADP
aji-155	103	5	capsule	capsule	NOUN
aji-155	103	6	and	and	CCONJ
aji-155	103	7	outermembrane	outermembrane	NOUN
aji-155	103	8	proteins	protein	NOUN
aji-155	103	9	of	of	ADP
aji-155	103	10	a	a	DET
aji-155	103	11	local	local	ADJ
aji-155	103	12	neurotropic	neurotropic	NOUN
aji-155	103	13	isolate	isolate	NOUN
aji-155	103	14	of	of	ADP
aji-155	103	15	hemophilus	hemophilus	ADJ
aji-155	103	16	infleunzae	infleunzae	NOUN
aji-155	103	17	b	b	PROPN
aji-155	103	18	in	in	ADP
aji-155	103	19	a	a	DET
aji-155	103	20	lapin	lapin	NOUN
aji-155	103	21	model	model	NOUN
aji-155	103	22	”	"	PUNCT
aji-155	103	23	.	.	PUNCT
aji-155	104	1	asian	asian	ADJ
aji-155	104	2	journal	journal	NOUN
aji-155	104	3	of	of	ADP
aji-155	104	4	immunology	immunology	NOUN
aji-155	104	5	8	8	NUM
aji-155	104	6	(	(	PUNCT
aji-155	104	7	1):1	1):1	NUM
aji-155	104	8	-	-	SYM
aji-155	104	9	7	7	NUM
aji-155	104	10	.	.	PUNCT
aji-155	105	1	https://doi.org/10.9734/aji/2025/v8i1155	https://doi.org/10.9734/aji/2025/v8i1155	PROPN
aji-155	105	2	.	.	PUNCT
aji-155	106	1	asian	asian	PROPN
aji-155	106	2	journal	journal	PROPN
aji-155	106	3	of	of	ADP
aji-155	106	4	immunology	immunology	NOUN
aji-155	106	5	volume	volume	NOUN
aji-155	106	6	8	8	NUM
aji-155	106	7	,	,	PUNCT
aji-155	106	8	issue	issue	NOUN
aji-155	106	9	1	1	NUM
aji-155	106	10	,	,	PUNCT
aji-155	106	11	page	page	NOUN
aji-155	106	12	1	1	NUM
aji-155	106	13	-	-	SYM
aji-155	106	14	7	7	NUM
aji-155	106	15	,	,	PUNCT
aji-155	106	16	2025	2025	NUM
aji-155	106	17	;	;	PUNCT
aji-155	106	18	article	article	NOUN
aji-155	106	19	no.aji.129951	no.aji.129951	PRON
aji-155	106	20	preclinical	preclinical	ADJ
aji-155	106	21	immunogenicity	immunogenicity	NOUN
aji-155	106	22	of	of	ADP
aji-155	106	23	capsule	capsule	NOUN
aji-155	106	24	and	and	CCONJ
aji-155	106	25	outermembrane	outermembrane	NOUN
aji-155	106	26	proteins	protein	NOUN
aji-155	106	27	of	of	ADP
aji-155	106	28	a	a	DET
aji-155	106	29	local	local	ADJ
aji-155	106	30	neurotropic	neurotropic	NOUN
aji-155	106	31	isolate	isolate	NOUN
aji-155	106	32	of	of	ADP
aji-155	106	33	hemophilus	hemophilus	ADJ
aji-155	106	34	infleunzae	infleunzae	NOUN
aji-155	106	35	b	b	PROPN
aji-155	106	36	in	in	ADP
aji-155	106	37	a	a	DET
aji-155	106	38	lapin	lapin	NOUN
aji-155	106	39	model	model	NOUN
aji-155	107	1	ibrahim	ibrahim	PROPN
aji-155	107	2	m	m	PROPN
aji-155	107	3	s	s	VERB
aji-155	107	4	shnawa	shnawa	NOUN
aji-155	107	5	a	a	DET
aji-155	107	6	,	,	PUNCT
aji-155	107	7	b	b	PROPN
aji-155	107	8	*	*	PROPN
aji-155	107	9	,	,	PUNCT
aji-155	107	10	azhar	azhar	PROPN
aji-155	107	11	o	o	PROPN
aji-155	107	12	al	al	PROPN
aji-155	107	13	-	-	PUNCT
aji-155	107	14	thahab	thahab	PROPN
aji-155	107	15	c	c	PROPN
aji-155	107	16	and	and	CCONJ
aji-155	107	17	kasim	kasim	PROPN
aji-155	107	18	n	n	CCONJ
aji-155	107	19	a.thewaini	a.thewaini	VERB
aji-155	107	20	a	a	DET
aji-155	107	21	a	a	DET
aji-155	107	22	department	department	NOUN
aji-155	107	23	of	of	ADP
aji-155	107	24	medical	medical	ADJ
aji-155	107	25	biotechnology	biotechnology	NOUN
aji-155	107	26	,	,	PUNCT
aji-155	107	27	college	college	NOUN
aji-155	107	28	of	of	ADP
aji-155	107	29	biotechnology	biotechnology	NOUN
aji-155	107	30	,	,	PUNCT
aji-155	107	31	al	al	PROPN
aji-155	107	32	-	-	PUNCT
aji-155	107	33	qasim	qasim	PROPN
aji-155	107	34	green	green	PROPN
aji-155	107	35	university	university	PROPN
aji-155	107	36	,	,	PUNCT
aji-155	107	37	babylon	babylon	PROPN
aji-155	107	38	,	,	PUNCT
aji-155	107	39	iraq	iraq	PROPN
aji-155	107	40	.	.	PUNCT
aji-155	108	1	b	b	X
aji-155	108	2	college	college	NOUN
aji-155	108	3	of	of	ADP
aji-155	108	4	nursing	nursing	NOUN
aji-155	108	5	,	,	PUNCT
aji-155	108	6	university	university	NOUN
aji-155	108	7	of	of	ADP
aji-155	108	8	hillah	hillah	PROPN
aji-155	108	9	,	,	PUNCT
aji-155	108	10	babylon	babylon	PROPN
aji-155	108	11	,	,	PUNCT
aji-155	108	12	iraq	iraq	PROPN
aji-155	108	13	.	.	PUNCT
aji-155	109	1	c	c	PROPN
aji-155	109	2	department	department	PROPN
aji-155	109	3	of	of	ADP
aji-155	109	4	biology	biology	NOUN
aji-155	109	5	,	,	PUNCT
aji-155	109	6	college	college	NOUN
aji-155	109	7	of	of	ADP
aji-155	109	8	science	science	NOUN
aji-155	109	9	,	,	PUNCT
aji-155	109	10	university	university	NOUN
aji-155	109	11	of	of	ADP
aji-155	109	12	babylon	babylon	PROPN
aji-155	109	13	,	,	PUNCT
aji-155	109	14	babylon	babylon	PROPN
aji-155	109	15	,	,	PUNCT
aji-155	109	16	iraq	iraq	PROPN
aji-155	109	17	.	.	PUNCT
aji-155	110	1	authors	author	NOUN
aji-155	110	2	’	'	PUNCT
aji-155	110	3	contributions	contribution	NOUN
aji-155	110	4	this	this	DET
aji-155	110	5	work	work	NOUN
aji-155	110	6	was	be	AUX
aji-155	110	7	carried	carry	VERB
aji-155	110	8	out	out	ADP
aji-155	110	9	in	in	ADP
aji-155	110	10	collaboration	collaboration	NOUN
aji-155	110	11	among	among	ADP
aji-155	110	12	all	all	DET
aji-155	110	13	authors	author	NOUN
aji-155	110	14	.	.	PUNCT
aji-155	111	1	all	all	DET
aji-155	111	2	authors	author	NOUN
aji-155	111	3	read	read	VERB
aji-155	111	4	and	and	CCONJ
aji-155	111	5	approved	approve	VERB
aji-155	111	6	the	the	DET
aji-155	111	7	final	final	ADJ
aji-155	111	8	manuscript	manuscript	NOUN
aji-155	111	9	.	.	PUNCT
aji-155	112	1	article	article	NOUN
aji-155	112	2	information	information	PROPN
aji-155	112	3	doi	doi	PROPN
aji-155	112	4	:	:	PUNCT
aji-155	112	5	https://doi.org/10.9734/aji/2025/v8i1155	https://doi.org/10.9734/aji/2025/v8i1155	PROPN
aji-155	112	6	open	open	ADJ
aji-155	112	7	peer	peer	NOUN
aji-155	112	8	review	review	NOUN
aji-155	112	9	history	history	NOUN
aji-155	112	10	:	:	PUNCT
aji-155	112	11	this	this	DET
aji-155	112	12	journal	journal	NOUN
aji-155	112	13	follows	follow	VERB
aji-155	112	14	the	the	DET
aji-155	112	15	advanced	advance	VERB
aji-155	112	16	open	open	ADJ
aji-155	112	17	peer	peer	NOUN
aji-155	112	18	review	review	NOUN
aji-155	112	19	policy	policy	NOUN
aji-155	112	20	.	.	PUNCT
aji-155	113	1	identity	identity	NOUN
aji-155	113	2	of	of	ADP
aji-155	113	3	the	the	DET
aji-155	113	4	reviewers	reviewer	NOUN
aji-155	113	5	,	,	PUNCT
aji-155	113	6	editor(s	editor(s	NOUN
aji-155	113	7	)	)	PUNCT
aji-155	113	8	and	and	CCONJ
aji-155	113	9	additional	additional	ADJ
aji-155	113	10	reviewers	reviewer	NOUN
aji-155	113	11	,	,	PUNCT
aji-155	113	12	peer	peer	NOUN
aji-155	113	13	review	review	NOUN
aji-155	113	14	comments	comment	NOUN
aji-155	113	15	,	,	PUNCT
aji-155	113	16	different	different	ADJ
aji-155	113	17	versions	version	NOUN
aji-155	113	18	of	of	ADP
aji-155	113	19	the	the	DET
aji-155	113	20	manuscript	manuscript	NOUN
aji-155	113	21	,	,	PUNCT
aji-155	113	22	comments	comment	NOUN
aji-155	113	23	of	of	ADP
aji-155	113	24	the	the	DET
aji-155	113	25	editors	editor	NOUN
aji-155	113	26	,	,	PUNCT
aji-155	113	27	etc	etc	X
aji-155	113	28	are	be	AUX
aji-155	113	29	available	available	ADJ
aji-155	113	30	here	here	ADV
aji-155	113	31	:	:	PUNCT
aji-155	113	32	https://pr.sdiarticle5.com/review-history/129951	https://pr.sdiarticle5.com/review-history/129951	NOUN
aji-155	113	33	received	receive	VERB
aji-155	113	34	:	:	PUNCT
aji-155	113	35	26/11/2024	26/11/2024	NUM
aji-155	113	36	published	publish	VERB
aji-155	113	37	:	:	PUNCT
aji-155	113	38	06/02/2025	06/02/2025	NUM
aji-155	113	39	abstract	abstract	NOUN
aji-155	113	40	the	the	DET
aji-155	113	41	preclinical	preclinical	ADJ
aji-155	113	42	immunogenicity	immunogenicity	NOUN
aji-155	113	43	of	of	ADP
aji-155	113	44	capsule	capsule	NOUN
aji-155	113	45	c	c	PROPN
aji-155	113	46	and	and	CCONJ
aji-155	113	47	outer	outer	ADJ
aji-155	113	48	membrane	membrane	NOUN
aji-155	113	49	protein	protein	NOUN
aji-155	113	50	omp	omp	NOUN
aji-155	113	51	of	of	ADP
aji-155	113	52	human	human	PROPN
aji-155	113	53	neurotropic	neurotropic	PROPN
aji-155	113	54	isolate	isolate	NOUN
aji-155	113	55	of	of	ADP
aji-155	113	56	hemophilus	hemophilus	ADJ
aji-155	113	57	influenzae	influenzae	X
aji-155	113	58	b	b	PROPN
aji-155	113	59	hib	hib	NOUN
aji-155	113	60	in	in	ADP
aji-155	113	61	a	a	DET
aji-155	113	62	lapin	lapin	NOUN
aji-155	113	63	model	model	NOUN
aji-155	113	64	is	be	AUX
aji-155	113	65	being	be	AUX
aji-155	113	66	reported	report	VERB
aji-155	113	67	.	.	PUNCT
aji-155	114	1	hemophilus	hemophilus	ADJ
aji-155	114	2	influenzae	influenzae	PROPN
aji-155	114	3	b	b	PROPN
aji-155	114	4	is	be	AUX
aji-155	114	5	gram	gram	NOUN
aji-155	114	6	negative	negative	ADJ
aji-155	114	7	,	,	PUNCT
aji-155	114	8	short	short	ADJ
aji-155	114	9	rods	rod	NOUN
aji-155	114	10	,	,	PUNCT
aji-155	114	11	encapsulated	encapsulate	VERB
aji-155	114	12	bacterium	bacterium	NOUN
aji-155	114	13	,	,	PUNCT
aji-155	114	14	microaerophilic	microaerophilic	ADJ
aji-155	114	15	,	,	PUNCT
aji-155	114	16	fastidious	fastidious	ADJ
aji-155	114	17	,	,	PUNCT
aji-155	114	18	need	need	VERB
aji-155	114	19	original	original	ADJ
aji-155	114	20	research	research	NOUN
aji-155	114	21	article	article	NOUN
aji-155	114	22	https://doi.org/10.9734/aji/2025/v8i1155	https://doi.org/10.9734/aji/2025/v8i1155	PROPN
aji-155	115	1	https://pr.sdiarticle5.com/review-history/129951	https://pr.sdiarticle5.com/review-history/129951	PROPN
aji-155	115	2	shnawa	shnawa	PROPN
aji-155	115	3	et	et	PROPN
aji-155	115	4	al	al	PROPN
aji-155	115	5	.	.	PROPN
aji-155	115	6	;	;	PUNCT
aji-155	116	1	asian	asian	PROPN
aji-155	116	2	j.	j.	PROPN
aji-155	116	3	immunol	immunol	PROPN
aji-155	116	4	.	.	PROPN
aji-155	116	5	,	,	PUNCT
aji-155	116	6	vol	vol	NOUN
aji-155	116	7	.	.	PROPN
aji-155	116	8	8	8	NUM
aji-155	116	9	,	,	PUNCT
aji-155	116	10	no	no	INTJ
aji-155	116	11	.	.	NOUN
aji-155	116	12	1	1	NUM
aji-155	116	13	,	,	PUNCT
aji-155	116	14	pp	pp	ADJ
aji-155	116	15	.	.	PUNCT
aji-155	117	1	1	1	NUM
aji-155	117	2	-	-	SYM
aji-155	117	3	7	7	NUM
aji-155	117	4	,	,	PUNCT
aji-155	117	5	2025	2025	NUM
aji-155	117	6	;	;	PUNCT
aji-155	117	7	article	article	NOUN
aji-155	117	8	no.aji.129951	no.aji.129951	PROPN
aji-155	117	9	2	2	NUM
aji-155	117	10	x	x	NOUN
aji-155	117	11	and	and	CCONJ
aji-155	117	12	v	v	NUM
aji-155	117	13	factor	factor	NOUN
aji-155	117	14	for	for	ADP
aji-155	117	15	growth	growth	NOUN
aji-155	117	16	with	with	ADP
aji-155	117	17	six	six	NUM
aji-155	117	18	capsular	capsular	ADJ
aji-155	117	19	serotypes	serotype	NOUN
aji-155	117	20	.	.	PUNCT
aji-155	118	1	among	among	ADP
aji-155	118	2	which	which	PRON
aji-155	118	3	serotype	serotype	NOUN
aji-155	118	4	b	b	PROPN
aji-155	118	5	was	be	AUX
aji-155	118	6	the	the	DET
aji-155	118	7	dominant	dominant	NOUN
aji-155	118	8	.	.	PUNCT
aji-155	119	1	itis	itis	NOUN
aji-155	119	2	associated	associate	VERB
aji-155	119	3	with	with	ADP
aji-155	119	4	human	human	ADJ
aji-155	119	5	pyogenic	pyogenic	ADJ
aji-155	119	6	respiratory	respiratory	ADJ
aji-155	119	7	and	and	CCONJ
aji-155	119	8	meningeal	meningeal	ADJ
aji-155	119	9	infections	infection	NOUN
aji-155	119	10	.	.	PUNCT
aji-155	120	1	the	the	DET
aji-155	120	2	c	c	PROPN
aji-155	120	3	and	and	CCONJ
aji-155	120	4	omp	omp	PROPN
aji-155	120	5	were	be	AUX
aji-155	120	6	separated	separate	VERB
aji-155	120	7	,	,	PUNCT
aji-155	120	8	purified	purified	ADJ
aji-155	120	9	,	,	PUNCT
aji-155	120	10	and	and	CCONJ
aji-155	120	11	characterized	characterize	VERB
aji-155	120	12	.	.	PUNCT
aji-155	121	1	then	then	ADV
aji-155	121	2	,	,	PUNCT
aji-155	121	3	quantfied	quantfie	VERB
aji-155	121	4	to	to	ADP
aji-155	121	5	the	the	DET
aji-155	121	6	rate	rate	NOUN
aji-155	121	7	of	of	ADP
aji-155	121	8	3	3	NUM
aji-155	121	9	mg	mg	PROPN
aji-155	121	10	/	/	SYM
aji-155	121	11	m	m	PROPN
aji-155	121	12	l	l	NOUN
aji-155	121	13	and	and	CCONJ
aji-155	121	14	2.27	2.27	NUM
aji-155	121	15	mg	mg	NUM
aji-155	121	16	/	/	SYM
aji-155	121	17	ml	ml	ADV
aji-155	121	18	accordingly	accordingly	ADV
aji-155	121	19	.	.	PUNCT
aji-155	122	1	both	both	PRON
aji-155	122	2	of	of	ADP
aji-155	122	3	the	the	DET
aji-155	122	4	preparations	preparation	NOUN
aji-155	122	5	were	be	AUX
aji-155	122	6	used	use	VERB
aji-155	122	7	as	as	ADP
aji-155	122	8	test	test	NOUN
aji-155	122	9	antigens	antigen	NOUN
aji-155	122	10	for	for	ADP
aji-155	122	11	the	the	DET
aji-155	122	12	invitro	invitro	ADJ
aji-155	122	13	use	use	NOUN
aji-155	122	14	and	and	CCONJ
aji-155	122	15	for	for	ADP
aji-155	122	16	speific	speific	ADJ
aji-155	122	17	immune	immune	ADJ
aji-155	122	18	priming	priming	NOUN
aji-155	122	19	of	of	ADP
aji-155	122	20	rabbits	rabbit	NOUN
aji-155	122	21	.	.	PUNCT
aji-155	123	1	cell	cell	NOUN
aji-155	123	2	free	free	ADJ
aji-155	123	3	culture	culture	NOUN
aji-155	123	4	filtrate	filtrate	NOUN
aji-155	123	5	of	of	ADP
aji-155	123	6	test	test	NOUN
aji-155	123	7	isolate	isolate	NOUN
aji-155	123	8	was	be	AUX
aji-155	123	9	prepared	prepare	VERB
aji-155	123	10	and	and	CCONJ
aji-155	123	11	used	use	VERB
aji-155	123	12	as	as	ADP
aji-155	123	13	a	a	DET
aji-155	123	14	skin	skin	NOUN
aji-155	123	15	sensitin	sensitin	NOUN
aji-155	123	16	in	in	ADP
aji-155	123	17	dth	dth	ADJ
aji-155	123	18	test	test	NOUN
aji-155	123	19	.	.	PUNCT
aji-155	124	1	rabbits	rabbit	NOUN
aji-155	124	2	were	be	AUX
aji-155	124	3	were	be	AUX
aji-155	124	4	preconditioned	precondition	VERB
aji-155	124	5	with	with	ADP
aji-155	124	6	cfa	cfa	PROPN
aji-155	124	7	adjuvant	adjuvant	NOUN
aji-155	124	8	for	for	ADP
aji-155	124	9	two	two	NUM
aji-155	124	10	weeks	week	NOUN
aji-155	124	11	then	then	ADV
aji-155	124	12	specific	specific	ADJ
aji-155	124	13	immune	immune	NOUN
aji-155	124	14	primed	prime	VERB
aji-155	124	15	using	use	VERB
aji-155	124	16	multisite	multisite	ADJ
aji-155	124	17	multi	multi	ADJ
aji-155	124	18	-	-	ADJ
aji-155	124	19	injection	injection	ADJ
aji-155	124	20	protocols	protocol	NOUN
aji-155	124	21	.	.	PUNCT
aji-155	125	1	capsule	capsule	NOUN
aji-155	125	2	immunogen	immunogen	NOUN
aji-155	125	3	induce	induce	VERB
aji-155	125	4	leukocyte	leukocyte	NOUN
aji-155	125	5	stimulatory	stimulatory	ADJ
aji-155	125	6	factor	factor	NOUN
aji-155	125	7	cytokines	cytokine	NOUN
aji-155	125	8	.	.	PUNCT
aji-155	126	1	four	four	NUM
aji-155	126	2	to	to	PART
aji-155	126	3	six	six	NUM
aji-155	126	4	folds	fold	NOUN
aji-155	126	5	rise	rise	VERB
aji-155	126	6	both	both	DET
aji-155	126	7	titres	titre	NOUN
aji-155	126	8	and	and	CCONJ
aji-155	126	9	concentrations	concentration	NOUN
aji-155	126	10	of	of	ADP
aji-155	126	11	anti	anti	NOUN
aji-155	126	12	capsular	capsular	VERB
aji-155	126	13	precipitins	precipitin	NOUN
aji-155	126	14	and	and	CCONJ
aji-155	126	15	anti	anti	ADJ
aji-155	126	16	omp	omp	PROPN
aji-155	126	17	hemagglutinins	hemagglutinin	NOUN
aji-155	126	18	were	be	AUX
aji-155	126	19	noted	note	VERB
aji-155	126	20	.	.	PUNCT
aji-155	127	1	both	both	DET
aji-155	127	2	c	c	PROPN
aji-155	127	3	and	and	CCONJ
aji-155	127	4	amp	amp	PROPN
aji-155	127	5	are	be	AUX
aji-155	127	6	proved	prove	VERB
aji-155	127	7	to	to	PART
aji-155	127	8	be	be	AUX
aji-155	127	9	lapin	lapin	NOUN
aji-155	127	10	immunogens	immunogen	NOUN
aji-155	127	11	stimulate	stimulate	VERB
aji-155	127	12	humoral	humoral	ADJ
aji-155	127	13	immune	immune	ADJ
aji-155	127	14	responses	response	NOUN
aji-155	127	15	at	at	ADP
aji-155	127	16	both	both	CCONJ
aji-155	127	17	systemic	systemic	ADJ
aji-155	127	18	and	and	CCONJ
aji-155	127	19	mucosal	mucosal	ADJ
aji-155	127	20	immune	immune	ADJ
aji-155	127	21	compartments	compartment	NOUN
aji-155	127	22	.	.	PUNCT
aji-155	128	1	these	these	DET
aji-155	128	2	findings	finding	NOUN
aji-155	128	3	may	may	AUX
aji-155	128	4	forms	form	VERB
aji-155	128	5	the	the	DET
aji-155	128	6	background	background	NOUN
aji-155	128	7	information	information	NOUN
aji-155	128	8	and	and	CCONJ
aji-155	128	9	be	be	AUX
aji-155	128	10	an	an	DET
aji-155	128	11	integral	integral	ADJ
aji-155	128	12	part	part	NOUN
aji-155	128	13	of	of	ADP
aji-155	128	14	preclinical	preclinical	ADJ
aji-155	128	15	and	and	CCONJ
aji-155	128	16	clinical	clinical	ADJ
aji-155	128	17	development	development	NOUN
aji-155	128	18	and	and	CCONJ
aji-155	128	19	production	production	NOUN
aji-155	128	20	of	of	ADP
aji-155	128	21	local	local	ADJ
aji-155	128	22	h.	h.	PROPN
aji-155	128	23	infleunzae	infleunzae	PROPN
aji-155	128	24	b	b	PROPN
aji-155	128	25	systemic	systemic	ADJ
aji-155	128	26	and/or	and/or	CCONJ
aji-155	128	27	mucosal	mucosal	ADJ
aji-155	128	28	vaccines	vaccine	NOUN
aji-155	128	29	.	.	PUNCT
aji-155	129	1	which	which	PRON
aji-155	129	2	could	could	AUX
aji-155	129	3	be	be	AUX
aji-155	129	4	valid	valid	ADJ
aji-155	129	5	on	on	ADP
aji-155	129	6	approval	approval	NOUN
aji-155	129	7	for	for	ADP
aji-155	129	8	local	local	ADJ
aji-155	129	9	mass	mass	NOUN
aji-155	129	10	vaccination	vaccination	NOUN
aji-155	129	11	against	against	ADP
aji-155	129	12	childhood	childhood	NOUN
aji-155	129	13	meningitis	meningitis	NOUN
aji-155	129	14	in	in	ADP
aji-155	129	15	this	this	DET
aji-155	129	16	area	area	NOUN
aji-155	129	17	.	.	PUNCT
aji-155	130	1	keywords	keyword	NOUN
aji-155	130	2	:	:	PUNCT
aji-155	130	3	antigen	antigen	ADV
aji-155	130	4	;	;	PUNCT
aji-155	130	5	cellular	cellular	ADJ
aji-155	130	6	;	;	PUNCT
aji-155	130	7	humoral	humoral	ADJ
aji-155	130	8	;	;	PUNCT
aji-155	130	9	immunogens	immunogen	NOUN
aji-155	130	10	;	;	PUNCT
aji-155	130	11	vaccines	vaccine	NOUN
aji-155	130	12	.	.	PUNCT
aji-155	131	1	1	1	X
aji-155	131	2	.	.	X
aji-155	131	3	introduction	introduction	NOUN
aji-155	131	4	hemophilus	hemophilus	ADV
aji-155	131	5	influenzae	influenzae	PROPN
aji-155	131	6	b	b	PROPN
aji-155	131	7	is	be	AUX
aji-155	131	8	short	short	ADJ
aji-155	131	9	gram	gram	ADJ
aji-155	131	10	negative	negative	ADJ
aji-155	131	11	rods	rod	NOUN
aji-155	131	12	,	,	PUNCT
aji-155	131	13	encapsulated	encapsulate	VERB
aji-155	131	14	bacterium	bacterium	NOUN
aji-155	131	15	.	.	PUNCT
aji-155	132	1	microaerophilic	microaerophilic	ADJ
aji-155	132	2	,	,	PUNCT
aji-155	132	3	fastidious	fastidious	ADJ
aji-155	132	4	need	need	NOUN
aji-155	132	5	x	x	PUNCT
aji-155	132	6	and	and	CCONJ
aji-155	132	7	v	v	NUM
aji-155	132	8	factor	factor	NOUN
aji-155	132	9	for	for	ADP
aji-155	132	10	growth	growth	NOUN
aji-155	132	11	with	with	ADP
aji-155	132	12	six	six	NUM
aji-155	132	13	capsular	capsular	ADJ
aji-155	132	14	serotypes	serotype	NOUN
aji-155	132	15	.	.	PUNCT
aji-155	133	1	among	among	ADP
aji-155	133	2	which	which	PRON
aji-155	133	3	serotype	serotype	NOUN
aji-155	133	4	b	b	PROPN
aji-155	133	5	was	be	AUX
aji-155	133	6	the	the	DET
aji-155	133	7	dominant	dominant	NOUN
aji-155	133	8	.	.	PUNCT
aji-155	134	1	hib	hib	PROPN
aji-155	134	2	is	be	AUX
aji-155	134	3	associated	associate	VERB
aji-155	134	4	with	with	ADP
aji-155	134	5	human	human	ADJ
aji-155	134	6	pyogenic	pyogenic	ADJ
aji-155	134	7	respiratory	respiratory	ADJ
aji-155	134	8	and	and	CCONJ
aji-155	134	9	meningeal	meningeal	ADJ
aji-155	134	10	infections	infection	NOUN
aji-155	134	11	(	(	PUNCT
aji-155	134	12	levenison	levenison	PROPN
aji-155	134	13	et	et	PROPN
aji-155	134	14	al	al	PROPN
aji-155	134	15	.	.	PROPN
aji-155	134	16	,	,	PUNCT
aji-155	134	17	2018	2018	NUM
aji-155	134	18	)	)	PUNCT
aji-155	134	19	.	.	PUNCT
aji-155	135	1	meningitis	meningitis	PROPN
aji-155	135	2	is	be	AUX
aji-155	135	3	a	a	DET
aji-155	135	4	life	life	NOUN
aji-155	135	5	threatining	threatining	NOUN
aji-155	135	6	disease	disease	NOUN
aji-155	135	7	affects	affect	VERB
aji-155	135	8	millions	million	NOUN
aji-155	135	9	of	of	ADP
aji-155	135	10	people	people	NOUN
aji-155	135	11	of	of	ADP
aji-155	135	12	all	all	DET
aji-155	135	13	ages	age	NOUN
aji-155	135	14	allover	allover	VERB
aji-155	135	15	the	the	DET
aji-155	135	16	world	world	NOUN
aji-155	135	17	and	and	CCONJ
aji-155	135	18	is	be	AUX
aji-155	135	19	considered	consider	VERB
aji-155	135	20	a	a	DET
aji-155	135	21	major	major	ADJ
aji-155	135	22	global	global	ADJ
aji-155	135	23	public	public	ADJ
aji-155	135	24	health	health	NOUN
aji-155	135	25	issue	issue	NOUN
aji-155	135	26	(	(	PUNCT
aji-155	135	27	international	international	ADJ
aji-155	135	28	society	society	NOUN
aji-155	135	29	of	of	ADP
aji-155	135	30	infectious	infectious	ADJ
aji-155	135	31	diseases	disease	NOUN
aji-155	135	32	2023	2023	NUM
aji-155	135	33	)	)	PUNCT
aji-155	135	34	.	.	PUNCT
aji-155	136	1	the	the	DET
aji-155	136	2	nature	nature	NOUN
aji-155	136	3	of	of	ADP
aji-155	136	4	the	the	DET
aji-155	136	5	immunity	immunity	NOUN
aji-155	136	6	induced	induce	VERB
aji-155	136	7	by	by	ADP
aji-155	136	8	h.	h.	PROPN
aji-155	136	9	infleunzae	infleunzae	PROPN
aji-155	136	10	b	b	PROPN
aji-155	136	11	in	in	ADP
aji-155	136	12	rabbit	rabbit	NOUN
aji-155	136	13	,	,	PUNCT
aji-155	136	14	rat	rat	NOUN
aji-155	136	15	and	and	CCONJ
aji-155	136	16	mice	mouse	NOUN
aji-155	136	17	is	be	AUX
aji-155	136	18	humoral	humoral	ADJ
aji-155	136	19	by	by	ADP
aji-155	136	20	a	a	DET
aji-155	136	21	t	t	NOUN
aji-155	136	22	cell	cell	NOUN
aji-155	136	23	independent	independent	ADJ
aji-155	136	24	epitopes	epitope	NOUN
aji-155	136	25	(	(	PUNCT
aji-155	136	26	levenison	levenison	PROPN
aji-155	136	27	et	et	PROPN
aji-155	136	28	al	al	PROPN
aji-155	136	29	.	.	PROPN
aji-155	136	30	,	,	PUNCT
aji-155	136	31	2018	2018	NUM
aji-155	136	32	;	;	PUNCT
aji-155	136	33	wisplwey	wisplwey	VERB
aji-155	136	34	et	et	PROPN
aji-155	136	35	al	al	PROPN
aji-155	136	36	.	.	PROPN
aji-155	136	37	,	,	PUNCT
aji-155	136	38	1989	1989	NUM
aji-155	136	39	)	)	PUNCT
aji-155	136	40	.	.	PUNCT
aji-155	137	1	circulating	circulate	VERB
aji-155	137	2	anti	anti	ADJ
aji-155	137	3	capsular	capsular	ADJ
aji-155	137	4	prp	prp	PROPN
aji-155	137	5	antibodies	antibody	NOUN
aji-155	137	6	promote	promote	VERB
aji-155	137	7	complement	complement	VERB
aji-155	137	8	dependent	dependent	ADJ
aji-155	137	9	bactericidal	bactericidal	ADJ
aji-155	137	10	power	power	NOUN
aji-155	137	11	and	and	CCONJ
aji-155	137	12	phagocytosis	phagocytosis	NOUN
aji-155	137	13	found	find	VERB
aji-155	137	14	in	in	ADP
aji-155	137	15	meningitis	meningitis	NOUN
aji-155	137	16	patients	patient	NOUN
aji-155	137	17	and	and	CCONJ
aji-155	137	18	vaccinee	vaccinee	VERB
aji-155	137	19	.	.	PUNCT
aji-155	138	1	there	there	PRON
aji-155	138	2	is	be	VERB
aji-155	138	3	a	a	DET
aji-155	138	4	correlation	correlation	NOUN
aji-155	138	5	between	between	ADP
aji-155	138	6	the	the	DET
aji-155	138	7	presence	presence	NOUN
aji-155	138	8	of	of	ADP
aji-155	138	9	bactericidal	bactericidal	ADJ
aji-155	138	10	antibodies	antibody	NOUN
aji-155	138	11	and	and	CCONJ
aji-155	138	12	resistance	resistance	NOUN
aji-155	138	13	to	to	ADP
aji-155	138	14	h.	h.	PROPN
aji-155	138	15	infleunzae	infleunzae	PROPN
aji-155	138	16	b	b	PROPN
aji-155	138	17	infection	infection	NOUN
aji-155	138	18	(	(	PUNCT
aji-155	138	19	international	international	ADJ
aji-155	138	20	society	society	NOUN
aji-155	138	21	of	of	ADP
aji-155	138	22	infectious	infectious	ADJ
aji-155	138	23	diseases	disease	NOUN
aji-155	138	24	2023	2023	NUM
aji-155	138	25	;	;	PUNCT
aji-155	138	26	wisplwey	wisplwey	VERB
aji-155	138	27	et	et	PROPN
aji-155	138	28	al	al	PROPN
aji-155	138	29	.	.	PROPN
aji-155	138	30	,	,	PUNCT
aji-155	138	31	1989	1989	NUM
aji-155	138	32	)	)	PUNCT
aji-155	138	33	.	.	PUNCT
aji-155	139	1	hemophilus	hemophilus	ADJ
aji-155	139	2	infleunzae	infleunzae	PROPN
aji-155	139	3	b	b	PROPN
aji-155	139	4	omp	omp	PROPN
aji-155	139	5	have	have	AUX
aji-155	139	6	been	be	AUX
aji-155	139	7	proved	prove	VERB
aji-155	139	8	to	to	PART
aji-155	139	9	be	be	AUX
aji-155	139	10	immunogens	immunogen	NOUN
aji-155	139	11	in	in	ADP
aji-155	139	12	infant	infant	NOUN
aji-155	139	13	rat	rat	NOUN
aji-155	139	14	(	(	PUNCT
aji-155	139	15	hansen	hansen	PROPN
aji-155	139	16	et	et	PROPN
aji-155	139	17	al	al	PROPN
aji-155	139	18	.	.	PROPN
aji-155	139	19	,	,	PUNCT
aji-155	139	20	1981	1981	NUM
aji-155	139	21	)	)	PUNCT
aji-155	139	22	.	.	PUNCT
aji-155	140	1	the	the	DET
aji-155	140	2	noncapsulated	noncapsulated	ADJ
aji-155	140	3	atypical	atypical	PROPN
aji-155	140	4	h.	h.	NOUN
aji-155	140	5	infleunzae	infleunzae	ADV
aji-155	140	6	suppress	suppress	VERB
aji-155	140	7	and	and	CCONJ
aji-155	140	8	modulate	modulate	VERB
aji-155	140	9	cellular	cellular	ADJ
aji-155	140	10	and	and	CCONJ
aji-155	140	11	humoral	humoral	ADJ
aji-155	140	12	immune	immune	ADJ
aji-155	140	13	responses	response	NOUN
aji-155	140	14	to	to	ADP
aji-155	140	15	atypical	atypical	ADJ
aji-155	140	16	h.	h.	NOUN
aji-155	140	17	infleunzae	infleunzae	NOUN
aji-155	140	18	vaccine	vaccine	NOUN
aji-155	140	19	due	due	ADJ
aji-155	140	20	to	to	PART
aji-155	140	21	interference	interference	VERB
aji-155	140	22	phenomena	phenomenon	NOUN
aji-155	140	23	(	(	PUNCT
aji-155	140	24	mawas	mawas	INTJ
aji-155	140	25	et	et	PROPN
aji-155	140	26	al	al	PROPN
aji-155	140	27	.	.	PROPN
aji-155	140	28	,	,	PUNCT
aji-155	140	29	2006	2006	NUM
aji-155	140	30	;	;	PUNCT
aji-155	140	31	lee	lee	PROPN
aji-155	140	32	et	et	PROPN
aji-155	140	33	al	al	PROPN
aji-155	140	34	.	.	PROPN
aji-155	140	35	,	,	PUNCT
aji-155	140	36	2010	2010	NUM
aji-155	140	37	;	;	PUNCT
aji-155	140	38	griffiths	griffiths	PROPN
aji-155	140	39	et	et	PROPN
aji-155	140	40	al	al	PROPN
aji-155	140	41	.	.	PROPN
aji-155	140	42	,	,	PUNCT
aji-155	140	43	2012	2012	NUM
aji-155	140	44	;	;	PUNCT
aji-155	140	45	latez	latez	PROPN
aji-155	140	46	et	et	PROPN
aji-155	140	47	al	al	PROPN
aji-155	140	48	.	.	PROPN
aji-155	140	49	,	,	PUNCT
aji-155	140	50	2004	2004	NUM
aji-155	140	51	;	;	PUNCT
aji-155	140	52	santosham	santosham	PROPN
aji-155	140	53	,	,	PUNCT
aji-155	140	54	1993	1993	NUM
aji-155	140	55	)	)	PUNCT
aji-155	140	56	.	.	PUNCT
aji-155	141	1	omp	omp	PROPN
aji-155	141	2	of	of	ADP
aji-155	141	3	atypical	atypical	PROPN
aji-155	141	4	h.	h.	PROPN
aji-155	141	5	infleunzae	infleunzae	NOUN
aji-155	141	6	is	be	AUX
aji-155	141	7	affected	affect	VERB
aji-155	141	8	by	by	ADP
aji-155	141	9	the	the	DET
aji-155	141	10	function	function	NOUN
aji-155	141	11	of	of	ADP
aji-155	141	12	treg	treg	PROPN
aji-155	141	13	on	on	ADP
aji-155	141	14	b	b	PROPN
aji-155	141	15	cells	cell	NOUN
aji-155	141	16	specific	specific	ADJ
aji-155	141	17	for	for	ADP
aji-155	141	18	omp	omp	PROPN
aji-155	141	19	in	in	ADP
aji-155	141	20	a	a	DET
aji-155	141	21	cell	cell	NOUN
aji-155	141	22	culture	culture	NOUN
aji-155	141	23	system	system	NOUN
aji-155	141	24	(	(	PUNCT
aji-155	141	25	hirano	hirano	PROPN
aji-155	141	26	et	et	PROPN
aji-155	141	27	al	al	PROPN
aji-155	141	28	.	.	PROPN
aji-155	141	29	,	,	PUNCT
aji-155	141	30	2019	2019	NUM
aji-155	141	31	)	)	PUNCT
aji-155	141	32	.	.	PUNCT
aji-155	142	1	the	the	DET
aji-155	142	2	objective	objective	NOUN
aji-155	142	3	of	of	ADP
aji-155	142	4	the	the	DET
aji-155	142	5	present	present	ADJ
aji-155	142	6	work	work	NOUN
aji-155	142	7	was	be	AUX
aji-155	142	8	to	to	PART
aji-155	142	9	map	map	VERB
aji-155	142	10	immunogenicity	immunogenicity	NOUN
aji-155	142	11	of	of	ADP
aji-155	142	12	capsule	capsule	NOUN
aji-155	142	13	and	and	CCONJ
aji-155	142	14	outer	outer	ADJ
aji-155	142	15	membrane	membrane	NOUN
aji-155	142	16	proteins	protein	NOUN
aji-155	142	17	of	of	ADP
aji-155	142	18	h.	h.	PROPN
aji-155	142	19	infleunzae	infleunzae	PROPN
aji-155	142	20	b	b	PROPN
aji-155	142	21	local	local	ADJ
aji-155	142	22	isolate	isolate	NOUN
aji-155	142	23	.	.	PUNCT
aji-155	143	1	2	2	X
aji-155	143	2	.	.	X
aji-155	143	3	materials	material	NOUN
aji-155	143	4	and	and	CCONJ
aji-155	143	5	methods	method	NOUN
aji-155	143	6	2.1	2.1	NUM
aji-155	143	7	reviewer	reviewer	NOUN
aji-155	143	8	inquiry	inquiry	NOUN
aji-155	143	9	it	it	PRON
aji-155	143	10	is	be	AUX
aji-155	143	11	a	a	DET
aji-155	143	12	reviva	reviva	NOUN
aji-155	143	13	revista	revista	NOUN
aji-155	143	14	study	study	NOUN
aji-155	143	15	that	that	PRON
aji-155	143	16	has	have	AUX
aji-155	143	17	been	be	AUX
aji-155	143	18	a	a	DET
aji-155	143	19	part	part	NOUN
aji-155	143	20	of	of	ADP
aji-155	143	21	al	al	PROPN
aji-155	143	22	thahab	thahab	PROPN
aji-155	143	23	ph	ph	PROPN
aji-155	143	24	.	.	PROPN
aji-155	143	25	d.	d.	PROPN
aji-155	143	26	thesis	thesis	NOUN
aji-155	143	27	at	at	ADP
aji-155	143	28	2006	2006	NUM
aji-155	143	29	on	on	ADP
aji-155	143	30	hib	hib	PROPN
aji-155	143	31	meningitis	meningitis	PROPN
aji-155	143	32	;	;	PUNCT
aji-155	143	33	pathogenesis	pathogenesis	NOUN
aji-155	143	34	and	and	CCONJ
aji-155	143	35	immunology	immunology	NOUN
aji-155	143	36	in	in	ADP
aji-155	143	37	man	man	NOUN
aji-155	143	38	and	and	CCONJ
aji-155	143	39	laboratory	laboratory	NOUN
aji-155	143	40	animal	animal	NOUN
aji-155	143	41	.	.	PUNCT
aji-155	144	1	prof	prof	PROPN
aji-155	144	2	.	.	PUNCT
aji-155	145	1	shnawa	shnawa	PROPN
aji-155	145	2	and	and	CCONJ
aji-155	145	3	ass	ass	PROPN
aji-155	145	4	.	.	PUNCT
aji-155	145	5	prof	prof	PROPN
aji-155	145	6	.	.	PUNCT
aji-155	146	1	thewaini	thewaini	PROPN
aji-155	146	2	had	have	AUX
aji-155	146	3	been	be	AUX
aji-155	146	4	supervisor	supervisor	NOUN
aji-155	146	5	and	and	CCONJ
aji-155	146	6	coadvisor	coadvisor	NOUN
aji-155	146	7	.	.	PUNCT
aji-155	147	1	whereby	whereby	SCONJ
aji-155	147	2	had	have	AUX
aji-155	147	3	been	be	AUX
aji-155	147	4	faculty	faculty	NOUN
aji-155	147	5	membership	membership	NOUN
aji-155	147	6	at	at	ADP
aji-155	147	7	babylon	babylon	PROPN
aji-155	147	8	university	university	PROPN
aji-155	147	9	.	.	PUNCT
aji-155	148	1	2.2	2.2	NUM
aji-155	148	2	neuropathic	neuropathic	ADJ
aji-155	148	3	h.	h.	PROPN
aji-155	148	4	infleunzae	infleunzae	PROPN
aji-155	148	5	local	local	PROPN
aji-155	148	6	h.	h.	PROPN
aji-155	148	7	infleunzae	infleunzae	PROPN
aji-155	148	8	b	b	PROPN
aji-155	148	9	isolate	isolate	NOUN
aji-155	148	10	from	from	ADP
aji-155	148	11	a	a	DET
aji-155	148	12	clinically	clinically	ADV
aji-155	148	13	proven	prove	VERB
aji-155	148	14	human	human	ADJ
aji-155	148	15	meningitis	meningitis	NOUN
aji-155	148	16	cases	case	NOUN
aji-155	148	17	the	the	DET
aji-155	148	18	isolate	isolate	NOUN
aji-155	148	19	was	be	AUX
aji-155	148	20	,	,	PUNCT
aji-155	148	21	culturally	culturally	ADV
aji-155	148	22	and	and	CCONJ
aji-155	148	23	biochemically	biochemically	ADV
aji-155	148	24	characterized	characterize	VERB
aji-155	148	25	through	through	ADP
aji-155	148	26	classical	classical	ADJ
aji-155	148	27	and	and	CCONJ
aji-155	148	28	api20e	api20e	NUM
aji-155	148	29	system	system	NOUN
aji-155	148	30	.	.	PUNCT
aji-155	149	1	serotyped	serotype	VERB
aji-155	149	2	using	use	VERB
aji-155	149	3	difco	difco	NOUN
aji-155	149	4	,	,	PUNCT
aji-155	149	5	co	co	VERB
aji-155	149	6	,	,	PUNCT
aji-155	149	7	bdtm	bdtm	NOUN
aji-155	149	8	kit	kit	NOUN
aji-155	149	9	(	(	PUNCT
aji-155	149	10	gonzalez	gonzalez	PROPN
aji-155	149	11	&	&	CCONJ
aji-155	149	12	ledeboer	ledeboer	PROPN
aji-155	149	13	2023	2023	NUM
aji-155	149	14	)	)	PUNCT
aji-155	149	15	.	.	PUNCT
aji-155	150	1	2.3	2.3	NUM
aji-155	150	2	preparation	preparation	NOUN
aji-155	150	3	of	of	ADP
aji-155	150	4	immune	immune	ADJ
aji-155	150	5	reagents	reagent	NOUN
aji-155	150	6	the	the	DET
aji-155	150	7	capsule	capsule	NOUN
aji-155	150	8	was	be	AUX
aji-155	150	9	saparated	saparate	VERB
aji-155	150	10	,	,	PUNCT
aji-155	150	11	purified	purified	ADJ
aji-155	150	12	,	,	PUNCT
aji-155	150	13	identified	identify	VERB
aji-155	150	14	and	and	CCONJ
aji-155	150	15	quantified	quantify	VERB
aji-155	150	16	to	to	ADP
aji-155	150	17	the	the	DET
aji-155	150	18	concentration	concentration	NOUN
aji-155	150	19	of	of	ADP
aji-155	150	20	3	3	NUM
aji-155	150	21	mg	mg	NOUN
aji-155	150	22	/	/	SYM
aji-155	150	23	ml	ml	PROPN
aji-155	150	24	(	(	PUNCT
aji-155	150	25	kwapnski	kwapnski	PROPN
aji-155	150	26	,	,	PUNCT
aji-155	150	27	1972	1972	NUM
aji-155	150	28	)	)	PUNCT
aji-155	150	29	.	.	PUNCT
aji-155	151	1	omp	omp	PROPN
aji-155	151	2	was	be	AUX
aji-155	151	3	separated	separate	VERB
aji-155	151	4	,	,	PUNCT
aji-155	151	5	purified	purified	ADJ
aji-155	151	6	,	,	PUNCT
aji-155	151	7	identified	identify	VERB
aji-155	151	8	and	and	CCONJ
aji-155	151	9	quantified	quantify	VERB
aji-155	151	10	to	to	ADP
aji-155	151	11	the	the	DET
aji-155	151	12	concentration	concentration	NOUN
aji-155	151	13	of	of	ADP
aji-155	151	14	2.27	2.27	NUM
aji-155	151	15	mg	mg	NOUN
aji-155	151	16	/	/	SYM
aji-155	151	17	ml	ml	PROPN
aji-155	152	1	(	(	PUNCT
aji-155	152	2	catlin	catlin	PROPN
aji-155	152	3	et	et	PROPN
aji-155	152	4	al	al	PROPN
aji-155	152	5	.	.	PROPN
aji-155	152	6	,	,	PUNCT
aji-155	152	7	1972	1972	NUM
aji-155	152	8	)	)	PUNCT
aji-155	152	9	.	.	PUNCT
aji-155	153	1	sensitin	sensitin	NOUN
aji-155	153	2	was	be	AUX
aji-155	153	3	prepared	prepare	VERB
aji-155	153	4	as	as	ADP
aji-155	153	5	cell	cell	NOUN
aji-155	153	6	free	free	ADJ
aji-155	153	7	culture	culture	NOUN
aji-155	153	8	filtrates	filtrate	NOUN
aji-155	153	9	as	as	ADP
aji-155	153	10	in	in	ADP
aji-155	153	11	(	(	PUNCT
aji-155	153	12	shnawa	shnawa	PROPN
aji-155	153	13	&	&	CCONJ
aji-155	153	14	thewaini	thewaini	PROPN
aji-155	153	15	2002	2002	NUM
aji-155	153	16	)	)	PUNCT
aji-155	153	17	.	.	PUNCT
aji-155	154	1	2.4	2.4	NUM
aji-155	154	2	rabbits	rabbit	NOUN
aji-155	154	3	a	a	DET
aji-155	154	4	newzeland	newzeland	NOUN
aji-155	154	5	white	white	ADJ
aji-155	154	6	rabbits	rabbit	NOUN
aji-155	154	7	weighing	weigh	VERB
aji-155	154	8	11.5	11.5	NUM
aji-155	154	9	kgs	kg	NOUN
aji-155	154	10	were	be	AUX
aji-155	154	11	checked	check	VERB
aji-155	154	12	to	to	PART
aji-155	154	13	be	be	AUX
aji-155	154	14	free	free	ADJ
aji-155	154	15	of	of	ADP
aji-155	154	16	parasite	parasite	NOUN
aji-155	154	17	,	,	PUNCT
aji-155	154	18	bacteria	bacteria	NOUN
aji-155	154	19	,	,	PUNCT
aji-155	154	20	and	and	CCONJ
aji-155	154	21	antibodies	antibodie	VERB
aji-155	154	22	.	.	PUNCT
aji-155	155	1	these	these	DET
aji-155	155	2	rabbits	rabbit	NOUN
aji-155	155	3	were	be	AUX
aji-155	155	4	adapted	adapt	VERB
aji-155	155	5	to	to	ADP
aji-155	155	6	housing	housing	NOUN
aji-155	155	7	conditions	condition	NOUN
aji-155	155	8	for	for	ADP
aji-155	155	9	one	one	NUM
aji-155	155	10	week	week	NOUN
aji-155	155	11	and	and	CCONJ
aji-155	155	12	kept	keep	VERB
aji-155	155	13	ad	ad	NOUN
aji-155	155	14	libitum	libitum	PROPN
aji-155	155	15	conditions	condition	NOUN
aji-155	155	16	.	.	PUNCT
aji-155	156	1	they	they	PRON
aji-155	156	2	were	be	AUX
aji-155	156	3	grouped	group	VERB
aji-155	156	4	and	and	CCONJ
aji-155	156	5	assigned	assign	VERB
aji-155	156	6	into	into	ADP
aji-155	156	7	three	three	NUM
aji-155	156	8	groups	group	NOUN
aji-155	156	9	each	each	PRON
aji-155	156	10	of	of	ADP
aji-155	156	11	three	three	NUM
aji-155	156	12	.	.	PUNCT
aji-155	157	1	two	two	NUM
aji-155	157	2	test	test	NOUN
aji-155	157	3	groups	group	NOUN
aji-155	157	4	and	and	CCONJ
aji-155	157	5	one	one	NUM
aji-155	157	6	control	control	NOUN
aji-155	157	7	group	group	NOUN
aji-155	157	8	.	.	PUNCT
aji-155	158	1	shnawa	shnawa	PROPN
aji-155	158	2	et	et	PROPN
aji-155	158	3	al	al	PROPN
aji-155	158	4	.	.	PROPN
aji-155	158	5	;	;	PUNCT
aji-155	158	6	asian	asian	PROPN
aji-155	158	7	j.	j.	PROPN
aji-155	158	8	immunol	immunol	PROPN
aji-155	158	9	.	.	PROPN
aji-155	158	10	,	,	PUNCT
aji-155	158	11	vol	vol	NOUN
aji-155	158	12	.	.	PROPN
aji-155	158	13	8	8	NUM
aji-155	158	14	,	,	PUNCT
aji-155	158	15	no	no	INTJ
aji-155	158	16	.	.	NOUN
aji-155	158	17	1	1	NUM
aji-155	158	18	,	,	PUNCT
aji-155	158	19	pp	pp	ADJ
aji-155	158	20	.	.	PUNCT
aji-155	159	1	1	1	NUM
aji-155	159	2	-	-	SYM
aji-155	159	3	7	7	NUM
aji-155	159	4	,	,	PUNCT
aji-155	159	5	2025	2025	NUM
aji-155	159	6	;	;	PUNCT
aji-155	159	7	article	article	NOUN
aji-155	159	8	no.aji.129951	no.aji.129951	PART
aji-155	159	9	3	3	NUM
aji-155	159	10	2.5	2.5	NUM
aji-155	159	11	immunization	immunization	NOUN
aji-155	159	12	protocol	protocol	NOUN
aji-155	159	13	the	the	DET
aji-155	159	14	test	test	NOUN
aji-155	159	15	groups	group	NOUN
aji-155	159	16	were	be	AUX
aji-155	159	17	primed	prime	VERB
aji-155	159	18	with	with	ADP
aji-155	159	19	complete	complete	ADJ
aji-155	159	20	freund	freund	PROPN
aji-155	159	21	adjuvant	adjuvant	PROPN
aji-155	159	22	cfa	cfa	PROPN
aji-155	159	23	in	in	ADP
aji-155	159	24	a	a	DET
aji-155	159	25	rate	rate	NOUN
aji-155	159	26	of	of	ADP
aji-155	159	27	one	one	NUM
aji-155	159	28	ml	ml	NOUN
aji-155	159	29	for	for	ADP
aji-155	159	30	each	each	DET
aji-155	159	31	rabbit	rabbit	NOUN
aji-155	159	32	,	,	PUNCT
aji-155	159	33	control	control	NOUN
aji-155	159	34	group	group	NOUN
aji-155	159	35	was	be	AUX
aji-155	159	36	primed	prime	VERB
aji-155	159	37	with	with	ADP
aji-155	159	38	saline	saline	NOUN
aji-155	159	39	.	.	PUNCT
aji-155	160	1	test	test	NOUN
aji-155	160	2	and	and	CCONJ
aji-155	160	3	control	control	NOUN
aji-155	160	4	groups	group	NOUN
aji-155	160	5	were	be	AUX
aji-155	160	6	left	leave	VERB
aji-155	160	7	for	for	ADP
aji-155	160	8	two	two	NUM
aji-155	160	9	weeks	week	NOUN
aji-155	160	10	.	.	PUNCT
aji-155	161	1	after	after	ADP
aji-155	161	2	preconditioning	precondition	VERB
aji-155	161	3	with	with	ADP
aji-155	161	4	cfa	cfa	PROPN
aji-155	161	5	.	.	PUNCT
aji-155	162	1	one	one	NUM
aji-155	162	2	group	group	NOUN
aji-155	162	3	was	be	AUX
aji-155	162	4	primed	prime	VERB
aji-155	162	5	with	with	ADP
aji-155	162	6	capsule	capsule	NOUN
aji-155	162	7	,	,	PUNCT
aji-155	162	8	3	3	NUM
aji-155	162	9	mg	mg	PROPN
aji-155	162	10	/	/	SYM
aji-155	162	11	l.	l.	PROPN
aji-155	162	12	and	and	CCONJ
aji-155	162	13	the	the	DET
aji-155	162	14	other	other	ADJ
aji-155	162	15	with	with	ADP
aji-155	162	16	omp	omp	PROPN
aji-155	162	17	2.27	2.27	NUM
aji-155	162	18	mg	mg	PROPN
aji-155	162	19	/	/	SYM
aji-155	162	20	ml	ml	NOUN
aji-155	162	21	.	.	PUNCT
aji-155	163	1	in	in	ADP
aji-155	163	2	a	a	DET
aji-155	163	3	two	two	NUM
aji-155	163	4	weeks	week	NOUN
aji-155	163	5	apart	apart	ADP
aji-155	163	6	multisite	multisite	ADJ
aji-155	163	7	multiinjection	multiinjection	NOUN
aji-155	163	8	protocol	protocol	NOUN
aji-155	163	9	followed	follow	VERB
aji-155	163	10	by	by	ADP
aji-155	163	11	one	one	NUM
aji-155	163	12	weeek	weeek	NOUN
aji-155	163	13	leave	leave	VERB
aji-155	163	14	then	then	ADV
aji-155	163	15	test	test	NOUN
aji-155	163	16	bleed	bleed	NOUN
aji-155	163	17	(	(	PUNCT
aji-155	163	18	alshahery	alshahery	NOUN
aji-155	163	19	&	&	CCONJ
aji-155	163	20	shnawa	shnawa	PROPN
aji-155	163	21	1989	1989	NUM
aji-155	163	22	)	)	PUNCT
aji-155	163	23	.	.	PUNCT
aji-155	164	1	capsule	capsule	NOUN
aji-155	164	2	in	in	ADP
aji-155	164	3	3	3	NUM
aji-155	164	4	mg	mg	PROPN
aji-155	164	5	/	/	SYM
aji-155	164	6	l	l	NOUN
aji-155	164	7	......................	......................	PUNCT
aji-155	164	8	three	three	NUM
aji-155	164	9	rabbits	rabbit	NOUN
aji-155	164	10	outermemberane	outermemberane	VERB
aji-155	164	11	protein	protein	NOUN
aji-155	164	12	2.27	2.27	NUM
aji-155	164	13	mg	mg	PROPN
aji-155	164	14	/	/	SYM
aji-155	164	15	l	l	NOUN
aji-155	164	16	.....................	.....................	PUNCT
aji-155	164	17	three	three	NUM
aji-155	164	18	rabbits	rabbit	NOUN
aji-155	164	19	saline	saline	VERB
aji-155	164	20	sham	sham	ADJ
aji-155	164	21	control	control	NOUN
aji-155	164	22	....................	....................	PUNCT
aji-155	164	23	three	three	NUM
aji-155	164	24	rabbits	rabbit	NOUN
aji-155	164	25	2.6	2.6	NUM
aji-155	164	26	sampling	sample	VERB
aji-155	164	27	and	and	CCONJ
aji-155	164	28	processing	process	VERB
aji-155	164	29	blood	blood	NOUN
aji-155	164	30	samples	sample	NOUN
aji-155	164	31	were	be	AUX
aji-155	164	32	collected	collect	VERB
aji-155	164	33	from	from	ADP
aji-155	164	34	test	test	NOUN
aji-155	164	35	and	and	CCONJ
aji-155	164	36	control	control	NOUN
aji-155	164	37	rabbits	rabbit	NOUN
aji-155	164	38	by	by	ADP
aji-155	164	39	cardiac	cardiac	ADJ
aji-155	164	40	punctutre	punctutre	NOUN
aji-155	164	41	with	with	ADP
aji-155	164	42	a	a	DET
aji-155	164	43	rate	rate	NOUN
aji-155	164	44	of	of	ADP
aji-155	164	45	six	six	NUM
aji-155	164	46	mls	mls	NOUN
aji-155	164	47	from	from	ADP
aji-155	164	48	each	each	DET
aji-155	164	49	rabbit	rabbit	NOUN
aji-155	164	50	.	.	PUNCT
aji-155	165	1	samples	sample	NOUN
aji-155	165	2	were	be	AUX
aji-155	165	3	divided	divide	VERB
aji-155	165	4	into	into	ADP
aji-155	165	5	two	two	NUM
aji-155	165	6	parts	part	NOUN
aji-155	165	7	each	each	PRON
aji-155	165	8	of	of	ADP
aji-155	165	9	three	three	NUM
aji-155	165	10	mls	mls	PROPN
aji-155	165	11	amounts	amount	NOUN
aji-155	165	12	.	.	PUNCT
aji-155	166	1	tubes	tube	NOUN
aji-155	166	2	without	without	ADP
aji-155	166	3	anticoaggulant	anticoaggulant	NOUN
aji-155	166	4	and	and	CCONJ
aji-155	166	5	three	three	NUM
aji-155	166	6	mls	mls	PROPN
aji-155	166	7	.	.	PROPN
aji-155	166	8	,	,	PUNCT
aji-155	166	9	and	and	CCONJ
aji-155	166	10	tube	tube	NOUN
aji-155	166	11	with	with	ADP
aji-155	166	12	anticoaggulant	anticoaggulant	NOUN
aji-155	166	13	.	.	PUNCT
aji-155	167	1	sera	sera	PROPN
aji-155	167	2	were	be	AUX
aji-155	167	3	saved	save	VERB
aji-155	167	4	from	from	ADP
aji-155	167	5	samples	sample	NOUN
aji-155	167	6	without	without	ADP
aji-155	167	7	anticoaggulants	anticoaggulant	NOUN
aji-155	167	8	in	in	ADP
aji-155	167	9	a	a	DET
aji-155	167	10	rate	rate	NOUN
aji-155	167	11	of	of	ADP
aji-155	167	12	0.5	0.5	NUM
aji-155	167	13	ml	ml	NOUN
aji-155	167	14	amounts	amount	NOUN
aji-155	167	15	in	in	ADP
aji-155	167	16	an	an	DET
aji-155	167	17	append	append	NOUN
aji-155	167	18	roff	roff	NOUN
aji-155	167	19	tubes	tube	NOUN
aji-155	167	20	and	and	CCONJ
aji-155	167	21	kept	keep	VERB
aji-155	167	22	at	at	ADP
aji-155	167	23	18	18	NUM
aji-155	167	24	c.	c.	PROPN
aji-155	167	25	whole	whole	ADJ
aji-155	167	26	blood	blood	NOUN
aji-155	167	27	with	with	ADP
aji-155	167	28	anticoaggulant	anticoaggulant	NOUN
aji-155	167	29	uesed	uese	VERB
aji-155	167	30	for	for	ADP
aji-155	167	31	test	test	NOUN
aji-155	167	32	for	for	ADP
aji-155	167	33	leukocyte	leukocyte	NOUN
aji-155	167	34	inhibitory	inhibitory	ADJ
aji-155	167	35	factors	factor	NOUN
aji-155	167	36	by	by	ADP
aji-155	167	37	capillary	capillary	ADJ
aji-155	167	38	method	method	NOUN
aji-155	167	39	(	(	PUNCT
aji-155	167	40	soberg	soberg	NOUN
aji-155	167	41	,	,	PUNCT
aji-155	167	42	1969	1969	NUM
aji-155	167	43	)	)	PUNCT
aji-155	167	44	.	.	PUNCT
aji-155	168	1	appendecies	appendecie	NOUN
aji-155	168	2	were	be	AUX
aji-155	168	3	collected	collect	VERB
aji-155	168	4	from	from	ADP
aji-155	168	5	primed	primed	ADJ
aji-155	168	6	and	and	CCONJ
aji-155	168	7	control	control	NOUN
aji-155	168	8	rabbits	rabbit	NOUN
aji-155	168	9	.	.	PUNCT
aji-155	169	1	they	they	PRON
aji-155	169	2	were	be	AUX
aji-155	169	3	opened	open	VERB
aji-155	169	4	up	up	ADP
aji-155	169	5	,	,	PUNCT
aji-155	169	6	freed	free	VERB
aji-155	169	7	from	from	ADP
aji-155	169	8	digesta	digesta	NOUN
aji-155	169	9	and	and	CCONJ
aji-155	169	10	scrapped	scrap	VERB
aji-155	169	11	with	with	ADP
aji-155	169	12	sterile	sterile	ADJ
aji-155	169	13	clean	clean	ADJ
aji-155	169	14	scalpel	scalpel	NOUN
aji-155	169	15	to	to	PART
aji-155	169	16	remove	remove	VERB
aji-155	169	17	mucus	mucus	NOUN
aji-155	169	18	from	from	ADP
aji-155	169	19	the	the	DET
aji-155	169	20	mucosal	mucosal	NOUN
aji-155	169	21	surfaces	surface	NOUN
aji-155	169	22	.	.	PUNCT
aji-155	170	1	proportional	proportional	ADJ
aji-155	170	2	mucus	mucus	NOUN
aji-155	170	3	-	-	PUNCT
aji-155	170	4	saline	saline	NOUN
aji-155	170	5	were	be	AUX
aji-155	170	6	mixed	mix	VERB
aji-155	170	7	in	in	ADP
aji-155	170	8	a	a	DET
aji-155	170	9	sterile	sterile	ADJ
aji-155	170	10	petri	petri	ADJ
aji-155	170	11	-	-	PUNCT
aji-155	170	12	dish	dish	NOUN
aji-155	170	13	.	.	PUNCT
aji-155	171	1	mixtures	mixture	NOUN
aji-155	171	2	were	be	AUX
aji-155	171	3	tubbed	tubbe	VERB
aji-155	171	4	in	in	ADP
aji-155	171	5	centrifuge	centrifuge	NOUN
aji-155	171	6	tubes	tube	NOUN
aji-155	171	7	and	and	CCONJ
aji-155	171	8	centrifuged	centrifuge	VERB
aji-155	171	9	at	at	ADP
aji-155	171	10	5000	5000	NUM
aji-155	171	11	rpm	rpm	NOUN
aji-155	171	12	for	for	ADP
aji-155	171	13	ten	ten	NUM
aji-155	171	14	minutes	minute	NOUN
aji-155	171	15	.	.	PUNCT
aji-155	172	1	supenates	supenate	NOUN
aji-155	172	2	of	of	ADP
aji-155	172	3	three	three	NUM
aji-155	172	4	mls	mls	NOUN
aji-155	172	5	amounts	amount	NOUN
aji-155	172	6	were	be	AUX
aji-155	172	7	mixed	mix	VERB
aji-155	172	8	with	with	ADP
aji-155	172	9	equal	equal	ADJ
aji-155	172	10	amounts	amount	NOUN
aji-155	172	11	of	of	ADP
aji-155	172	12	peb	peb	PROPN
aji-155	172	13	6	6	NUM
aji-155	172	14	%	%	NOUN
aji-155	172	15	,	,	PUNCT
aji-155	172	16	6000	6000	NUM
aji-155	172	17	and	and	CCONJ
aji-155	172	18	left	leave	VERB
aji-155	172	19	at	at	ADP
aji-155	172	20	4	4	NUM
aji-155	172	21	c	c	NOUN
aji-155	172	22	for	for	ADP
aji-155	172	23	one	one	NUM
aji-155	172	24	hr	hr	NOUN
aji-155	172	25	and	and	CCONJ
aji-155	172	26	centrfuged	centrfuge	VERB
aji-155	172	27	for	for	ADP
aji-155	172	28	5000	5000	NUM
aji-155	172	29	rpm	rpm	NOUN
aji-155	172	30	for	for	ADP
aji-155	172	31	15	15	NUM
aji-155	172	32	minutes	minute	NOUN
aji-155	172	33	.	.	PUNCT
aji-155	173	1	precipitates	precipitate	NOUN
aji-155	173	2	were	be	AUX
aji-155	173	3	saved	save	VERB
aji-155	173	4	and	and	CCONJ
aji-155	173	5	reconstituted	reconstitute	VERB
aji-155	173	6	with	with	ADP
aji-155	173	7	sterile	sterile	ADJ
aji-155	173	8	formal	formal	ADJ
aji-155	173	9	normal	normal	ADJ
aji-155	173	10	saline	saline	NOUN
aji-155	173	11	(	(	PUNCT
aji-155	173	12	shnawa	shnawa	PROPN
aji-155	173	13	&	&	CCONJ
aji-155	173	14	thewaini	thewaini	PROPN
aji-155	173	15	2002	2002	NUM
aji-155	173	16	)	)	PUNCT
aji-155	173	17	.	.	PUNCT
aji-155	174	1	2.7	2.7	NUM
aji-155	174	2	immune	immune	ADJ
aji-155	174	3	function	function	NOUN
aji-155	174	4	tests	test	VERB
aji-155	174	5	the	the	DET
aji-155	174	6	anticapsular	anticapsular	ADJ
aji-155	174	7	antisera	antisera	NOUN
aji-155	174	8	and	and	CCONJ
aji-155	174	9	mucosal	mucosal	NOUN
aji-155	174	10	globulin	globulin	NOUN
aji-155	174	11	were	be	AUX
aji-155	174	12	titrated	titrate	VERB
aji-155	174	13	with	with	ADP
aji-155	174	14	capsule	capsule	ADJ
aji-155	174	15	antigen	antigen	NOUN
aji-155	174	16	using	use	VERB
aji-155	174	17	capillary	capillary	ADJ
aji-155	174	18	tube	tube	NOUN
aji-155	174	19	precipitation	precipitation	NOUN
aji-155	174	20	test	test	NOUN
aji-155	174	21	(	(	PUNCT
aji-155	174	22	turgeon	turgeon	NOUN
aji-155	174	23	,	,	PUNCT
aji-155	174	24	2020	2020	NUM
aji-155	174	25	)	)	PUNCT
aji-155	174	26	.	.	PUNCT
aji-155	175	1	the	the	DET
aji-155	175	2	anti	anti	PROPN
aji-155	175	3	omp	omp	PROPN
aji-155	175	4	antisera	antisera	PROPN
aji-155	175	5	and	and	CCONJ
aji-155	175	6	mucosal	mucosal	NOUN
aji-155	175	7	globulin	globulin	NOUN
aji-155	175	8	were	be	AUX
aji-155	175	9	titrated	titrate	VERB
aji-155	175	10	with	with	ADP
aji-155	175	11	omp	omp	PROPN
aji-155	175	12	coated	coat	VERB
aji-155	175	13	tanned	tan	VERB
aji-155	175	14	sheep	sheep	NOUN
aji-155	175	15	red	red	ADJ
aji-155	175	16	cells	cell	NOUN
aji-155	175	17	by	by	ADP
aji-155	175	18	micro	micro	PROPN
aji-155	175	19	hemagglutination	hemagglutination	PROPN
aji-155	175	20	test	test	NOUN
aji-155	175	21	(	(	PUNCT
aji-155	175	22	joshi	joshi	PROPN
aji-155	175	23	&	&	CCONJ
aji-155	175	24	chauhan	chauhan	PROPN
aji-155	175	25	2022	2022	NUM
aji-155	175	26	)	)	PUNCT
aji-155	175	27	.	.	PUNCT
aji-155	176	1	mucus	mucus	NOUN
aji-155	176	2	-	-	PUNCT
aji-155	176	3	saline	saline	NOUN
aji-155	176	4	mixture	mixture	NOUN
aji-155	176	5	was	be	AUX
aji-155	176	6	mixed	mix	VERB
aji-155	176	7	with	with	ADP
aji-155	176	8	dextran	dextran	ADJ
aji-155	176	9	solutions	solution	NOUN
aji-155	176	10	in	in	ADP
aji-155	176	11	an	an	DET
aji-155	176	12	equal	equal	ADJ
aji-155	176	13	amounts	amount	NOUN
aji-155	176	14	for	for	ADP
aji-155	176	15	separation	separation	NOUN
aji-155	176	16	of	of	ADP
aji-155	176	17	mucosal	mucosal	NOUN
aji-155	176	18	leukocytes	leukocyte	NOUN
aji-155	176	19	as	as	ADP
aji-155	176	20	in	in	ADP
aji-155	176	21	metcalf	metcalf	PROPN
aji-155	176	22	et	et	PROPN
aji-155	176	23	al	al	PROPN
aji-155	176	24	.	.	PROPN
aji-155	177	1	(	(	PUNCT
aji-155	177	2	1986	1986	NUM
aji-155	177	3	)	)	PUNCT
aji-155	177	4	.	.	PUNCT
aji-155	178	1	systemic	systemic	ADJ
aji-155	178	2	and	and	CCONJ
aji-155	178	3	mucosal	mucosal	ADJ
aji-155	178	4	leukocyte	leukocyte	NOUN
aji-155	178	5	inhibitory	inhibitory	ADJ
aji-155	178	6	factor	factor	NOUN
aji-155	178	7	was	be	AUX
aji-155	178	8	done	do	VERB
aji-155	178	9	by	by	ADP
aji-155	178	10	capillary	capillary	ADJ
aji-155	178	11	method	method	NOUN
aji-155	178	12	as	as	ADP
aji-155	178	13	in	in	ADP
aji-155	178	14	soberg	soberg	PROPN
aji-155	178	15	(	(	PUNCT
aji-155	178	16	1969	1969	NUM
aji-155	178	17	)	)	PUNCT
aji-155	178	18	.	.	PUNCT
aji-155	179	1	3	3	X
aji-155	179	2	.	.	NOUN
aji-155	179	3	results	result	VERB
aji-155	179	4	3.1	3.1	NUM
aji-155	179	5	baseline	baseline	ADJ
aji-155	179	6	immune	immune	ADJ
aji-155	179	7	functions	function	NOUN
aji-155	179	8	control	control	NOUN
aji-155	179	9	rabbits	rabbit	NOUN
aji-155	179	10	reveals	reveal	VERB
aji-155	179	11	the	the	DET
aji-155	179	12	normal	normal	ADJ
aji-155	179	13	baseline	baseline	ADJ
aji-155	179	14	immune	immune	ADJ
aji-155	179	15	functions	function	NOUN
aji-155	179	16	in	in	ADP
aji-155	179	17	this	this	DET
aji-155	179	18	experimental	experimental	ADJ
aji-155	179	19	settings	setting	NOUN
aji-155	179	20	.	.	PUNCT
aji-155	180	1	the	the	DET
aji-155	180	2	serum	serum	NOUN
aji-155	180	3	globulin	globulin	NOUN
aji-155	180	4	protein	protein	NOUN
aji-155	180	5	concentration	concentration	NOUN
aji-155	180	6	was	be	AUX
aji-155	180	7	6.75	6.75	NUM
aji-155	180	8	g	g	NOUN
aji-155	180	9	/	/	SYM
aji-155	180	10	l.	l.	NOUN
aji-155	180	11	while	while	SCONJ
aji-155	180	12	,	,	PUNCT
aji-155	180	13	the	the	DET
aji-155	180	14	normal	normal	ADJ
aji-155	180	15	appendex	appendex	NOUN
aji-155	180	16	glubulin	glubulin	PROPN
aji-155	180	17	protein	protein	NOUN
aji-155	180	18	concentration	concentration	NOUN
aji-155	180	19	was	be	AUX
aji-155	180	20	0.425	0.425	NUM
aji-155	180	21	g	g	NOUN
aji-155	180	22	/	/	SYM
aji-155	180	23	l.	l.	PROPN
aji-155	180	24	natural	natural	PROPN
aji-155	180	25	serum	serum	PROPN
aji-155	180	26	baseline	baseline	PROPN
aji-155	180	27	titre	titre	NOUN
aji-155	180	28	mean	mean	VERB
aji-155	180	29	was	be	AUX
aji-155	180	30	10	10	NUM
aji-155	180	31	both	both	CCONJ
aji-155	180	32	for	for	ADP
aji-155	180	33	anticapsular	anticapsular	ADJ
aji-155	180	34	and	and	CCONJ
aji-155	180	35	anti	anti	ADJ
aji-155	180	36	-	-	ADJ
aji-155	180	37	omp	omp	ADJ
aji-155	180	38	antibodies	antibody	NOUN
aji-155	180	39	and	and	CCONJ
aji-155	180	40	normal	normal	ADJ
aji-155	180	41	mucosal	mucosal	ADJ
aji-155	180	42	globulin	globulin	NOUN
aji-155	180	43	concentration	concentration	NOUN
aji-155	180	44	were	be	AUX
aji-155	180	45	0.425	0.425	NUM
aji-155	180	46	and	and	CCONJ
aji-155	180	47	0.4g	0.4g	PROPN
aji-155	180	48	/	/	SYM
aji-155	180	49	l.	l.	NOUN
aji-155	180	50	both	both	PRON
aji-155	180	51	for	for	ADP
aji-155	180	52	anti	anti	ADJ
aji-155	180	53	-	-	ADJ
aji-155	180	54	capsular	capsular	ADJ
aji-155	180	55	and	and	CCONJ
aji-155	180	56	anti	anti	ADJ
aji-155	180	57	-	-	ADJ
aji-155	180	58	omp	omp	ADJ
aji-155	180	59	antibodies	antibodie	VERB
aji-155	180	60	.	.	PUNCT
aji-155	181	1	while	while	SCONJ
aji-155	181	2	the	the	DET
aji-155	181	3	normal	normal	ADJ
aji-155	181	4	leukocyte	leukocyte	NOUN
aji-155	181	5	inhibitory	inhibitory	ADJ
aji-155	181	6	factor	factor	NOUN
aji-155	181	7	cytokines	cytokine	NOUN
aji-155	181	8	were	be	AUX
aji-155	181	9	ranging	range	VERB
aji-155	181	10	between	between	ADP
aji-155	181	11	0.95	0.95	NUM
aji-155	181	12	and	and	CCONJ
aji-155	181	13	0.97	0.97	NUM
aji-155	181	14	%	%	NOUN
aji-155	181	15	.	.	PUNCT
aji-155	182	1	3.2	3.2	NUM
aji-155	182	2	cellular	cellular	ADJ
aji-155	182	3	immune	immune	ADJ
aji-155	182	4	conversion	conversion	NOUN
aji-155	182	5	specific	specific	ADJ
aji-155	182	6	omp	omp	PROPN
aji-155	182	7	priming	priming	NOUN
aji-155	182	8	to	to	ADP
aji-155	182	9	rabbits	rabbit	NOUN
aji-155	182	10	lead	lead	VERB
aji-155	182	11	to	to	ADP
aji-155	182	12	nonsignificant	nonsignificant	ADJ
aji-155	182	13	leukocyte	leukocyte	NOUN
aji-155	182	14	inhibitory	inhibitory	ADJ
aji-155	182	15	factor	factor	NOUN
aji-155	182	16	cytokines	cytokine	NOUN
aji-155	182	17	and	and	CCONJ
aji-155	182	18	mild	mild	ADJ
aji-155	182	19	leukocyte	leukocyte	NOUN
aji-155	182	20	stimulatory	stimulatory	ADJ
aji-155	182	21	factor	factor	NOUN
aji-155	182	22	cytokines	cytokine	NOUN
aji-155	182	23	in	in	ADP
aji-155	182	24	one	one	NUM
aji-155	182	25	rabbit	rabbit	NOUN
aji-155	182	26	replicate	replicate	VERB
aji-155	182	27	both	both	PRON
aji-155	182	28	at	at	ADP
aji-155	182	29	mucosal	mucosal	NOUN
aji-155	182	30	and	and	CCONJ
aji-155	182	31	systemic	systemic	ADJ
aji-155	182	32	responses	response	NOUN
aji-155	182	33	.	.	PUNCT
aji-155	183	1	specific	specific	ADJ
aji-155	183	2	capsular	capsular	NOUN
aji-155	183	3	primed	prime	VERB
aji-155	183	4	rabbits	rabbit	NOUN
aji-155	183	5	have	have	AUX
aji-155	183	6	shown	show	VERB
aji-155	183	7	leukocyte	leukocyte	NOUN
aji-155	183	8	stimulatory	stimulatory	ADJ
aji-155	183	9	factor	factor	NOUN
aji-155	183	10	cytokines	cytokine	NOUN
aji-155	183	11	as	as	SCONJ
aji-155	183	12	compared	compare	VERB
aji-155	183	13	to	to	ADP
aji-155	183	14	lif	lif	PROPN
aji-155	183	15	of	of	ADP
aji-155	183	16	normal	normal	ADJ
aji-155	183	17	baseline	baseline	ADJ
aji-155	183	18	immune	immune	ADJ
aji-155	183	19	functions	function	NOUN
aji-155	183	20	.	.	PUNCT
aji-155	184	1	omp	omp	PROPN
aji-155	184	2	and	and	CCONJ
aji-155	184	3	capsular	capsular	ADJ
aji-155	184	4	immune	immune	ADJ
aji-155	184	5	primied	primie	VERB
aji-155	184	6	rabbits	rabbit	NOUN
aji-155	184	7	indicate	indicate	VERB
aji-155	184	8	cellular	cellular	ADJ
aji-155	184	9	immune	immune	ADJ
aji-155	184	10	conversion	conversion	NOUN
aji-155	184	11	than	than	ADP
aji-155	184	12	that	that	PRON
aji-155	184	13	of	of	ADP
aji-155	184	14	basline	basline	ADJ
aji-155	184	15	cellular	cellular	ADJ
aji-155	184	16	immune	immune	ADJ
aji-155	184	17	functions	function	NOUN
aji-155	184	18	,	,	PUNCT
aji-155	184	19	table	table	NOUN
aji-155	184	20	1	1	NUM
aji-155	184	21	.	.	SYM
aji-155	184	22	3.3	3.3	NUM
aji-155	184	23	delayed	delay	VERB
aji-155	184	24	allergenic	allergenic	ADJ
aji-155	184	25	immune	immune	ADJ
aji-155	184	26	conversion	conversion	NOUN
aji-155	184	27	at	at	ADP
aji-155	184	28	72	72	NUM
aji-155	184	29	hrs	hrs	NOUN
aji-155	184	30	post	post	NOUN
aji-155	184	31	-	-	NOUN
aji-155	184	32	sensitization	sensitization	NOUN
aji-155	184	33	with	with	ADP
aji-155	184	34	the	the	DET
aji-155	184	35	skin	skin	NOUN
aji-155	184	36	sensitins	sensitin	NOUN
aji-155	184	37	cfcf	cfcf	VERB
aji-155	184	38	through	through	ADP
aji-155	184	39	intradermal	intradermal	ADJ
aji-155	184	40	injection	injection	NOUN
aji-155	184	41	of	of	ADP
aji-155	184	42	the	the	DET
aji-155	184	43	primed	prime	VERB
aji-155	184	44	rabbits	rabbit	NOUN
aji-155	184	45	.	.	PUNCT
aji-155	185	1	neither	neither	CCONJ
aji-155	185	2	classical	classical	ADJ
aji-155	185	3	dth	dth	ADJ
aji-155	185	4	nor	nor	CCONJ
aji-155	185	5	jone	jone	PROPN
aji-155	185	6	-	-	PUNCT
aji-155	185	7	moote	moote	PROPN
aji-155	185	8	reaction	reaction	NOUN
aji-155	185	9	noted	note	VERB
aji-155	185	10	in	in	ADP
aji-155	185	11	both	both	PRON
aji-155	185	12	of	of	ADP
aji-155	185	13	the	the	DET
aji-155	185	14	primed	prime	VERB
aji-155	185	15	groups	group	NOUN
aji-155	185	16	.	.	PUNCT
aji-155	186	1	this	this	PRON
aji-155	186	2	may	may	AUX
aji-155	186	3	indicate	indicate	VERB
aji-155	186	4	that	that	SCONJ
aji-155	186	5	there	there	PRON
aji-155	186	6	were	be	VERB
aji-155	186	7	no	no	DET
aji-155	186	8	delayed	delay	VERB
aji-155	186	9	allergenic	allergenic	ADJ
aji-155	186	10	immune	immune	ADJ
aji-155	186	11	conversion	conversion	NOUN
aji-155	186	12	in	in	ADP
aji-155	186	13	these	these	DET
aji-155	186	14	immune	immune	ADJ
aji-155	186	15	primed	prime	VERB
aji-155	186	16	test	test	NOUN
aji-155	186	17	rabbits	rabbit	NOUN
aji-155	186	18	table	table	NOUN
aji-155	186	19	1	1	NUM
aji-155	186	20	.	.	NOUN
aji-155	186	21	3.4	3.4	NUM
aji-155	186	22	humoral	humoral	ADJ
aji-155	186	23	immune	immune	ADJ
aji-155	186	24	conversion	conversion	NOUN
aji-155	186	25	the	the	DET
aji-155	186	26	mean	mean	NOUN
aji-155	186	27	of	of	ADP
aji-155	186	28	serum	serum	NOUN
aji-155	186	29	anticapsular	anticapsular	ADJ
aji-155	186	30	antibody	antibody	NOUN
aji-155	186	31	titre	titre	NOUN
aji-155	186	32	was	be	AUX
aji-155	186	33	533.3	533.3	NUM
aji-155	186	34	compared	compare	VERB
aji-155	186	35	to	to	ADP
aji-155	186	36	the	the	DET
aji-155	186	37	baseline	baseline	ADJ
aji-155	186	38	humoral	humoral	ADJ
aji-155	186	39	immune	immune	ADJ
aji-155	186	40	function	function	NOUN
aji-155	186	41	was	be	AUX
aji-155	186	42	10	10	NUM
aji-155	186	43	.	.	PUNCT
aji-155	187	1	while	while	SCONJ
aji-155	187	2	,	,	PUNCT
aji-155	187	3	the	the	DET
aji-155	187	4	mucosal	mucosal	ADJ
aji-155	187	5	anti	anti	ADJ
aji-155	187	6	-	-	ADJ
aji-155	187	7	capsular	capsular	ADJ
aji-155	187	8	antibody	antibody	NOUN
aji-155	187	9	mean	mean	NOUN
aji-155	187	10	titre	titre	NOUN
aji-155	187	11	was	be	AUX
aji-155	187	12	42.66	42.66	NUM
aji-155	187	13	.	.	PUNCT
aji-155	188	1	as	as	SCONJ
aji-155	188	2	compare	compare	VERB
aji-155	188	3	to	to	ADP
aji-155	188	4	normal	normal	ADJ
aji-155	188	5	humoral	humoral	ADJ
aji-155	188	6	baseline	baseline	ADJ
aji-155	188	7	immune	immune	ADJ
aji-155	188	8	function	function	NOUN
aji-155	188	9	was	be	AUX
aji-155	188	10	2	2	NUM
aji-155	188	11	.	.	PUNCT
aji-155	189	1	in	in	ADP
aji-155	189	2	other	other	ADJ
aji-155	189	3	word	word	NOUN
aji-155	189	4	five	five	NUM
aji-155	189	5	folds	fold	NOUN
aji-155	189	6	increase	increase	NOUN
aji-155	189	7	folds	fold	NOUN
aji-155	189	8	increase	increase	VERB
aji-155	189	9	inthe	inthe	PRON
aji-155	189	10	serum	serum	NOUN
aji-155	189	11	titer	titer	NOUN
aji-155	189	12	means	mean	NOUN
aji-155	189	13	and	and	CCONJ
aji-155	189	14	four	four	NUM
aji-155	189	15	folds	fold	NOUN
aji-155	189	16	in	in	ADP
aji-155	189	17	the	the	DET
aji-155	189	18	mucosa	mucosa	NOUN
aji-155	189	19	mean	mean	NOUN
aji-155	189	20	titres	titre	NOUN
aji-155	189	21	.	.	PUNCT
aji-155	190	1	while	while	SCONJ
aji-155	190	2	,	,	PUNCT
aji-155	190	3	the	the	DET
aji-155	190	4	mean	mean	NOUN
aji-155	190	5	serum	serum	NOUN
aji-155	190	6	anti	anti	ADJ
aji-155	190	7	-	-	ADJ
aji-155	190	8	omp	omp	ADJ
aji-155	190	9	titre	titre	NOUN
aji-155	190	10	was	be	AUX
aji-155	190	11	853.3	853.3	NUM
aji-155	190	12	compared	compare	VERB
aji-155	190	13	to	to	ADP
aji-155	190	14	normal	normal	ADJ
aji-155	190	15	baseline	baseline	NOUN
aji-155	190	16	function	function	NOUN
aji-155	190	17	mean	mean	NOUN
aji-155	190	18	titre	titre	NOUN
aji-155	190	19	was	be	AUX
aji-155	190	20	10	10	NUM
aji-155	190	21	.	.	PUNCT
aji-155	191	1	the	the	DET
aji-155	191	2	mucosal	mucosal	ADJ
aji-155	191	3	anti	anti	ADJ
aji-155	191	4	-	-	ADJ
aji-155	191	5	omp	omp	ADJ
aji-155	191	6	mean	mean	NOUN
aji-155	191	7	titre	titre	NOUN
aji-155	191	8	was	be	AUX
aji-155	191	9	85.33	85.33	NUM
aji-155	191	10	compared	compare	VERB
aji-155	191	11	to	to	ADP
aji-155	191	12	normal	normal	ADJ
aji-155	191	13	baseline	baseline	ADJ
aji-155	191	14	humoral	humoral	ADJ
aji-155	191	15	immune	immune	ADJ
aji-155	191	16	fuction	fuction	NOUN
aji-155	191	17	was	be	AUX
aji-155	191	18	2	2	NUM
aji-155	191	19	.	.	PUNCT
aji-155	191	20	that	that	PRON
aji-155	191	21	is	be	AUX
aji-155	191	22	to	to	PART
aji-155	191	23	say	say	VERB
aji-155	191	24	six	six	NUM
aji-155	191	25	folds	fold	NOUN
aji-155	191	26	increase	increase	NOUN
aji-155	191	27	in	in	ADP
aji-155	191	28	shnawa	shnawa	PROPN
aji-155	191	29	et	et	PROPN
aji-155	191	30	al	al	PROPN
aji-155	191	31	.	.	PROPN
aji-155	191	32	;	;	PUNCT
aji-155	191	33	asian	asian	PROPN
aji-155	191	34	j.	j.	PROPN
aji-155	191	35	immunol	immunol	PROPN
aji-155	191	36	.	.	PROPN
aji-155	191	37	,	,	PUNCT
aji-155	191	38	vol	vol	NOUN
aji-155	191	39	.	.	PROPN
aji-155	191	40	8	8	NUM
aji-155	191	41	,	,	PUNCT
aji-155	191	42	no	no	INTJ
aji-155	191	43	.	.	NOUN
aji-155	191	44	1	1	NUM
aji-155	191	45	,	,	PUNCT
aji-155	191	46	pp	pp	ADJ
aji-155	191	47	.	.	PUNCT
aji-155	192	1	1	1	NUM
aji-155	192	2	-	-	SYM
aji-155	192	3	7	7	NUM
aji-155	192	4	,	,	PUNCT
aji-155	192	5	2025	2025	NUM
aji-155	192	6	;	;	PUNCT
aji-155	192	7	article	article	NOUN
aji-155	192	8	no.aji.129951	no.aji.129951	PROPN
aji-155	192	9	4	4	NUM
aji-155	192	10	serum	serum	NOUN
aji-155	192	11	and	and	CCONJ
aji-155	192	12	five	five	NUM
aji-155	192	13	folds	fold	NOUN
aji-155	192	14	i	i	PRON
aji-155	192	15	m	m	VERB
aji-155	192	16	mucosal	mucosal	ADJ
aji-155	192	17	anti	anti	ADJ
aji-155	192	18	-	-	ADJ
aji-155	192	19	omp	omp	ADJ
aji-155	192	20	antibodies	antibodie	VERB
aji-155	192	21	.	.	PUNCT
aji-155	193	1	the	the	DET
aji-155	193	2	folds	fold	NOUN
aji-155	193	3	increase	increase	VERB
aji-155	193	4	in	in	ADP
aji-155	193	5	mean	mean	ADJ
aji-155	193	6	antibody	antibody	NOUN
aji-155	193	7	titres	titre	NOUN
aji-155	193	8	in	in	ADP
aji-155	193	9	serum	serum	NOUN
aji-155	193	10	and	and	CCONJ
aji-155	193	11	in	in	ADP
aji-155	193	12	mucosa	mucosa	NOUN
aji-155	193	13	indicated	indicate	VERB
aji-155	193	14	humoral	humoral	ADJ
aji-155	193	15	immune	immune	ADJ
aji-155	193	16	conversions	conversion	NOUN
aji-155	193	17	,	,	PUNCT
aji-155	193	18	table	table	NOUN
aji-155	193	19	2	2	NUM
aji-155	193	20	.	.	NOUN
aji-155	193	21	4	4	NUM
aji-155	193	22	.	.	X
aji-155	193	23	discussion	discussion	NOUN
aji-155	193	24	the	the	DET
aji-155	193	25	omp	omp	NOUN
aji-155	193	26	and	and	CCONJ
aji-155	193	27	capsular	capsular	VERB
aji-155	193	28	polysaccharide	polysaccharide	NOUN
aji-155	193	29	of	of	ADP
aji-155	193	30	h.	h.	PROPN
aji-155	193	31	influenzae	influenzae	PROPN
aji-155	193	32	b	b	PROPN
aji-155	193	33	are	be	AUX
aji-155	193	34	;	;	PUNCT
aji-155	193	35	pathogenicity	pathogenicity	NOUN
aji-155	193	36	determnant	determnant	NOUN
aji-155	193	37	,	,	PUNCT
aji-155	193	38	virulence	virulence	NOUN
aji-155	193	39	associated	associate	VERB
aji-155	193	40	antigens	antigen	NOUN
aji-155	193	41	and	and	CCONJ
aji-155	193	42	virulence	virulence	NOUN
aji-155	193	43	factor	factor	NOUN
aji-155	193	44	.	.	PUNCT
aji-155	194	1	so	so	ADV
aji-155	194	2	both	both	PRON
aji-155	194	3	in	in	ADP
aji-155	194	4	conjugate	conjugate	ADJ
aji-155	194	5	state	state	NOUN
aji-155	194	6	or	or	CCONJ
aji-155	194	7	in	in	ADP
aji-155	194	8	separate	separate	ADJ
aji-155	194	9	state	state	NOUN
aji-155	194	10	they	they	PRON
aji-155	194	11	are	be	AUX
aji-155	194	12	standing	stand	VERB
aji-155	194	13	as	as	ADP
aji-155	194	14	targets	target	NOUN
aji-155	194	15	for	for	ADP
aji-155	194	16	vaccine	vaccine	NOUN
aji-155	194	17	candidates	candidate	NOUN
aji-155	194	18	and	and	CCONJ
aji-155	194	19	human	human	ADJ
aji-155	194	20	approved	approve	VERB
aji-155	194	21	vaccines	vaccine	NOUN
aji-155	194	22	in	in	ADP
aji-155	194	23	more	more	ADJ
aji-155	194	24	than	than	ADP
aji-155	194	25	one	one	NUM
aji-155	194	26	vaccine	vaccine	NOUN
aji-155	194	27	qualifying	qualify	VERB
aji-155	194	28	boards	board	NOUN
aji-155	194	29	all	all	ADV
aji-155	194	30	over	over	ADP
aji-155	194	31	the	the	DET
aji-155	194	32	world	world	NOUN
aji-155	194	33	(	(	PUNCT
aji-155	194	34	shnawa	shnawa	PROPN
aji-155	194	35	,	,	PUNCT
aji-155	194	36	2019	2019	NUM
aji-155	194	37	)	)	PUNCT
aji-155	194	38	.	.	PUNCT
aji-155	195	1	in	in	ADP
aji-155	195	2	the	the	DET
aji-155	195	3	present	present	ADJ
aji-155	195	4	communication	communication	NOUN
aji-155	195	5	tempts	tempt	VERB
aji-155	195	6	to	to	PART
aji-155	195	7	investigate	investigate	VERB
aji-155	195	8	immunogenicity	immunogenicity	NOUN
aji-155	195	9	of	of	ADP
aji-155	195	10	subcellular	subcellular	ADJ
aji-155	195	11	fractions	fraction	NOUN
aji-155	195	12	of	of	ADP
aji-155	195	13	local	local	ADJ
aji-155	195	14	neurotropic	neurotropic	ADJ
aji-155	195	15	neurogenic	neurogenic	ADJ
aji-155	195	16	h.	h.	PROPN
aji-155	195	17	infleunzae	infleunzae	PROPN
aji-155	195	18	b.	b.	PROPN
aji-155	196	1	these	these	DET
aji-155	196	2	subfractions	subfraction	NOUN
aji-155	196	3	are	be	AUX
aji-155	196	4	;	;	PUNCT
aji-155	196	5	capsule	capsule	NOUN
aji-155	196	6	and	and	CCONJ
aji-155	196	7	omp	omp	PROPN
aji-155	196	8	in	in	ADP
aji-155	196	9	a	a	DET
aji-155	196	10	lapin	lapin	NOUN
aji-155	196	11	model	model	NOUN
aji-155	196	12	,	,	PUNCT
aji-155	196	13	tables	table	VERB
aji-155	196	14	1	1	NUM
aji-155	196	15	&	&	CCONJ
aji-155	196	16	2	2	NUM
aji-155	196	17	.	.	PUNCT
aji-155	197	1	the	the	DET
aji-155	197	2	specific	specific	ADJ
aji-155	197	3	immune	immune	ADJ
aji-155	197	4	priming	prime	VERB
aji-155	197	5	protocols	protocol	NOUN
aji-155	197	6	tempts	tempt	VERB
aji-155	197	7	to	to	PART
aji-155	197	8	precondition	precondition	VERB
aji-155	197	9	rabbits	rabbit	NOUN
aji-155	197	10	with	with	ADP
aji-155	197	11	freund	freund	PROPN
aji-155	197	12	complete	complete	ADJ
aji-155	197	13	adjuvant	adjuvant	PROPN
aji-155	197	14	cfa	cfa	PROPN
aji-155	197	15	for	for	ADP
aji-155	197	16	a	a	DET
aji-155	197	17	period	period	NOUN
aji-155	197	18	of	of	ADP
aji-155	197	19	two	two	NUM
aji-155	197	20	weeks	week	NOUN
aji-155	197	21	that	that	SCONJ
aji-155	197	22	provok	provok	ADJ
aji-155	197	23	non	non	ADJ
aji-155	197	24	-	-	ADJ
aji-155	197	25	specific	specific	ADJ
aji-155	197	26	immune	immune	ADJ
aji-155	197	27	stimulation	stimulation	NOUN
aji-155	197	28	to	to	ADP
aji-155	197	29	both	both	PRON
aji-155	197	30	of	of	ADP
aji-155	197	31	innate	innate	ADJ
aji-155	197	32	and	and	CCONJ
aji-155	197	33	adaptive	adaptive	ADJ
aji-155	197	34	immune	immune	ADJ
aji-155	197	35	cells	cell	NOUN
aji-155	197	36	(	(	PUNCT
aji-155	197	37	alshahery	alshahery	NOUN
aji-155	197	38	&	&	CCONJ
aji-155	197	39	shnawa	shnawa	PROPN
aji-155	197	40	1989	1989	NUM
aji-155	197	41	)	)	PUNCT
aji-155	197	42	.	.	PUNCT
aji-155	198	1	as	as	ADP
aji-155	198	2	a	a	DET
aji-155	198	3	pre	pre	ADJ
aji-155	198	4	-	-	ADJ
aji-155	198	5	immunization	immunization	ADJ
aji-155	198	6	adjuvant	adjuvant	NOUN
aji-155	198	7	followed	follow	VERB
aji-155	198	8	by	by	ADP
aji-155	198	9	two	two	NUM
aji-155	198	10	weeks	week	NOUN
aji-155	198	11	apart	apart	ADV
aji-155	198	12	b	b	X
aji-155	198	13	capsular	capsular	VERB
aji-155	198	14	antigen	antigen	ADV
aji-155	198	15	in	in	ADP
aji-155	198	16	separate	separate	ADJ
aji-155	198	17	and	and	CCONJ
aji-155	198	18	omp	omp	ADJ
aji-155	198	19	antigen	antigen	NOUN
aji-155	198	20	in	in	ADP
aji-155	198	21	separate	separate	ADJ
aji-155	198	22	rabbit	rabbit	NOUN
aji-155	198	23	groups	group	NOUN
aji-155	198	24	.	.	PUNCT
aji-155	199	1	this	this	PRON
aji-155	199	2	based	base	VERB
aji-155	199	3	on	on	ADP
aji-155	199	4	the	the	DET
aji-155	199	5	theme	theme	NOUN
aji-155	199	6	that	that	SCONJ
aji-155	199	7	immuoadjuvant	immuoadjuvant	NOUN
aji-155	199	8	can	can	AUX
aji-155	199	9	be	be	AUX
aji-155	199	10	of	of	ADP
aji-155	199	11	use	use	NOUN
aji-155	199	12	either	either	CCONJ
aji-155	199	13	pre	pre	ADJ
aji-155	199	14	,	,	PUNCT
aji-155	199	15	mix	mix	VERB
aji-155	199	16	with	with	ADP
aji-155	199	17	or	or	CCONJ
aji-155	199	18	post	post	ADJ
aji-155	199	19	-	-	ADJ
aji-155	199	20	antigen	antigen	ADJ
aji-155	199	21	priming	priming	NOUN
aji-155	199	22	to	to	ADP
aji-155	199	23	an	an	DET
aji-155	199	24	immune	immune	ADJ
aji-155	199	25	animal	animal	NOUN
aji-155	199	26	model	model	NOUN
aji-155	199	27	(	(	PUNCT
aji-155	199	28	zhao	zhao	PROPN
aji-155	199	29	et	et	PROPN
aji-155	199	30	al	al	PROPN
aji-155	199	31	.	.	PROPN
aji-155	199	32	,	,	PUNCT
aji-155	199	33	2023	2023	NUM
aji-155	199	34	)	)	PUNCT
aji-155	199	35	.	.	PUNCT
aji-155	200	1	both	both	PRON
aji-155	200	2	of	of	ADP
aji-155	200	3	the	the	DET
aji-155	200	4	prepared	prepared	ADJ
aji-155	200	5	antigens	antigen	NOUN
aji-155	200	6	bear	bear	VERB
aji-155	200	7	forigeness	forigeness	ADJ
aji-155	200	8	characters	character	NOUN
aji-155	200	9	from	from	ADP
aji-155	200	10	the	the	DET
aji-155	200	11	organism	organism	NOUN
aji-155	200	12	producing	produce	VERB
aji-155	200	13	them	they	PRON
aji-155	200	14	that	that	PRON
aji-155	200	15	are	be	AUX
aji-155	200	16	encoded	encode	VERB
aji-155	200	17	by	by	ADP
aji-155	200	18	the	the	DET
aji-155	200	19	genetic	genetic	ADJ
aji-155	200	20	system	system	NOUN
aji-155	200	21	of	of	ADP
aji-155	200	22	that	that	DET
aji-155	200	23	organism	organism	NOUN
aji-155	200	24	(	(	PUNCT
aji-155	200	25	venter	venter	NOUN
aji-155	200	26	,	,	PUNCT
aji-155	200	27	1998	1998	NUM
aji-155	200	28	)	)	PUNCT
aji-155	200	29	.	.	PUNCT
aji-155	201	1	parallel	parallel	ADJ
aji-155	201	2	to	to	ADP
aji-155	201	3	this	this	PRON
aji-155	201	4	the	the	DET
aji-155	201	5	immune	immune	ADJ
aji-155	201	6	system	system	NOUN
aji-155	201	7	cells	cell	NOUN
aji-155	201	8	of	of	ADP
aji-155	201	9	test	test	NOUN
aji-155	201	10	animal	animal	NOUN
aji-155	201	11	model	model	NOUN
aji-155	201	12	are	be	AUX
aji-155	201	13	encoded	encode	VERB
aji-155	201	14	by	by	ADP
aji-155	201	15	gene	gene	NOUN
aji-155	201	16	sets	set	NOUN
aji-155	201	17	that	that	SCONJ
aji-155	201	18	on	on	ADP
aji-155	201	19	their	their	PRON
aji-155	201	20	expression	expression	NOUN
aji-155	201	21	,	,	PUNCT
aji-155	201	22	these	these	DET
aji-155	201	23	cells	cell	NOUN
aji-155	201	24	recognize	recognize	VERB
aji-155	201	25	that	that	SCONJ
aji-155	201	26	the	the	DET
aji-155	201	27	introduced	introduce	VERB
aji-155	201	28	material	material	NOUN
aji-155	201	29	facing	face	VERB
aji-155	201	30	them	they	PRON
aji-155	201	31	are	be	AUX
aji-155	201	32	foreign	foreign	ADJ
aji-155	201	33	(	(	PUNCT
aji-155	201	34	lagou	lagou	NOUN
aji-155	201	35	et	et	PROPN
aji-155	201	36	al	al	PROPN
aji-155	201	37	.	.	PROPN
aji-155	201	38	,	,	PUNCT
aji-155	201	39	2018	2018	NUM
aji-155	201	40	)	)	PUNCT
aji-155	201	41	.	.	PUNCT
aji-155	202	1	immunogenicity	immunogenicity	NOUN
aji-155	202	2	in	in	ADP
aji-155	202	3	theoritical	theoritical	ADJ
aji-155	202	4	immunology	immunology	NOUN
aji-155	202	5	sense	sense	NOUN
aji-155	202	6	is	be	AUX
aji-155	202	7	a	a	DET
aji-155	202	8	matter	matter	NOUN
aji-155	202	9	of	of	ADP
aji-155	202	10	self	self	NOUN
aji-155	202	11	/	/	SYM
aji-155	202	12	non	non	ADJ
aji-155	202	13	-	-	ADJ
aji-155	202	14	self	self	ADJ
aji-155	202	15	recogntion	recogntion	NOUN
aji-155	202	16	theme	theme	NOUN
aji-155	202	17	(	(	PUNCT
aji-155	202	18	pradeu	pradeu	NOUN
aji-155	202	19	&	&	CCONJ
aji-155	202	20	carssella	carssella	NOUN
aji-155	202	21	2006	2006	NUM
aji-155	202	22	)	)	PUNCT
aji-155	202	23	.	.	PUNCT
aji-155	203	1	both	both	PRON
aji-155	203	2	of	of	ADP
aji-155	203	3	capsule	capsule	PROPN
aji-155	203	4	b	b	PROPN
aji-155	203	5	and	and	CCONJ
aji-155	203	6	omp	omp	PROPN
aji-155	203	7	were	be	AUX
aji-155	203	8	found	find	VERB
aji-155	203	9	to	to	PART
aji-155	203	10	be	be	AUX
aji-155	203	11	as	as	SCONJ
aji-155	203	12	lapin	lapin	PROPN
aji-155	203	13	immunogens	immunogen	VERB
aji-155	203	14	inducing	induce	VERB
aji-155	203	15	humoral	humoral	ADJ
aji-155	203	16	immune	immune	ADJ
aji-155	203	17	responses	response	NOUN
aji-155	203	18	both	both	CCONJ
aji-155	203	19	at	at	ADP
aji-155	203	20	systemic	systemic	ADJ
aji-155	203	21	[	[	X
aji-155	203	22	blood	blood	NOUN
aji-155	203	23	sera	sera	NOUN
aji-155	203	24	]	]	PUNCT
aji-155	203	25	and	and	CCONJ
aji-155	203	26	mucosal	mucosal	NOUN
aji-155	203	27	[	[	X
aji-155	203	28	appendex	appendex	NOUN
aji-155	203	29	globulin	globulin	NOUN
aji-155	203	30	]	]	PUNCT
aji-155	203	31	levels	level	NOUN
aji-155	203	32	.	.	PUNCT
aji-155	204	1	the	the	DET
aji-155	204	2	immune	immune	ADJ
aji-155	204	3	conversion	conversion	NOUN
aji-155	204	4	were	be	AUX
aji-155	204	5	estimated	estimate	VERB
aji-155	204	6	by	by	ADP
aji-155	204	7	the	the	DET
aji-155	204	8	folds	fold	NOUN
aji-155	204	9	increase	increase	NOUN
aji-155	204	10	of	of	ADP
aji-155	204	11	antibody	antibody	NOUN
aji-155	204	12	titre	titre	NOUN
aji-155	204	13	and	and	CCONJ
aji-155	204	14	concentrations	concentration	NOUN
aji-155	204	15	than	than	ADP
aji-155	204	16	the	the	DET
aji-155	204	17	baseline	baseline	NOUN
aji-155	204	18	titre	titre	NOUN
aji-155	204	19	and	and	CCONJ
aji-155	204	20	concentrations	concentration	NOUN
aji-155	204	21	from	from	ADP
aji-155	204	22	the	the	DET
aji-155	204	23	baseline	baseline	ADJ
aji-155	204	24	immune	immune	ADJ
aji-155	204	25	function	function	NOUN
aji-155	204	26	in	in	ADP
aji-155	204	27	normal	normal	ADJ
aji-155	204	28	control	control	NOUN
aji-155	204	29	rabbits	rabbit	NOUN
aji-155	204	30	.	.	PUNCT
aji-155	205	1	both	both	PRON
aji-155	205	2	of	of	ADP
aji-155	205	3	systemic	systemic	ADJ
aji-155	205	4	anticapsular	anticapsular	ADJ
aji-155	205	5	and	and	CCONJ
aji-155	205	6	anti	anti	ADJ
aji-155	205	7	-	-	ADJ
aji-155	205	8	omp	omp	PROPN
aji-155	205	9	were	be	AUX
aji-155	205	10	express	express	ADJ
aji-155	205	11	five	five	NUM
aji-155	205	12	to	to	PART
aji-155	205	13	six	six	NUM
aji-155	205	14	folds	fold	NOUN
aji-155	205	15	increase	increase	NOUN
aji-155	205	16	.	.	PUNCT
aji-155	206	1	while	while	SCONJ
aji-155	206	2	for	for	SCONJ
aji-155	206	3	mucosal	mucosal	ADJ
aji-155	206	4	antibody	antibody	NOUN
aji-155	206	5	titres	titre	NOUN
aji-155	206	6	rise	rise	VERB
aji-155	206	7	was	be	AUX
aji-155	206	8	four	four	NUM
aji-155	206	9	to	to	PART
aji-155	206	10	five	five	NUM
aji-155	206	11	folds	fold	NOUN
aji-155	206	12	increase	increase	NOUN
aji-155	206	13	than	than	ADP
aji-155	206	14	normal	normal	ADJ
aji-155	206	15	immune	immune	ADJ
aji-155	206	16	function	function	NOUN
aji-155	206	17	was	be	AUX
aji-155	206	18	five	five	NUM
aji-155	206	19	folds	fold	NOUN
aji-155	206	20	.	.	PUNCT
aji-155	207	1	capsular	capsular	VERB
aji-155	207	2	b	b	NOUN
aji-155	207	3	antigen	antigen	NOUN
aji-155	207	4	induce	induce	VERB
aji-155	207	5	leukocyte	leukocyte	NOUN
aji-155	207	6	stimulatory	stimulatory	ADJ
aji-155	207	7	factor	factor	NOUN
aji-155	207	8	up	up	ADP
aji-155	207	9	to	to	PART
aji-155	207	10	1.08	1.08	NUM
aji-155	207	11	%	%	NOUN
aji-155	207	12	as	as	ADP
aji-155	207	13	compared	compare	VERB
aji-155	207	14	to	to	ADP
aji-155	207	15	saline	saline	ADJ
aji-155	207	16	control	control	NOUN
aji-155	207	17	was	be	AUX
aji-155	207	18	0.95	0.95	NUM
aji-155	207	19	%	%	NOUN
aji-155	207	20	,	,	PUNCT
aji-155	207	21	which	which	PRON
aji-155	207	22	is	be	AUX
aji-155	207	23	a	a	DET
aji-155	207	24	kind	kind	NOUN
aji-155	207	25	of	of	ADP
aji-155	207	26	cytokine	cytokine	NOUN
aji-155	207	27	that	that	PRON
aji-155	207	28	promote	promote	VERB
aji-155	207	29	leukocyte	leukocyte	NOUN
aji-155	207	30	migration	migration	NOUN
aji-155	207	31	in	in	ADP
aji-155	207	32	capillary	capillary	ADJ
aji-155	207	33	tube	tube	NOUN
aji-155	207	34	approach	approach	NOUN
aji-155	207	35	(	(	PUNCT
aji-155	207	36	sixt	sixt	NOUN
aji-155	207	37	&	&	CCONJ
aji-155	207	38	lammermann	lammermann	PROPN
aji-155	207	39	2011	2011	NUM
aji-155	207	40	;	;	PUNCT
aji-155	207	41	thorley	thorley	PROPN
aji-155	207	42	et	et	PROPN
aji-155	207	43	al	al	PROPN
aji-155	207	44	.	.	PROPN
aji-155	207	45	2007	2007	NUM
aji-155	207	46	)	)	PUNCT
aji-155	207	47	.	.	PUNCT
aji-155	208	1	both	both	PRON
aji-155	208	2	of	of	ADP
aji-155	208	3	the	the	DET
aji-155	208	4	capsule	capsule	PROPN
aji-155	208	5	b	b	PROPN
aji-155	208	6	and	and	CCONJ
aji-155	208	7	omp	omp	PROPN
aji-155	208	8	antigens	antigen	NOUN
aji-155	208	9	does	do	AUX
aji-155	208	10	not	not	PART
aji-155	208	11	express	express	VERB
aji-155	208	12	delayed	delay	VERB
aji-155	208	13	allergenic	allergenic	ADJ
aji-155	208	14	immune	immune	ADJ
aji-155	208	15	conversions	conversion	NOUN
aji-155	208	16	than	than	ADP
aji-155	208	17	the	the	DET
aji-155	208	18	baseline	baseline	PROPN
aji-155	208	19	control	control	NOUN
aji-155	208	20	rabbits	rabbit	NOUN
aji-155	208	21	.	.	PUNCT
aji-155	209	1	table	table	NOUN
aji-155	209	2	1	1	NUM
aji-155	209	3	.	.	PUNCT
aji-155	209	4	cellular	cellular	ADJ
aji-155	209	5	immune	immune	ADJ
aji-155	209	6	functions	function	NOUN
aji-155	209	7	as	as	ADP
aji-155	209	8	leukocyte	leukocyte	ADJ
aji-155	209	9	inhibitory	inhibitory	ADJ
aji-155	209	10	factor	factor	NOUN
aji-155	209	11	cytokines[a	cytokines[a	NOUN
aji-155	209	12	]	]	PUNCT
aji-155	209	13	and	and	CCONJ
aji-155	209	14	skin	skin	NOUN
aji-155	209	15	dth[b	dth[b	NOUN
aji-155	209	16	]	]	PUNCT
aji-155	209	17	for	for	ADP
aji-155	209	18	h.	h.	PROPN
aji-155	209	19	infleunzae	infleunzae	PROPN
aji-155	209	20	b	b	PROPN
aji-155	209	21	a	a	DET
aji-155	209	22	specific	specific	ADJ
aji-155	209	23	immune	immune	NOUN
aji-155	209	24	primed	prime	VERB
aji-155	209	25	rabbit	rabbit	NOUN
aji-155	209	26	systemic	systemic	ADJ
aji-155	209	27	leukocyte	leukocyte	NOUN
aji-155	209	28	inhibitory	inhibitory	ADJ
aji-155	209	29	factor	factor	NOUN
aji-155	209	30	mucosal	mucosal	NOUN
aji-155	209	31	leukocyte	leukocyte	NOUN
aji-155	209	32	inhibitory	inhibitory	ADJ
aji-155	209	33	factor	factor	NOUN
aji-155	209	34	capsule	capsule	NOUN
aji-155	209	35	primed	prime	VERB
aji-155	209	36	r1	r1	PROPN
aji-155	209	37	r2	r2	PROPN
aji-155	209	38	r3	r3	PROPN
aji-155	209	39	rmean	rmean	PROPN
aji-155	209	40	control	control	PROPN
aji-155	210	1	1	1	NUM
aji-155	210	2	1	1	NUM
aji-155	210	3	1	1	NUM
aji-155	210	4	1	1	NUM
aji-155	210	5	0.98	0.98	NUM
aji-155	210	6	1	1	NUM
aji-155	210	7	1.09	1.09	NUM
aji-155	210	8	1.07	1.07	NUM
aji-155	210	9	1.08	1.08	NUM
aji-155	210	10	0.995	0.995	NUM
aji-155	210	11	omp	omp	NUM
aji-155	210	12	primed	prime	VERB
aji-155	210	13	r1	r1	PROPN
aji-155	210	14	r2	r2	PROPN
aji-155	210	15	r3	r3	PROPN
aji-155	210	16	rmean	rmean	PROPN
aji-155	210	17	control	control	PROPN
aji-155	210	18	1	1	NUM
aji-155	210	19	0.9	0.9	NUM
aji-155	210	20	0.9	0.9	NUM
aji-155	210	21	0.903	0.903	NUM
aji-155	210	22	0.98	0.98	NUM
aji-155	210	23	1	1	NUM
aji-155	210	24	0.95	0.95	NUM
aji-155	210	25	0.91	0.91	NUM
aji-155	210	26	0.95	0.95	NUM
aji-155	210	27	0.97	0.97	NUM
aji-155	210	28	b	b	NOUN
aji-155	210	29	/	/	SYM
aji-155	210	30	skin	skin	NOUN
aji-155	210	31	dth	dth	ADJ
aji-155	210	32	/	/	SYM
aji-155	210	33	hours	hour	NOUN
aji-155	210	34	erythema	erythema	ADJ
aji-155	210	35	induration	induration	NOUN
aji-155	210	36	necrosis	necrosis	NOUN
aji-155	210	37	capsule	capsule	NOUN
aji-155	210	38	primed	prime	VERB
aji-155	210	39	6	6	NUM
aji-155	210	40	48	48	NUM
aji-155	210	41	72	72	NUM
aji-155	210	42	omp	omp	NUM
aji-155	210	43	primed	prime	VERB
aji-155	210	44	6	6	NUM
aji-155	210	45	48	48	NUM
aji-155	210	46	72	72	NUM
aji-155	210	47	shnawa	shnawa	NOUN
aji-155	210	48	et	et	PROPN
aji-155	210	49	al	al	PROPN
aji-155	210	50	.	.	PROPN
aji-155	210	51	;	;	PUNCT
aji-155	210	52	asian	asian	PROPN
aji-155	210	53	j.	j.	PROPN
aji-155	210	54	immunol	immunol	PROPN
aji-155	210	55	.	.	PROPN
aji-155	210	56	,	,	PUNCT
aji-155	210	57	vol	vol	NOUN
aji-155	210	58	.	.	PROPN
aji-155	210	59	8	8	NUM
aji-155	210	60	,	,	PUNCT
aji-155	210	61	no	no	INTJ
aji-155	210	62	.	.	NOUN
aji-155	210	63	1	1	NUM
aji-155	210	64	,	,	PUNCT
aji-155	210	65	pp	pp	ADJ
aji-155	210	66	.	.	PUNCT
aji-155	211	1	1	1	NUM
aji-155	211	2	-	-	SYM
aji-155	211	3	7	7	NUM
aji-155	211	4	,	,	PUNCT
aji-155	211	5	2025	2025	NUM
aji-155	211	6	;	;	PUNCT
aji-155	211	7	article	article	NOUN
aji-155	211	8	no.aji.129951	no.aji.129951	NOUN
aji-155	211	9	5	5	NUM
aji-155	211	10	table	table	NOUN
aji-155	211	11	2	2	NUM
aji-155	211	12	.	.	PUNCT
aji-155	211	13	humoral	humoral	ADJ
aji-155	211	14	immune	immune	ADJ
aji-155	211	15	function	function	NOUN
aji-155	211	16	for	for	ADP
aji-155	211	17	capsular	capsular	NOUN
aji-155	211	18	[	[	X
aji-155	211	19	a	a	X
aji-155	211	20	]	]	X
aji-155	211	21	and	and	CCONJ
aji-155	211	22	omp	omp	PROPN
aji-155	212	1	[	[	X
aji-155	212	2	b	b	X
aji-155	212	3	]	]	X
aji-155	212	4	primed	prime	VERB
aji-155	212	5	rabbits	rabbit	NOUN
aji-155	212	6	as	as	SCONJ
aji-155	212	7	precipitins	precipitin	NOUN
aji-155	212	8	a	a	PRON
aji-155	212	9	and	and	CCONJ
aji-155	212	10	hemagglutinins	hemagglutinin	NOUN
aji-155	212	11	b.	b.	PROPN
aji-155	212	12	for	for	ADP
aji-155	212	13	the	the	DET
aji-155	212	14	neurogenic	neurogenic	ADJ
aji-155	212	15	h.	h.	PROPN
aji-155	212	16	infleunzae	infleunzae	NOUN
aji-155	212	17	b	b	PROPN
aji-155	212	18	animal	animal	NOUN
aji-155	212	19	groups	group	NOUN
aji-155	212	20	capsule	capsule	PROPN
aji-155	212	21	primed	prime	VERB
aji-155	212	22	rabbits	rabbit	NOUN
aji-155	212	23	serum	serum	VERB
aji-155	212	24	antibody	antibody	NOUN
aji-155	212	25	titre	titre	NOUN
aji-155	212	26	means	mean	VERB
aji-155	212	27	serum	serum	NOUN
aji-155	212	28	concentration	concentration	NOUN
aji-155	212	29	means	mean	VERB
aji-155	212	30	gm	gm	PROPN
aji-155	212	31	/	/	SYM
aji-155	212	32	l	l	NOUN
aji-155	212	33	mucus	mucus	NOUN
aji-155	212	34	titre	titre	NOUN
aji-155	212	35	means	mean	VERB
aji-155	212	36	mucus	mucus	NOUN
aji-155	212	37	concentration	concentration	NOUN
aji-155	212	38	means	mean	VERB
aji-155	212	39	gm	gm	PROPN
aji-155	212	40	/	/	SYM
aji-155	212	41	l	l	NOUN
aji-155	212	42	test	test	NOUN
aji-155	212	43	group	group	NOUN
aji-155	212	44	a	a	DET
aji-155	212	45	r1	r1	PROPN
aji-155	212	46	r2	r2	PROPN
aji-155	212	47	r3	r3	PROPN
aji-155	212	48	rmean	rmean	PROPN
aji-155	212	49	control	control	PROPN
aji-155	212	50	320	320	NUM
aji-155	212	51	640	640	NUM
aji-155	212	52	640	640	NUM
aji-155	212	53	533.3	533.3	NUM
aji-155	212	54	10	10	NUM
aji-155	212	55	26.3	26.3	NUM
aji-155	212	56	31.42	31.42	NUM
aji-155	213	1	32.1	32.1	NUM
aji-155	213	2	29.94	29.94	NUM
aji-155	213	3	6.75	6.75	NUM
aji-155	213	4	64	64	NUM
aji-155	213	5	32	32	NUM
aji-155	213	6	32	32	NUM
aji-155	213	7	42.6	42.6	NUM
aji-155	213	8	2	2	NUM
aji-155	213	9	1	1	NUM
aji-155	213	10	2.7	2.7	NUM
aji-155	213	11	2.3	2.3	NUM
aji-155	213	12	2.06	2.06	NUM
aji-155	213	13	0.45	0.45	NUM
aji-155	213	14	test	test	NOUN
aji-155	213	15	group	group	PROPN
aji-155	213	16	b	b	PROPN
aji-155	213	17	omp	omp	PROPN
aji-155	213	18	primed	prime	VERB
aji-155	213	19	r1	r1	PROPN
aji-155	213	20	r2	r2	PROPN
aji-155	213	21	r3	r3	PROPN
aji-155	213	22	rmean	rmean	PROPN
aji-155	213	23	control	control	PROPN
aji-155	213	24	1280	1280	NUM
aji-155	213	25	640	640	NUM
aji-155	213	26	640	640	NUM
aji-155	213	27	853.3	853.3	NUM
aji-155	213	28	10	10	NUM
aji-155	213	29	33.1	33.1	NUM
aji-155	213	30	21.2	21.2	NUM
aji-155	213	31	22.31	22.31	NUM
aji-155	213	32	25.4	25.4	NUM
aji-155	213	33	6.35	6.35	NUM
aji-155	213	34	64	64	NUM
aji-155	213	35	128	128	NUM
aji-155	213	36	64	64	NUM
aji-155	213	37	85.33	85.33	NUM
aji-155	213	38	2	2	NUM
aji-155	213	39	2.7	2.7	NUM
aji-155	213	40	1.0	1.0	NUM
aji-155	213	41	1.0	1.0	NUM
aji-155	213	42	1.56	1.56	NUM
aji-155	213	43	0.4	0.4	NUM
aji-155	213	44	since	since	SCONJ
aji-155	213	45	they	they	PRON
aji-155	213	46	neither	neither	CCONJ
aji-155	213	47	produce	produce	VERB
aji-155	213	48	typical	typical	ADJ
aji-155	213	49	skin	skin	NOUN
aji-155	213	50	dth	dth	ADJ
aji-155	213	51	reaction	reaction	NOUN
aji-155	213	52	nor	nor	CCONJ
aji-155	213	53	jone	jone	PROPN
aji-155	213	54	-	-	PUNCT
aji-155	213	55	moote	moote	PROPN
aji-155	213	56	reactions	reaction	NOUN
aji-155	213	57	(	(	PUNCT
aji-155	213	58	burrell	burrell	PROPN
aji-155	213	59	,	,	PUNCT
aji-155	213	60	1979	1979	NUM
aji-155	213	61	)	)	PUNCT
aji-155	213	62	,	,	PUNCT
aji-155	213	63	during	during	ADP
aji-155	213	64	the	the	DET
aji-155	213	65	observation	observation	NOUN
aji-155	213	66	period	period	NOUN
aji-155	213	67	6	6	NUM
aji-155	213	68	up	up	ADP
aji-155	213	69	to	to	PART
aji-155	213	70	72	72	NUM
aji-155	213	71	hrs	hrs	NOUN
aji-155	213	72	.	.	PUNCT
aji-155	214	1	post	post	VERB
aji-155	214	2	to	to	PART
aji-155	214	3	sensitin	sensitin	VERB
aji-155	214	4	intradermal	intradermal	ADJ
aji-155	214	5	injection	injection	NOUN
aji-155	214	6	in	in	ADP
aji-155	214	7	primed	prime	VERB
aji-155	214	8	test	test	NOUN
aji-155	214	9	animals	animal	NOUN
aji-155	214	10	groups	group	NOUN
aji-155	214	11	.	.	PUNCT
aji-155	215	1	the	the	DET
aji-155	215	2	possible	possible	ADJ
aji-155	215	3	epitope	epitope	NOUN
aji-155	215	4	nature	nature	NOUN
aji-155	215	5	of	of	ADP
aji-155	215	6	capsular	capsular	NOUN
aji-155	215	7	b	b	NOUN
aji-155	215	8	antigen	antigen	NOUN
aji-155	215	9	may	may	AUX
aji-155	215	10	be	be	AUX
aji-155	215	11	t	t	PROPN
aji-155	215	12	independent	independent	ADJ
aji-155	215	13	epitope	epitope	PROPN
aji-155	215	14	triggering	trigger	VERB
aji-155	215	15	anti	anti	ADJ
aji-155	215	16	-	-	ADJ
aji-155	215	17	prp	prp	ADJ
aji-155	215	18	antibodies	antibodie	VERB
aji-155	215	19	.	.	PUNCT
aji-155	216	1	while	while	SCONJ
aji-155	216	2	that	that	PRON
aji-155	216	3	of	of	ADP
aji-155	216	4	omp	omp	PROPN
aji-155	216	5	antibodies	antibody	NOUN
aji-155	216	6	may	may	AUX
aji-155	216	7	trigger	trigger	VERB
aji-155	216	8	th2	th2	PROPN
aji-155	216	9	cells	cell	NOUN
aji-155	216	10	and	and	CCONJ
aji-155	216	11	th2	th2	PROPN
aji-155	216	12	cells	cell	NOUN
aji-155	216	13	in	in	ADP
aji-155	216	14	turn	turn	NOUN
aji-155	216	15	activate	activate	VERB
aji-155	216	16	b	b	NOUN
aji-155	216	17	cells	cell	NOUN
aji-155	216	18	to	to	PART
aji-155	216	19	produce	produce	VERB
aji-155	216	20	anti	anti	ADJ
aji-155	216	21	-	-	ADJ
aji-155	216	22	omp	omp	ADJ
aji-155	216	23	antibodies	antibody	NOUN
aji-155	216	24	.	.	PUNCT
aji-155	217	1	apparently	apparently	ADV
aji-155	217	2	,	,	PUNCT
aji-155	217	3	it	it	PRON
aji-155	217	4	does	do	AUX
aji-155	217	5	not	not	PART
aji-155	217	6	contain	contain	VERB
aji-155	217	7	th1	th1	PROPN
aji-155	217	8	dependent	dependent	ADJ
aji-155	217	9	epitopes	epitope	NOUN
aji-155	217	10	but	but	CCONJ
aji-155	217	11	there	there	PRON
aji-155	217	12	is	be	VERB
aji-155	217	13	a	a	DET
aji-155	217	14	possibility	possibility	NOUN
aji-155	217	15	for	for	ADP
aji-155	217	16	shiffting	shiffte	VERB
aji-155	217	17	from	from	ADP
aji-155	217	18	th2	th2	PROPN
aji-155	217	19	to	to	ADP
aji-155	217	20	th1	th1	PROPN
aji-155	217	21	dependence	dependence	NOUN
aji-155	217	22	due	due	ADP
aji-155	217	23	to	to	ADP
aji-155	217	24	coexisting	coexist	VERB
aji-155	217	25	epitopes	epitope	NOUN
aji-155	217	26	mixed	mix	VERB
aji-155	217	27	with	with	ADP
aji-155	217	28	independent	independent	ADJ
aji-155	217	29	ones	one	NOUN
aji-155	217	30	(	(	PUNCT
aji-155	217	31	misseneir	misseneir	PROPN
aji-155	217	32	&	&	CCONJ
aji-155	217	33	lary	lary	PROPN
aji-155	217	34	2002	2002	NUM
aji-155	217	35	;	;	PUNCT
aji-155	217	36	mcvernon	mcvernon	NOUN
aji-155	217	37	et	et	PROPN
aji-155	217	38	al	al	PROPN
aji-155	217	39	.	.	PROPN
aji-155	217	40	,	,	PUNCT
aji-155	217	41	2005	2005	NUM
aji-155	217	42	;	;	PUNCT
aji-155	217	43	shnawa	shnawa	NOUN
aji-155	217	44	,	,	PUNCT
aji-155	217	45	2006	2006	NUM
aji-155	217	46	;	;	PUNCT
aji-155	217	47	haddadi	haddadi	PROPN
aji-155	217	48	et	et	PROPN
aji-155	217	49	al	al	PROPN
aji-155	217	50	.	.	PROPN
aji-155	217	51	,	,	PUNCT
aji-155	217	52	2022	2022	NUM
aji-155	217	53	;	;	PUNCT
aji-155	217	54	garcia	garcia	PROPN
aji-155	217	55	-	-	PUNCT
aji-155	217	56	diaz	diaz	PROPN
aji-155	217	57	et	et	PROPN
aji-155	217	58	al	al	PROPN
aji-155	217	59	.	.	PROPN
aji-155	217	60	,	,	PUNCT
aji-155	217	61	2013	2013	NUM
aji-155	217	62	;	;	PUNCT
aji-155	217	63	jackson	jackson	PROPN
aji-155	217	64	et	et	PROPN
aji-155	217	65	al	al	PROPN
aji-155	217	66	.	.	PROPN
aji-155	217	67	,	,	PUNCT
aji-155	217	68	2024	2024	NUM
aji-155	217	69	)	)	PUNCT
aji-155	217	70	.	.	PUNCT
aji-155	218	1	thus	thus	ADV
aji-155	218	2	type	type	NOUN
aji-155	218	3	b	b	PROPN
aji-155	218	4	capsule	capsule	NOUN
aji-155	218	5	and	and	CCONJ
aji-155	218	6	omp	omp	PROPN
aji-155	218	7	of	of	ADP
aji-155	218	8	h.	h.	PROPN
aji-155	218	9	infleunzae	infleunzae	PROPN
aji-155	218	10	induced	induce	VERB
aji-155	218	11	local	local	ADJ
aji-155	218	12	and	and	CCONJ
aji-155	218	13	systemic	systemic	ADJ
aji-155	218	14	humoral	humoral	ADJ
aji-155	218	15	immune	immune	ADJ
aji-155	218	16	responses	response	NOUN
aji-155	218	17	in	in	ADP
aji-155	218	18	rabbits	rabbit	NOUN
aji-155	218	19	primed	prime	VERB
aji-155	218	20	with	with	ADP
aji-155	218	21	them	they	PRON
aji-155	218	22	separately	separately	ADV
aji-155	218	23	.	.	PUNCT
aji-155	219	1	systemic	systemic	ADJ
aji-155	219	2	humoral	humoral	ADJ
aji-155	219	3	antibody	antibody	NOUN
aji-155	219	4	responses	response	NOUN
aji-155	219	5	were	be	AUX
aji-155	219	6	higher	high	ADJ
aji-155	219	7	than	than	ADP
aji-155	219	8	that	that	DET
aji-155	219	9	mucosal	mucosal	NOUN
aji-155	219	10	responses	response	NOUN
aji-155	219	11	.	.	PUNCT
aji-155	220	1	this	this	PRON
aji-155	220	2	was	be	AUX
aji-155	220	3	inline	inline	VERB
aji-155	220	4	with	with	ADP
aji-155	220	5	shnawa	shnawa	PROPN
aji-155	220	6	(	(	PUNCT
aji-155	220	7	2006	2006	NUM
aji-155	220	8	)	)	PUNCT
aji-155	220	9	,	,	PUNCT
aji-155	220	10	working	work	VERB
aji-155	220	11	on	on	ADP
aji-155	220	12	immunogenicity	immunogenicity	NOUN
aji-155	220	13	of	of	ADP
aji-155	220	14	c.	c.	PROPN
aji-155	220	15	fetus	fetus	NOUN
aji-155	220	16	in	in	ADP
aji-155	220	17	rabbits	rabbit	NOUN
aji-155	220	18	.	.	PUNCT
aji-155	221	1	the	the	DET
aji-155	221	2	ratio	ratio	NOUN
aji-155	221	3	of	of	ADP
aji-155	221	4	systemic	systemic	ADJ
aji-155	221	5	to	to	ADP
aji-155	221	6	mucosal	mucosal	NOUN
aji-155	221	7	were	be	AUX
aji-155	221	8	10;1	10;1	NUM
aji-155	221	9	in	in	ADP
aji-155	221	10	term	term	NOUN
aji-155	221	11	of	of	ADP
aji-155	221	12	titre	titre	NOUN
aji-155	221	13	while	while	SCONJ
aji-155	221	14	in	in	ADP
aji-155	221	15	term	term	NOUN
aji-155	221	16	of	of	ADP
aji-155	221	17	concentration	concentration	NOUN
aji-155	221	18	for	for	ADP
aji-155	221	19	omp	omp	PROPN
aji-155	221	20	was	be	AUX
aji-155	221	21	13:1	13:1	NUM
aji-155	221	22	and	and	CCONJ
aji-155	221	23	for	for	ADP
aji-155	221	24	capsule	capsule	NOUN
aji-155	221	25	was	be	AUX
aji-155	221	26	14:1	14:1	NUM
aji-155	221	27	(	(	PUNCT
aji-155	221	28	shnawa	shnawa	NOUN
aji-155	221	29	,	,	PUNCT
aji-155	221	30	2006	2006	NUM
aji-155	221	31	)	)	PUNCT
aji-155	221	32	.	.	PUNCT
aji-155	222	1	5	5	X
aji-155	222	2	.	.	X
aji-155	222	3	conclusions	conclusion	NOUN
aji-155	222	4	human	human	PROPN
aji-155	222	5	neurotropic	neurotropic	PROPN
aji-155	222	6	neurogenic	neurogenic	ADJ
aji-155	222	7	local	local	ADJ
aji-155	222	8	h.	h.	PROPN
aji-155	222	9	infleunzae	infleunzae	PROPN
aji-155	222	10	b	b	PROPN
aji-155	222	11	omp	omp	PROPN
aji-155	222	12	and	and	CCONJ
aji-155	222	13	capsule	capsule	PROPN
aji-155	222	14	b	b	PROPN
aji-155	222	15	are	be	AUX
aji-155	222	16	found	find	VERB
aji-155	222	17	as	as	ADP
aji-155	222	18	lapin	lapin	PROPN
aji-155	222	19	immunogen	immunogen	PROPN
aji-155	222	20	.	.	PUNCT
aji-155	223	1	adult	adult	NOUN
aji-155	223	2	rabbits	rabbit	NOUN
aji-155	223	3	proved	prove	VERB
aji-155	223	4	to	to	PART
aji-155	223	5	be	be	AUX
aji-155	223	6	valid	valid	ADJ
aji-155	223	7	immune	immune	ADJ
aji-155	223	8	model	model	NOUN
aji-155	223	9	for	for	ADP
aji-155	223	10	testing	test	VERB
aji-155	223	11	immunogenicity	immunogenicity	NOUN
aji-155	223	12	of	of	ADP
aji-155	223	13	these	these	DET
aji-155	223	14	antigens	antigen	NOUN
aji-155	223	15	.	.	PUNCT
aji-155	224	1	capsular	capsular	VERB
aji-155	224	2	b	b	NOUN
aji-155	224	3	antigen	antigen	NOUN
aji-155	224	4	induce	induce	VERB
aji-155	224	5	leukocyte	leukocyte	NOUN
aji-155	224	6	stimulatory	stimulatory	ADJ
aji-155	224	7	factor	factor	NOUN
aji-155	224	8	in	in	ADP
aji-155	224	9	capillary	capillary	ADJ
aji-155	224	10	method	method	NOUN
aji-155	224	11	.	.	PUNCT
aji-155	225	1	capsular	capsular	VERB
aji-155	225	2	and	and	CCONJ
aji-155	225	3	omp	omp	PROPN
aji-155	225	4	induces	induce	VERB
aji-155	225	5	humoral	humoral	ADJ
aji-155	225	6	hemagglutinin	hemagglutinin	NOUN
aji-155	225	7	and	and	CCONJ
aji-155	225	8	precipitin	precipitin	NOUN
aji-155	225	9	responses	response	NOUN
aji-155	225	10	both	both	CCONJ
aji-155	225	11	at	at	ADP
aji-155	225	12	systemic	systemic	ADJ
aji-155	225	13	and	and	CCONJ
aji-155	225	14	mucosal	mucosal	ADJ
aji-155	225	15	compartments	compartment	NOUN
aji-155	225	16	.	.	PUNCT
aji-155	226	1	such	such	ADJ
aji-155	226	2	findings	finding	NOUN
aji-155	226	3	be	be	VERB
aji-155	226	4	essential	essential	ADJ
aji-155	226	5	for	for	ADP
aji-155	226	6	preclinical	preclinical	ADJ
aji-155	226	7	and	and	CCONJ
aji-155	226	8	development	development	NOUN
aji-155	226	9	of	of	ADP
aji-155	226	10	systemic	systemic	ADJ
aji-155	226	11	and/or	and/or	CCONJ
aji-155	226	12	mucosal	mucosal	ADJ
aji-155	226	13	vaccine	vaccine	NOUN
aji-155	226	14	,	,	PUNCT
aji-155	226	15	on	on	ADP
aji-155	226	16	approval	approval	NOUN
aji-155	226	17	will	will	AUX
aji-155	226	18	be	be	AUX
aji-155	226	19	valid	valid	ADJ
aji-155	226	20	for	for	ADP
aji-155	226	21	local	local	ADJ
aji-155	226	22	mass	mass	NOUN
aji-155	226	23	vaccination	vaccination	NOUN
aji-155	226	24	of	of	ADP
aji-155	226	25	childhood	childhood	NOUN
aji-155	226	26	meningitis	meningitis	NOUN
aji-155	226	27	.	.	PUNCT
aji-155	227	1	disclaimer	disclaimer	PROPN
aji-155	227	2	(	(	PUNCT
aji-155	227	3	artificial	artificial	ADJ
aji-155	227	4	intelligence	intelligence	NOUN
aji-155	227	5	)	)	PUNCT
aji-155	227	6	authors	author	NOUN
aji-155	227	7	herebydeclare	herebydeclare	VERB
aji-155	227	8	that	that	SCONJ
aji-155	227	9	no	no	DET
aji-155	227	10	generative	generative	NOUN
aji-155	227	11	ai	ai	VERB
aji-155	227	12	technologies	technology	NOUN
aji-155	227	13	such	such	ADJ
aji-155	227	14	as	as	ADP
aji-155	227	15	large	large	ADJ
aji-155	227	16	language	language	NOUN
aji-155	227	17	models(chatgtp	models(chatgtp	NOUN
aji-155	227	18	,	,	PUNCT
aji-155	227	19	copilot	copilot	NOUN
aji-155	227	20	,	,	PUNCT
aji-155	227	21	etc	etc	X
aji-155	227	22	)	)	PUNCT
aji-155	227	23	and	and	CCONJ
aji-155	227	24	text	text	NOUN
aji-155	227	25	-	-	PUNCT
aji-155	227	26	toimage	toimage	NOUN
aji-155	227	27	generators	generator	NOUN
aji-155	227	28	have	have	AUX
aji-155	227	29	been	be	AUX
aji-155	227	30	used	use	VERB
aji-155	227	31	during	during	ADP
aji-155	227	32	wrting	wrting	NOUN
aji-155	227	33	or	or	CCONJ
aji-155	227	34	editing	editing	NOUN
aji-155	227	35	of	of	ADP
aji-155	227	36	this	this	DET
aji-155	227	37	mnanuscript	mnanuscript	NOUN
aji-155	227	38	.	.	PUNCT
aji-155	228	1	consent	consent	NOUN
aji-155	228	2	and	and	CCONJ
aji-155	228	3	ethical	ethical	ADJ
aji-155	228	4	approval	approval	NOUN
aji-155	228	5	it	it	PRON
aji-155	228	6	is	be	AUX
aji-155	228	7	not	not	PART
aji-155	228	8	applicable	applicable	ADJ
aji-155	228	9	.	.	PUNCT
aji-155	229	1	competing	compete	VERB
aji-155	229	2	interests	interest	NOUN
aji-155	229	3	authors	author	NOUN
aji-155	229	4	have	have	AUX
aji-155	229	5	declared	declare	VERB
aji-155	229	6	that	that	SCONJ
aji-155	229	7	no	no	DET
aji-155	229	8	competing	compete	VERB
aji-155	229	9	interests	interest	NOUN
aji-155	229	10	exist	exist	VERB
aji-155	229	11	.	.	PUNCT
aji-155	230	1	references	reference	NOUN
aji-155	230	2	alshahery	alshahery	NOUN
aji-155	230	3	,	,	PUNCT
aji-155	230	4	m.	m.	NOUN
aji-155	230	5	a.	a.	PROPN
aji-155	230	6	n.	n.	PROPN
aji-155	230	7	,	,	PUNCT
aji-155	230	8	&	&	CCONJ
aji-155	230	9	shnawa	shnawa	PROPN
aji-155	230	10	,	,	PUNCT
aji-155	230	11	i.	i.	PROPN
aji-155	230	12	m.	m.	PROPN
aji-155	230	13	s.	s.	PROPN
aji-155	230	14	(	(	PUNCT
aji-155	230	15	1989	1989	NUM
aji-155	230	16	)	)	PUNCT
aji-155	230	17	.	.	PUNCT
aji-155	231	1	the	the	DET
aji-155	231	2	immunological	immunological	ADJ
aji-155	231	3	adjuvanticity	adjuvanticity	NOUN
aji-155	231	4	of	of	ADP
aji-155	231	5	sunflower	sunflower	NOUN
aji-155	231	6	oil	oil	NOUN
aji-155	231	7	.	.	PUNCT
aji-155	232	1	cairo	cairo	PROPN
aji-155	232	2	veterinary	veterinary	PROPN
aji-155	232	3	medicine	medicine	PROPN
aji-155	232	4	journal	journal	PROPN
aji-155	232	5	,	,	PUNCT
aji-155	232	6	73(2	73(2	NUM
aji-155	232	7	)	)	PUNCT
aji-155	232	8	,	,	PUNCT
aji-155	232	9	291	291	NUM
aji-155	232	10	-	-	SYM
aji-155	232	11	298	298	NUM
aji-155	232	12	.	.	PUNCT
aji-155	233	1	burrell	burrell	PROPN
aji-155	233	2	,	,	PUNCT
aji-155	233	3	r.	r.	PROPN
aji-155	233	4	(	(	PUNCT
aji-155	233	5	1979	1979	NUM
aji-155	233	6	)	)	PUNCT
aji-155	233	7	.	.	PUNCT
aji-155	234	1	experimental	experimental	ADJ
aji-155	234	2	immunology	immunology	NOUN
aji-155	234	3	.	.	PUNCT
aji-155	235	1	burgess	burgess	PROPN
aji-155	235	2	publishing	publishing	PROPN
aji-155	235	3	co.	co.	PROPN
aji-155	235	4	catlin	catlin	PROPN
aji-155	235	5	,	,	PUNCT
aji-155	235	6	b.	b.	PROPN
aji-155	235	7	w.	w.	PROPN
aji-155	235	8	,	,	PUNCT
aji-155	235	9	bandler	bandler	PROPN
aji-155	235	10	iii	iii	PROPN
aji-155	235	11	,	,	PUNCT
aji-155	235	12	j.	j.	PROPN
aji-155	235	13	w.	w.	PROPN
aji-155	235	14	,	,	PUNCT
aji-155	235	15	&	&	CCONJ
aji-155	235	16	goodgal	goodgal	PROPN
aji-155	235	17	,	,	PUNCT
aji-155	235	18	s.	s.	PROPN
aji-155	235	19	h.	h.	PROPN
aji-155	235	20	(	(	PUNCT
aji-155	235	21	1972	1972	NUM
aji-155	235	22	)	)	PUNCT
aji-155	235	23	.	.	PUNCT
aji-155	236	1	the	the	DET
aji-155	236	2	type	type	NOUN
aji-155	236	3	b	b	PROPN
aji-155	236	4	capsule	capsule	NOUN
aji-155	236	5	locus	locus	NOUN
aji-155	236	6	of	of	ADP
aji-155	236	7	hemophilus	hemophilus	ADJ
aji-155	236	8	influenzae	influenzae	NOUN
aji-155	236	9	:	:	PUNCT
aji-155	236	10	map	map	VERB
aji-155	236	11	location	location	NOUN
aji-155	236	12	and	and	CCONJ
aji-155	236	13	size	size	NOUN
aji-155	236	14	.	.	PUNCT
aji-155	237	1	journal	journal	PROPN
aji-155	237	2	of	of	ADP
aji-155	237	3	general	general	ADJ
aji-155	237	4	microbiology	microbiology	NOUN
aji-155	237	5	,	,	PUNCT
aji-155	237	6	70	70	NUM
aji-155	237	7	,	,	PUNCT
aji-155	237	8	411	411	NUM
aji-155	237	9	-	-	SYM
aji-155	237	10	422	422	NUM
aji-155	237	11	.	.	PUNCT
aji-155	238	1	available	available	ADJ
aji-155	238	2	:	:	PUNCT
aji-155	239	1	https://doi.org/10.1099/00221287-70-3-411	https://doi.org/10.1099/00221287-70-3-411	ADJ
aji-155	239	2	garcia	garcia	PROPN
aji-155	239	3	-	-	PUNCT
aji-155	239	4	diaz	diaz	PROPN
aji-155	239	5	,	,	PUNCT
aji-155	239	6	d.	d.	PROPN
aji-155	239	7	,	,	PUNCT
aji-155	239	8	rodriguez	rodriguez	PROPN
aji-155	239	9	,	,	PUNCT
aji-155	239	10	i.	i.	PROPN
aji-155	239	11	,	,	PUNCT
aji-155	239	12	santisteban	santisteban	NOUN
aji-155	239	13	,	,	PUNCT
aji-155	239	14	y.	y.	PROPN
aji-155	239	15	,	,	PUNCT
aji-155	239	16	brown	brown	PROPN
aji-155	239	17	,	,	PUNCT
aji-155	239	18	e.	e.	PROPN
aji-155	239	19	,	,	PUNCT
aji-155	239	20	&	&	CCONJ
aji-155	239	21	iglesias	iglesias	PROPN
aji-155	239	22	,	,	PUNCT
aji-155	239	23	e.	e.	PROPN
aji-155	239	24	(	(	PUNCT
aji-155	239	25	2013	2013	NUM
aji-155	239	26	)	)	PUNCT
aji-155	239	27	.	.	PUNCT
aji-155	240	1	th2	th2	PROPN
aji-155	240	2	-	-	PUNCT
aji-155	240	3	th1	th1	PROPN
aji-155	240	4	shift	shift	NOUN
aji-155	240	5	with	with	ADP
aji-155	240	6	the	the	DET
aji-155	240	7	multiantigenic	multiantigenic	ADJ
aji-155	240	8	formulation	formulation	NOUN
aji-155	240	9	shnawa	shnawa	NOUN
aji-155	240	10	et	et	PROPN
aji-155	240	11	al	al	PROPN
aji-155	240	12	.	.	PROPN
aji-155	240	13	;	;	PUNCT
aji-155	240	14	asian	asian	PROPN
aji-155	240	15	j.	j.	PROPN
aji-155	240	16	immunol	immunol	PROPN
aji-155	240	17	.	.	PROPN
aji-155	240	18	,	,	PUNCT
aji-155	240	19	vol	vol	NOUN
aji-155	240	20	.	.	PROPN
aji-155	240	21	8	8	NUM
aji-155	240	22	,	,	PUNCT
aji-155	240	23	no	no	INTJ
aji-155	240	24	.	.	NOUN
aji-155	240	25	1	1	NUM
aji-155	240	26	,	,	PUNCT
aji-155	240	27	pp	pp	ADJ
aji-155	240	28	.	.	PUNCT
aji-155	241	1	1	1	NUM
aji-155	241	2	-	-	SYM
aji-155	241	3	7	7	NUM
aji-155	241	4	,	,	PUNCT
aji-155	241	5	2025	2025	NUM
aji-155	241	6	;	;	PUNCT
aji-155	241	7	article	article	NOUN
aji-155	241	8	no.aji.129951	no.aji.129951	NOUN
aji-155	241	9	6	6	NUM
aji-155	241	10	teravac	teravac	NOUN
aji-155	241	11	-	-	PUNCT
aji-155	241	12	hiv-1	hiv-1	PUNCT
aji-155	241	13	in	in	ADP
aji-155	241	14	balb	balb	ADJ
aji-155	241	15	/	/	SYM
aji-155	241	16	c	c	NOUN
aji-155	241	17	mice	mouse	NOUN
aji-155	241	18	.	.	PUNCT
aji-155	242	1	immunology	immunology	NOUN
aji-155	242	2	letters	letter	NOUN
aji-155	242	3	,	,	PUNCT
aji-155	242	4	149(1	149(1	NUM
aji-155	242	5	-	-	SYM
aji-155	242	6	2	2	NUM
aji-155	242	7	)	)	PUNCT
aji-155	242	8	,	,	PUNCT
aji-155	242	9	77	77	NUM
aji-155	242	10	-	-	SYM
aji-155	242	11	84	84	NUM
aji-155	242	12	.	.	PUNCT
aji-155	243	1	available	available	ADJ
aji-155	243	2	:	:	PUNCT
aji-155	243	3	https://doi.org/10.1016/j.imlet.2013.08.004	https://doi.org/10.1016/j.imlet.2013.08.004	PROPN
aji-155	243	4	gonzalez	gonzalez	PROPN
aji-155	243	5	,	,	PUNCT
aji-155	243	6	m.	m.	NOUN
aji-155	243	7	d.	d.	PROPN
aji-155	243	8	,	,	PUNCT
aji-155	243	9	&	&	CCONJ
aji-155	243	10	ledeboer	ledeboer	PROPN
aji-155	243	11	,	,	PUNCT
aji-155	243	12	n.	n.	NOUN
aji-155	243	13	a.	a.	NOUN
aji-155	243	14	(	(	PUNCT
aji-155	243	15	2023	2023	NUM
aji-155	243	16	)	)	PUNCT
aji-155	243	17	.	.	PUNCT
aji-155	244	1	hemophilus	hemophilus	ADJ
aji-155	244	2	.	.	PUNCT
aji-155	245	1	in	in	ADP
aji-155	245	2	r.	r.	PROPN
aji-155	245	3	patel	patel	PROPN
aji-155	245	4	(	(	PUNCT
aji-155	245	5	ed	ed	NOUN
aji-155	245	6	.	.	PUNCT
aji-155	245	7	)	)	PUNCT
aji-155	245	8	,	,	PUNCT
aji-155	245	9	manual	manual	NOUN
aji-155	245	10	of	of	ADP
aji-155	245	11	clinical	clinical	ADJ
aji-155	245	12	microbiology	microbiology	NOUN
aji-155	245	13	(	(	PUNCT
aji-155	245	14	13th	13th	NOUN
aji-155	245	15	ed	ed	NOUN
aji-155	245	16	.	.	PUNCT
aji-155	245	17	)	)	PUNCT
aji-155	245	18	.	.	PUNCT
aji-155	246	1	asm	asm	NOUN
aji-155	246	2	press	press	NOUN
aji-155	246	3	.	.	PUNCT
aji-155	247	1	griffiths	griffiths	PROPN
aji-155	247	2	,	,	PUNCT
aji-155	247	3	u.	u.	PROPN
aji-155	247	4	k.	k.	PROPN
aji-155	247	5	,	,	PUNCT
aji-155	247	6	clark	clark	PROPN
aji-155	247	7	,	,	PUNCT
aji-155	247	8	a.	a.	NOUN
aji-155	247	9	,	,	PUNCT
aji-155	247	10	gessner	gessner	NOUN
aji-155	247	11	,	,	PUNCT
aji-155	247	12	b.	b.	PROPN
aji-155	247	13	,	,	PUNCT
aji-155	247	14	miners	miner	NOUN
aji-155	247	15	,	,	PUNCT
aji-155	247	16	a.	a.	NOUN
aji-155	247	17	,	,	PUNCT
aji-155	247	18	sanderson	sanderson	PROPN
aji-155	247	19	,	,	PUNCT
aji-155	247	20	c.	c.	PROPN
aji-155	247	21	,	,	PUNCT
aji-155	247	22	sedyaningsih	sedyaningsih	PROPN
aji-155	247	23	,	,	PUNCT
aji-155	247	24	&	&	CCONJ
aji-155	247	25	mulholland	mulholland	PROPN
aji-155	247	26	,	,	PUNCT
aji-155	247	27	k.	k.	PROPN
aji-155	247	28	e.	e.	PROPN
aji-155	247	29	(	(	PUNCT
aji-155	247	30	2012	2012	NUM
aji-155	247	31	)	)	PUNCT
aji-155	247	32	.	.	PUNCT
aji-155	248	1	dose	dose	NOUN
aji-155	248	2	-	-	PUNCT
aji-155	248	3	specific	specific	ADJ
aji-155	248	4	hemophilus	hemophilus	ADJ
aji-155	248	5	influenzae	influenzae	NOUN
aji-155	248	6	b	b	NUM
aji-155	248	7	conjugate	conjugate	ADJ
aji-155	248	8	vaccines	vaccine	NOUN
aji-155	248	9	:	:	PUNCT
aji-155	248	10	a	a	DET
aji-155	248	11	systematic	systematic	ADJ
aji-155	248	12	review	review	NOUN
aji-155	248	13	and	and	CCONJ
aji-155	248	14	metaanalysis	metaanalysis	NOUN
aji-155	248	15	of	of	ADP
aji-155	248	16	controlled	control	VERB
aji-155	248	17	clinical	clinical	ADJ
aji-155	248	18	trials	trial	NOUN
aji-155	248	19	.	.	PUNCT
aji-155	249	1	epidemiology	epidemiology	NOUN
aji-155	249	2	and	and	CCONJ
aji-155	249	3	infection	infection	NOUN
aji-155	249	4	,	,	PUNCT
aji-155	249	5	140	140	NUM
aji-155	249	6	,	,	PUNCT
aji-155	249	7	13431355	13431355	NUM
aji-155	249	8	.	.	PUNCT
aji-155	250	1	available	available	ADJ
aji-155	250	2	:	:	PUNCT
aji-155	250	3	https://doi.org/10.1017/s09502688110026	https://doi.org/10.1017/s09502688110026	NUM
aji-155	250	4	74	74	NUM
aji-155	250	5	haddadi	haddadi	NOUN
aji-155	250	6	,	,	PUNCT
aji-155	250	7	n.	n.	PROPN
aji-155	250	8	s.	s.	PROPN
aji-155	250	9	,	,	PUNCT
aji-155	250	10	mande	mande	PROPN
aji-155	250	11	,	,	PUNCT
aji-155	250	12	p.	p.	NOUN
aji-155	250	13	,	,	PUNCT
aji-155	250	14	brodeur	brodeur	PROPN
aji-155	250	15	,	,	PUNCT
aji-155	250	16	t.	t.	PROPN
aji-155	250	17	y.	y.	PROPN
aji-155	250	18	,	,	PUNCT
aji-155	250	19	haok	haok	NOUN
aji-155	250	20	,	,	PUNCT
aji-155	250	21	r.	r.	PROPN
aji-155	250	22	g.	g.	PROPN
aji-155	250	23	,	,	PUNCT
aji-155	250	24	moses	moses	PROPN
aji-155	250	25	,	,	PUNCT
aji-155	250	26	s.	s.	PROPN
aji-155	250	27	,	,	PUNCT
aji-155	250	28	sabramanian	sabramanian	PROPN
aji-155	250	29	,	,	PUNCT
aji-155	250	30	s.	s.	PROPN
aji-155	250	31	,	,	PUNCT
aji-155	250	32	picari	picari	PROPN
aji-155	250	33	,	,	PUNCT
aji-155	250	34	x.	x.	PROPN
aji-155	250	35	,	,	PUNCT
aji-155	250	36	afatari	afatari	PROPN
aji-155	250	37	,	,	PUNCT
aji-155	250	38	k.	k.	PROPN
aji-155	250	39	,	,	PUNCT
aji-155	250	40	marshak	marshak	ADV
aji-155	250	41	-	-	PUNCT
aji-155	250	42	rothstein	rothstein	NOUN
aji-155	250	43	,	,	PUNCT
aji-155	250	44	a.	a.	PROPN
aji-155	250	45	,	,	PUNCT
aji-155	250	46	&	&	CCONJ
aji-155	250	47	richmond	richmond	PROPN
aji-155	250	48	,	,	PUNCT
aji-155	250	49	j.	j.	PROPN
aji-155	250	50	m.	m.	PROPN
aji-155	250	51	(	(	PUNCT
aji-155	250	52	2022	2022	NUM
aji-155	250	53	)	)	PUNCT
aji-155	250	54	.	.	PUNCT
aji-155	251	1	th2	th2	PROPN
aji-155	251	2	to	to	ADP
aji-155	251	3	th1	th1	PROPN
aji-155	251	4	transition	transition	NOUN
aji-155	251	5	is	be	AUX
aji-155	251	6	required	require	VERB
aji-155	251	7	for	for	ADP
aji-155	251	8	induction	induction	NOUN
aji-155	251	9	of	of	ADP
aji-155	251	10	skin	skin	NOUN
aji-155	251	11	lesions	lesion	NOUN
aji-155	251	12	in	in	ADP
aji-155	251	13	an	an	DET
aji-155	251	14	inducible	inducible	ADJ
aji-155	251	15	and	and	CCONJ
aji-155	251	16	recurrent	recurrent	ADJ
aji-155	251	17	murine	murine	ADJ
aji-155	251	18	model	model	NOUN
aji-155	251	19	of	of	ADP
aji-155	251	20	lupus	lupus	NOUN
aji-155	251	21	-	-	PUNCT
aji-155	251	22	like	like	ADJ
aji-155	251	23	inflammation	inflammation	NOUN
aji-155	251	24	.	.	PUNCT
aji-155	252	1	frontiers	frontier	NOUN
aji-155	252	2	in	in	ADP
aji-155	252	3	immunology	immunology	NOUN
aji-155	252	4	,	,	PUNCT
aji-155	252	5	13	13	NUM
aji-155	252	6	,	,	PUNCT
aji-155	252	7	883375	883375	NUM
aji-155	252	8	.	.	PUNCT
aji-155	253	1	available	available	ADJ
aji-155	253	2	:	:	PUNCT
aji-155	254	1	https://doi.org/10.3389/fimmu.2022.883375	https://doi.org/10.3389/fimmu.2022.883375	PROPN
aji-155	254	2	hansen	hansen	PROPN
aji-155	254	3	,	,	PUNCT
aji-155	254	4	e.	e.	PROPN
aji-155	254	5	j.	j.	PROPN
aji-155	254	6	,	,	PUNCT
aji-155	254	7	fresch	fresch	PROPN
aji-155	254	8	,	,	PUNCT
aji-155	254	9	c.	c.	PROPN
aji-155	254	10	f.	f.	PROPN
aji-155	254	11	,	,	PUNCT
aji-155	254	12	mcdade	mcdade	PROPN
aji-155	254	13	,	,	PUNCT
aji-155	254	14	r.	r.	PROPN
aji-155	254	15	l.	l.	PROPN
aji-155	254	16	,	,	PUNCT
aji-155	254	17	&	&	CCONJ
aji-155	254	18	johnston	johnston	PROPN
aji-155	254	19	,	,	PUNCT
aji-155	254	20	k.	k.	PROPN
aji-155	254	21	h.	h.	PROPN
aji-155	254	22	(	(	PUNCT
aji-155	254	23	1981	1981	NUM
aji-155	254	24	)	)	PUNCT
aji-155	254	25	.	.	PUNCT
aji-155	255	1	identification	identification	NOUN
aji-155	255	2	of	of	ADP
aji-155	255	3	immunogenic	immunogenic	ADJ
aji-155	255	4	outer	outer	ADJ
aji-155	255	5	membrane	membrane	NOUN
aji-155	255	6	protein	protein	NOUN
aji-155	255	7	of	of	ADP
aji-155	255	8	h.	h.	PROPN
aji-155	255	9	influenzae	influenzae	PROPN
aji-155	255	10	type	type	NOUN
aji-155	255	11	b	b	PROPN
aji-155	255	12	in	in	ADP
aji-155	255	13	the	the	DET
aji-155	255	14	infant	infant	NOUN
aji-155	255	15	rat	rat	NOUN
aji-155	255	16	model	model	NOUN
aji-155	255	17	system	system	NOUN
aji-155	255	18	.	.	PUNCT
aji-155	256	1	infection	infection	NOUN
aji-155	256	2	and	and	CCONJ
aji-155	256	3	immunity	immunity	NOUN
aji-155	256	4	,	,	PUNCT
aji-155	256	5	32(3	32(3	NUM
aji-155	256	6	)	)	PUNCT
aji-155	256	7	,	,	PUNCT
aji-155	256	8	1084	1084	NUM
aji-155	256	9	-	-	SYM
aji-155	256	10	1092	1092	NUM
aji-155	256	11	.	.	PUNCT
aji-155	257	1	available	available	ADJ
aji-155	257	2	:	:	PUNCT
aji-155	257	3	https://doi.org/10.1128/iai.32.3.10841092.1981	https://doi.org/10.1128/iai.32.3.10841092.1981	PUNCT
aji-155	257	4	hirano	hirano	PROPN
aji-155	257	5	,	,	PUNCT
aji-155	257	6	j.	j.	PROPN
aji-155	257	7	,	,	PUNCT
aji-155	257	8	kadowaki	kadowaki	PROPN
aji-155	257	9	,	,	PUNCT
aji-155	257	10	y.	y.	NOUN
aji-155	257	11	,	,	PUNCT
aji-155	257	12	susule	susule	NOUN
aji-155	257	13	,	,	PUNCT
aji-155	257	14	m.	m.	NOUN
aji-155	257	15	,	,	PUNCT
aji-155	257	16	et	et	PROPN
aji-155	257	17	al	al	PROPN
aji-155	257	18	.	.	PROPN
aji-155	258	1	(	(	PUNCT
aji-155	258	2	2019	2019	NUM
aji-155	258	3	)	)	PUNCT
aji-155	258	4	.	.	PUNCT
aji-155	259	1	interaction	interaction	NOUN
aji-155	259	2	between	between	ADP
aji-155	259	3	regulatory	regulatory	ADJ
aji-155	259	4	t	t	NOUN
aji-155	259	5	cells	cell	NOUN
aji-155	259	6	and	and	CCONJ
aji-155	259	7	antibody	antibody	NOUN
aji-155	259	8	-	-	PUNCT
aji-155	259	9	producing	produce	VERB
aji-155	259	10	b	b	NOUN
aji-155	259	11	cells	cell	NOUN
aji-155	259	12	for	for	ADP
aji-155	259	13	immune	immune	ADJ
aji-155	259	14	responses	response	NOUN
aji-155	259	15	at	at	ADP
aji-155	259	16	upper	upper	ADJ
aji-155	259	17	respiratory	respiratory	ADJ
aji-155	259	18	mucosa	mucosa	NOUN
aji-155	259	19	against	against	ADP
aji-155	259	20	nontypable	nontypable	ADJ
aji-155	259	21	hemophilus	hemophilus	ADJ
aji-155	259	22	influenzae	influenzae	NOUN
aji-155	259	23	.	.	PUNCT
aji-155	260	1	annals	annal	NOUN
aji-155	260	2	of	of	ADP
aji-155	260	3	otology	otology	NOUN
aji-155	260	4	,	,	PUNCT
aji-155	260	5	rhinology	rhinology	NOUN
aji-155	260	6	&	&	CCONJ
aji-155	260	7	laryngology	laryngology	NOUN
aji-155	260	8	,	,	PUNCT
aji-155	260	9	128(supp	128(supp	NUM
aji-155	260	10	6	6	NUM
aji-155	260	11	)	)	PUNCT
aji-155	260	12	,	,	PUNCT
aji-155	260	13	45s-51s	45s-51s	PROPN
aji-155	260	14	.	.	PUNCT
aji-155	261	1	available	available	ADJ
aji-155	261	2	:	:	PUNCT
aji-155	262	1	https://doi.org/10.1177/0003489419859537	https://doi.org/10.1177/0003489419859537	ADJ
aji-155	262	2	international	international	ADJ
aji-155	262	3	society	society	NOUN
aji-155	262	4	of	of	ADP
aji-155	262	5	infectious	infectious	ADJ
aji-155	262	6	diseases	disease	NOUN
aji-155	262	7	.	.	PUNCT
aji-155	263	1	(	(	PUNCT
aji-155	263	2	2023	2023	NUM
aji-155	263	3	)	)	PUNCT
aji-155	263	4	.	.	PUNCT
aji-155	264	1	bacterial	bacterial	ADJ
aji-155	264	2	meningitis	meningitis	NOUN
aji-155	264	3	:	:	PUNCT
aji-155	264	4	a	a	DET
aji-155	264	5	global	global	ADJ
aji-155	264	6	public	public	ADJ
aji-155	264	7	health	health	NOUN
aji-155	264	8	challenge	challenge	NOUN
aji-155	264	9	.	.	PUNCT
aji-155	265	1	retrieved	retrieve	VERB
aji-155	265	2	from	from	ADP
aji-155	265	3	https://www.isid.org	https://www.isid.org	PROPN
aji-155	265	4	jackson	jackson	PROPN
aji-155	265	5	,	,	PUNCT
aji-155	265	6	b.	b.	PROPN
aji-155	265	7	d.	d.	PROPN
aji-155	265	8	,	,	PUNCT
aji-155	265	9	miernyk	miernyk	VERB
aji-155	265	10	,	,	PUNCT
aji-155	265	11	k.	k.	PROPN
aji-155	265	12	,	,	PUNCT
aji-155	265	13	steinberg	steinberg	PROPN
aji-155	265	14	,	,	PUNCT
aji-155	265	15	j.	j.	PROPN
aji-155	265	16	,	,	PUNCT
aji-155	265	17	et	et	PROPN
aji-155	265	18	al	al	PROPN
aji-155	265	19	.	.	PUNCT
aji-155	266	1	(	(	PUNCT
aji-155	266	2	2024	2024	NUM
aji-155	266	3	)	)	PUNCT
aji-155	266	4	.	.	PUNCT
aji-155	267	1	h.	h.	PROPN
aji-155	267	2	influenzae	influenzae	PROPN
aji-155	267	3	type	type	NOUN
aji-155	267	4	b	b	PROPN
aji-155	267	5	vaccine	vaccine	NOUN
aji-155	267	6	immunogenicity	immunogenicity	NOUN
aji-155	267	7	in	in	ADP
aji-155	267	8	american	american	PROPN
aji-155	267	9	indian	indian	PROPN
aji-155	267	10	/	/	SYM
aji-155	267	11	alaska	alaska	PROPN
aji-155	267	12	native	native	ADJ
aji-155	267	13	infants	infant	NOUN
aji-155	267	14	.	.	PUNCT
aji-155	268	1	pediatrics	pediatric	NOUN
aji-155	268	2	,	,	PUNCT
aji-155	268	3	154(4	154(4	NUM
aji-155	268	4	)	)	PUNCT
aji-155	268	5	,	,	PUNCT
aji-155	268	6	e2024066658	e2024066658	NUM
aji-155	268	7	.	.	PUNCT
aji-155	268	8	available	available	ADJ
aji-155	268	9	:	:	PUNCT
aji-155	268	10	https://doi.org/10.1542/peds.2024-066658	https://doi.org/10.1542/peds.2024-066658	PROPN
aji-155	268	11	joshi	joshi	PROPN
aji-155	268	12	,	,	PUNCT
aji-155	268	13	a.	a.	PROPN
aji-155	268	14	,	,	PUNCT
aji-155	268	15	&	&	CCONJ
aji-155	268	16	chauhan	chauhan	PROPN
aji-155	268	17	,	,	PUNCT
aji-155	268	18	r.	r.	PROPN
aji-155	268	19	s.	s.	PROPN
aji-155	268	20	(	(	PUNCT
aji-155	268	21	2022	2022	NUM
aji-155	268	22	)	)	PUNCT
aji-155	268	23	.	.	PUNCT
aji-155	269	1	immunological	immunological	ADJ
aji-155	269	2	techniques	technique	NOUN
aji-155	269	3	:	:	PUNCT
aji-155	269	4	interpretation	interpretation	NOUN
aji-155	269	5	,	,	PUNCT
aji-155	269	6	validation	validation	NOUN
aji-155	269	7	,	,	PUNCT
aji-155	269	8	and	and	CCONJ
aji-155	269	9	safety	safety	NOUN
aji-155	269	10	measures	measure	NOUN
aji-155	269	11	.	.	PUNCT
aji-155	270	1	prakashan	prakashan	VERB
aji-155	270	2	,	,	PUNCT
aji-155	270	3	haryana	haryana	PROPN
aji-155	270	4	,	,	PUNCT
aji-155	270	5	india	india	PROPN
aji-155	270	6	.	.	PUNCT
aji-155	270	7	kwapnski	kwapnski	PROPN
aji-155	270	8	,	,	PUNCT
aji-155	270	9	j.	j.	PROPN
aji-155	270	10	b.	b.	PROPN
aji-155	270	11	(	(	PUNCT
aji-155	270	12	1972	1972	NUM
aji-155	270	13	)	)	PUNCT
aji-155	270	14	.	.	PUNCT
aji-155	271	1	methodology	methodology	NOUN
aji-155	271	2	of	of	ADP
aji-155	271	3	immunochemical	immunochemical	ADJ
aji-155	271	4	and	and	CCONJ
aji-155	271	5	immunological	immunological	ADJ
aji-155	271	6	research	research	NOUN
aji-155	271	7	.	.	PUNCT
aji-155	272	1	wiley	wiley	NOUN
aji-155	272	2	-	-	PUNCT
aji-155	272	3	interscience	interscience	NOUN
aji-155	272	4	.	.	PUNCT
aji-155	273	1	lagou	lagou	PROPN
aji-155	273	2	,	,	PUNCT
aji-155	273	3	v.	v.	PROPN
aji-155	273	4	,	,	PUNCT
aji-155	273	5	garcia	garcia	PROPN
aji-155	273	6	-	-	PUNCT
aji-155	273	7	perez	perez	PROPN
aji-155	273	8	,	,	PUNCT
aji-155	273	9	j.	j.	PROPN
aji-155	273	10	e.	e.	PROPN
aji-155	273	11	,	,	PUNCT
aji-155	273	12	smet	smet	PROPN
aji-155	273	13	,	,	PUNCT
aji-155	273	14	i.	i.	PROPN
aji-155	273	15	,	,	PUNCT
aji-155	273	16	et	et	PROPN
aji-155	273	17	al	al	PROPN
aji-155	273	18	.	.	PUNCT
aji-155	274	1	(	(	PUNCT
aji-155	274	2	2018	2018	NUM
aji-155	274	3	)	)	PUNCT
aji-155	274	4	.	.	PUNCT
aji-155	275	1	genetic	genetic	ADJ
aji-155	275	2	architecture	architecture	NOUN
aji-155	275	3	of	of	ADP
aji-155	275	4	the	the	DET
aji-155	275	5	adaptive	adaptive	ADJ
aji-155	275	6	immune	immune	ADJ
aji-155	275	7	system	system	NOUN
aji-155	275	8	identifies	identify	VERB
aji-155	275	9	key	key	ADJ
aji-155	275	10	immune	immune	ADJ
aji-155	275	11	regulators	regulator	NOUN
aji-155	275	12	.	.	PUNCT
aji-155	276	1	cell	cell	NOUN
aji-155	276	2	reports	report	NOUN
aji-155	276	3	,	,	PUNCT
aji-155	276	4	25	25	NUM
aji-155	276	5	,	,	PUNCT
aji-155	276	6	78810	78810	NUM
aji-155	276	7	.	.	PUNCT
aji-155	277	1	available	available	ADJ
aji-155	277	2	:	:	PUNCT
aji-155	278	1	https://doi.org/10.1016/j.celrep.2018.09.08	https://doi.org/10.1016/j.celrep.2018.09.08	ADJ
aji-155	278	2	0	0	NUM
aji-155	278	3	latez	latez	PROPN
aji-155	278	4	,	,	PUNCT
aji-155	278	5	e.	e.	PROPN
aji-155	278	6	,	,	PUNCT
aji-155	278	7	franko	franko	PROPN
aji-155	278	8	,	,	PUNCT
aji-155	278	9	j.	j.	PROPN
aji-155	278	10	,	,	PUNCT
aji-155	278	11	golenbock	golenbock	PROPN
aji-155	278	12	,	,	PUNCT
aji-155	278	13	d.	d.	PROPN
aji-155	278	14	t.	t.	PROPN
aji-155	278	15	,	,	PUNCT
aji-155	278	16	&	&	CCONJ
aji-155	278	17	schreiber	schreiber	PROPN
aji-155	278	18	,	,	PUNCT
aji-155	278	19	j.	j.	PROPN
aji-155	278	20	r.	r.	PROPN
aji-155	278	21	(	(	PUNCT
aji-155	278	22	2004	2004	NUM
aji-155	278	23	)	)	PUNCT
aji-155	278	24	.	.	PUNCT
aji-155	279	1	hemophilus	hemophilus	ADV
aji-155	279	2	influenzae	influenzae	PROPN
aji-155	279	3	b	b	PROPN
aji-155	279	4	outer	outer	ADJ
aji-155	279	5	-	-	PUNCT
aji-155	279	6	membrane	membrane	NOUN
aji-155	279	7	protein	protein	NOUN
aji-155	279	8	glycoconjugates	glycoconjugate	NOUN
aji-155	279	9	vaccine	vaccine	NOUN
aji-155	279	10	induces	induce	VERB
aji-155	279	11	cytokine	cytokine	ADJ
aji-155	279	12	production	production	NOUN
aji-155	279	13	by	by	ADP
aji-155	279	14	engagement	engagement	NOUN
aji-155	279	15	with	with	ADP
aji-155	279	16	toll	toll	NOUN
aji-155	279	17	-	-	PUNCT
aji-155	279	18	like	like	ADJ
aji-155	279	19	receptor	receptor	NOUN
aji-155	279	20	2	2	NUM
aji-155	279	21	(	(	PUNCT
aji-155	279	22	tlr2	tlr2	PROPN
aji-155	279	23	)	)	PUNCT
aji-155	279	24	and	and	CCONJ
aji-155	279	25	requires	require	VERB
aji-155	279	26	the	the	DET
aji-155	279	27	presence	presence	NOUN
aji-155	279	28	of	of	ADP
aji-155	279	29	optimal	optimal	ADJ
aji-155	279	30	immunogenicity	immunogenicity	NOUN
aji-155	279	31	.	.	PUNCT
aji-155	280	1	journal	journal	NOUN
aji-155	280	2	of	of	ADP
aji-155	280	3	immunology	immunology	NOUN
aji-155	280	4	,	,	PUNCT
aji-155	280	5	172	172	NUM
aji-155	280	6	,	,	PUNCT
aji-155	280	7	2431	2431	NUM
aji-155	280	8	-	-	SYM
aji-155	280	9	2438	2438	NUM
aji-155	280	10	.	.	PUNCT
aji-155	281	1	available	available	ADJ
aji-155	281	2	:	:	PUNCT
aji-155	281	3	https://doi.org/10.4049/jimmunol.172.4.243	https://doi.org/10.4049/jimmunol.172.4.243	PROPN
aji-155	281	4	1	1	NUM
aji-155	281	5	lee	lee	PROPN
aji-155	281	6	,	,	PUNCT
aji-155	281	7	h.	h.	PROPN
aji-155	281	8	,	,	PUNCT
aji-155	281	9	hahn	hahn	PROPN
aji-155	281	10	,	,	PUNCT
aji-155	281	11	s.	s.	PROPN
aji-155	281	12	,	,	PUNCT
aji-155	281	13	lee	lee	PROPN
aji-155	281	14	,	,	PUNCT
aji-155	281	15	h.	h.	PROPN
aji-155	281	16	j.	j.	PROPN
aji-155	281	17	,	,	PUNCT
aji-155	281	18	&	&	CCONJ
aji-155	281	19	kim	kim	PROPN
aji-155	281	20	,	,	PUNCT
aji-155	281	21	k.	k.	PROPN
aji-155	281	22	h.	h.	PROPN
aji-155	281	23	(	(	PUNCT
aji-155	281	24	2010	2010	NUM
aji-155	281	25	)	)	PUNCT
aji-155	281	26	.	.	PUNCT
aji-155	282	1	immunogenicity	immunogenicity	NOUN
aji-155	282	2	of	of	ADP
aji-155	282	3	hemophilus	hemophilus	ADJ
aji-155	282	4	influenzae	influenzae	ADJ
aji-155	282	5	type	type	NOUN
aji-155	282	6	b	b	PROPN
aji-155	282	7	conjugate	conjugate	ADJ
aji-155	282	8	vaccine	vaccine	NOUN
aji-155	282	9	in	in	ADP
aji-155	282	10	korean	korean	ADJ
aji-155	282	11	infants	infant	NOUN
aji-155	282	12	:	:	PUNCT
aji-155	282	13	a	a	DET
aji-155	282	14	meta	meta	ADJ
aji-155	282	15	-	-	PUNCT
aji-155	282	16	analysis	analysis	NOUN
aji-155	282	17	.	.	PUNCT
aji-155	283	1	journal	journal	NOUN
aji-155	283	2	of	of	ADP
aji-155	283	3	korean	korean	PROPN
aji-155	283	4	medical	medical	ADJ
aji-155	283	5	science	science	NOUN
aji-155	283	6	,	,	PUNCT
aji-155	283	7	25(1	25(1	NUM
aji-155	283	8	)	)	PUNCT
aji-155	283	9	,	,	PUNCT
aji-155	283	10	90	90	NUM
aji-155	283	11	-	-	SYM
aji-155	283	12	96	96	NUM
aji-155	283	13	.	.	PUNCT
aji-155	284	1	available	available	ADJ
aji-155	284	2	:	:	PUNCT
aji-155	284	3	https://doi.org/10.3346/jkms.2010.25.1.90	https://doi.org/10.3346/jkms.2010.25.1.90	ADV
aji-155	284	4	levenison	levenison	PROPN
aji-155	284	5	,	,	PUNCT
aji-155	284	6	w.	w.	PROPN
aji-155	284	7	,	,	PUNCT
aji-155	284	8	chin	chin	PROPN
aji-155	284	9	-	-	PUNCT
aji-155	284	10	hong	hong	PROPN
aji-155	284	11	,	,	PUNCT
aji-155	284	12	p.	p.	PROPN
aji-155	284	13	,	,	PUNCT
aji-155	284	14	joyc	joyc	PROPN
aji-155	284	15	,	,	PUNCT
aji-155	284	16	e.	e.	PROPN
aji-155	284	17	a.	a.	PROPN
aji-155	284	18	,	,	PUNCT
aji-155	284	19	nussbaum	nussbaum	PROPN
aji-155	284	20	,	,	PUNCT
aji-155	284	21	j.	j.	PROPN
aji-155	284	22	,	,	PUNCT
aji-155	284	23	&	&	CCONJ
aji-155	284	24	schwartz	schwartz	PROPN
aji-155	284	25	,	,	PUNCT
aji-155	284	26	b.	b.	PROPN
aji-155	284	27	(	(	PUNCT
aji-155	284	28	2018	2018	NUM
aji-155	284	29	)	)	PUNCT
aji-155	284	30	.	.	PUNCT
aji-155	285	1	review	review	NOUN
aji-155	285	2	of	of	ADP
aji-155	285	3	medical	medical	ADJ
aji-155	285	4	microbiology	microbiology	NOUN
aji-155	285	5	and	and	CCONJ
aji-155	285	6	immunology	immunology	NOUN
aji-155	285	7	(	(	PUNCT
aji-155	285	8	15th	15th	ADJ
aji-155	285	9	ed	ed	NOUN
aji-155	285	10	.	.	PUNCT
aji-155	285	11	)	)	PUNCT
aji-155	285	12	.	.	PUNCT
aji-155	286	1	mcgraw	mcgraw	PROPN
aji-155	286	2	-	-	PUNCT
aji-155	286	3	hill	hill	NOUN
aji-155	286	4	lange	lange	NOUN
aji-155	286	5	.	.	PUNCT
aji-155	287	1	mawas	mawas	PROPN
aji-155	287	2	,	,	PUNCT
aji-155	287	3	f.	f.	PROPN
aji-155	287	4	,	,	PUNCT
aji-155	287	5	newman	newman	PROPN
aji-155	287	6	,	,	PUNCT
aji-155	287	7	g.	g.	PROPN
aji-155	287	8	,	,	PUNCT
aji-155	287	9	burns	burn	NOUN
aji-155	287	10	,	,	PUNCT
aji-155	287	11	s.	s.	PROPN
aji-155	287	12	,	,	PUNCT
aji-155	287	13	&	&	CCONJ
aji-155	287	14	carbel	carbel	PROPN
aji-155	287	15	,	,	PUNCT
aji-155	287	16	m.	m.	NOUN
aji-155	287	17	j.	j.	PROPN
aji-155	287	18	(	(	PUNCT
aji-155	287	19	2006	2006	NUM
aji-155	287	20	)	)	PUNCT
aji-155	287	21	.	.	PUNCT
aji-155	288	1	suppression	suppression	NOUN
aji-155	288	2	and	and	CCONJ
aji-155	288	3	modulation	modulation	NOUN
aji-155	288	4	of	of	ADP
aji-155	288	5	cellular	cellular	ADJ
aji-155	288	6	and	and	CCONJ
aji-155	288	7	humoral	humoral	ADJ
aji-155	288	8	immune	immune	ADJ
aji-155	288	9	responses	response	NOUN
aji-155	288	10	to	to	ADP
aji-155	288	11	h.	h.	PROPN
aji-155	288	12	influenzae	influenzae	PROPN
aji-155	288	13	type	type	NOUN
aji-155	288	14	b	b	PROPN
aji-155	288	15	conjugate	conjugate	ADJ
aji-155	288	16	vaccine	vaccine	NOUN
aji-155	288	17	in	in	ADP
aji-155	288	18	hib	hib	NOUN
aji-155	288	19	-	-	PUNCT
aji-155	288	20	diphtheria	diphtheria	NOUN
aji-155	288	21	-	-	PUNCT
aji-155	288	22	tetanus	tetanus	NOUN
aji-155	288	23	-	-	PUNCT
aji-155	288	24	toxoid	toxoid	VERB
aji-155	288	25	-	-	ADJ
aji-155	288	26	acellular	acellular	ADJ
aji-155	288	27	pertussis	pertussis	NOUN
aji-155	288	28	combination	combination	NOUN
aji-155	288	29	vaccines	vaccine	NOUN
aji-155	288	30	:	:	PUNCT
aji-155	288	31	a	a	DET
aji-155	288	32	study	study	NOUN
aji-155	288	33	in	in	ADP
aji-155	288	34	a	a	DET
aji-155	288	35	rat	rat	NOUN
aji-155	288	36	model	model	NOUN
aji-155	288	37	.	.	PUNCT
aji-155	289	1	journal	journal	PROPN
aji-155	289	2	of	of	ADP
aji-155	289	3	infectious	infectious	ADJ
aji-155	289	4	diseases	disease	NOUN
aji-155	289	5	,	,	PUNCT
aji-155	289	6	191	191	NUM
aji-155	289	7	,	,	PUNCT
aji-155	289	8	58	58	NUM
aji-155	289	9	-	-	SYM
aji-155	289	10	64	64	NUM
aji-155	289	11	.	.	PUNCT
aji-155	290	1	available	available	ADJ
aji-155	290	2	:	:	PUNCT
aji-155	290	3	https://doi.org/10.1086/496954	https://doi.org/10.1086/496954	VERB
aji-155	290	4	mcvernon	mcvernon	NOUN
aji-155	290	5	,	,	PUNCT
aji-155	290	6	j.	j.	PROPN
aji-155	290	7	,	,	PUNCT
aji-155	290	8	johnson	johnson	PROPN
aji-155	290	9	,	,	PUNCT
aji-155	290	10	p.	p.	PROPN
aji-155	290	11	,	,	PUNCT
aji-155	290	12	pollard	pollard	PROPN
aji-155	290	13	,	,	PUNCT
aji-155	290	14	a.	a.	PROPN
aji-155	290	15	,	,	PUNCT
aji-155	290	16	elack	elack	VERB
aji-155	290	17	,	,	PUNCT
aji-155	290	18	m.	m.	NOUN
aji-155	290	19	,	,	PUNCT
aji-155	290	20	&	&	CCONJ
aji-155	290	21	moxon	moxon	PROPN
aji-155	290	22	,	,	PUNCT
aji-155	290	23	e.	e.	PROPN
aji-155	290	24	(	(	PUNCT
aji-155	290	25	2005	2005	NUM
aji-155	290	26	)	)	PUNCT
aji-155	290	27	.	.	PUNCT
aji-155	291	1	immunological	immunological	ADJ
aji-155	291	2	memory	memory	NOUN
aji-155	291	3	in	in	ADP
aji-155	291	4	hib	hib	PROPN
aji-155	291	5	conjugate	conjugate	ADJ
aji-155	291	6	vaccine	vaccine	NOUN
aji-155	291	7	failure	failure	NOUN
aji-155	291	8	.	.	PUNCT
aji-155	292	1	archives	archive	NOUN
aji-155	292	2	of	of	ADP
aji-155	292	3	disease	disease	NOUN
aji-155	292	4	in	in	ADP
aji-155	292	5	childhood	childhood	NOUN
aji-155	292	6	,	,	PUNCT
aji-155	292	7	88	88	NUM
aji-155	292	8	,	,	PUNCT
aji-155	292	9	379383	379383	NUM
aji-155	292	10	.	.	PUNCT
aji-155	293	1	available	available	ADJ
aji-155	293	2	:	:	PUNCT
aji-155	293	3	https://doi.org/10.1136/adc.2004.062460	https://doi.org/10.1136/adc.2004.062460	PROPN
aji-155	293	4	metcalf	metcalf	PROPN
aji-155	293	5	,	,	PUNCT
aji-155	293	6	j.	j.	PROPN
aji-155	293	7	a.	a.	PROPN
aji-155	293	8	,	,	PUNCT
aji-155	293	9	gallin	gallin	PROPN
aji-155	293	10	,	,	PUNCT
aji-155	293	11	j.	j.	PROPN
aji-155	293	12	i.	i.	PROPN
aji-155	293	13	,	,	PUNCT
aji-155	293	14	nauseef	nauseef	PROPN
aji-155	293	15	,	,	PUNCT
aji-155	293	16	w.	w.	PROPN
aji-155	293	17	m.	m.	PROPN
aji-155	293	18	,	,	PUNCT
aji-155	293	19	&	&	CCONJ
aji-155	293	20	root	root	PROPN
aji-155	293	21	,	,	PUNCT
aji-155	293	22	r.	r.	PROPN
aji-155	293	23	k.	k.	PROPN
aji-155	293	24	(	(	PUNCT
aji-155	293	25	1986	1986	NUM
aji-155	293	26	)	)	PUNCT
aji-155	293	27	.	.	PUNCT
aji-155	294	1	laboratory	laboratory	NOUN
aji-155	294	2	manual	manual	NOUN
aji-155	294	3	of	of	ADP
aji-155	294	4	neutrophil	neutrophil	ADJ
aji-155	294	5	function	function	NOUN
aji-155	294	6	.	.	PUNCT
aji-155	295	1	raven	raven	PROPN
aji-155	295	2	press	press	PROPN
aji-155	295	3	.	.	PUNCT
aji-155	296	1	misseneir	misseneir	PROPN
aji-155	296	2	,	,	PUNCT
aji-155	296	3	h.	h.	PROPN
aji-155	296	4	,	,	PUNCT
aji-155	296	5	&	&	CCONJ
aji-155	296	6	lary	lary	PROPN
aji-155	296	7	,	,	PUNCT
aji-155	296	8	k.	k.	PROPN
aji-155	296	9	(	(	PUNCT
aji-155	296	10	2002	2002	NUM
aji-155	296	11	)	)	PUNCT
aji-155	296	12	.	.	PUNCT
aji-155	297	1	control	control	NOUN
aji-155	297	2	of	of	ADP
aji-155	297	3	diseases	disease	NOUN
aji-155	297	4	attributable	attributable	ADJ
aji-155	297	5	to	to	ADP
aji-155	297	6	hemophilus	hemophilus	ADJ
aji-155	297	7	influenzae	influenzae	PROPN
aji-155	297	8	b	b	PROPN
aji-155	297	9	and	and	CCONJ
aji-155	297	10	the	the	DET
aji-155	297	11	national	national	ADJ
aji-155	297	12	immunization	immunization	NOUN
aji-155	297	13	program	program	NOUN
aji-155	297	14	.	.	PUNCT
aji-155	298	1	pediatrics	pediatric	NOUN
aji-155	298	2	,	,	PUNCT
aji-155	298	3	110(4	110(4	NUM
aji-155	298	4	)	)	PUNCT
aji-155	298	5	,	,	PUNCT
aji-155	298	6	820	820	NUM
aji-155	298	7	-	-	SYM
aji-155	298	8	823	823	NUM
aji-155	298	9	.	.	PUNCT
aji-155	299	1	shnawa	shnawa	PROPN
aji-155	299	2	et	et	PROPN
aji-155	299	3	al	al	PROPN
aji-155	299	4	.	.	PROPN
aji-155	299	5	;	;	PUNCT
aji-155	299	6	asian	asian	PROPN
aji-155	299	7	j.	j.	PROPN
aji-155	299	8	immunol	immunol	PROPN
aji-155	299	9	.	.	PROPN
aji-155	299	10	,	,	PUNCT
aji-155	299	11	vol	vol	NOUN
aji-155	299	12	.	.	PROPN
aji-155	299	13	8	8	NUM
aji-155	299	14	,	,	PUNCT
aji-155	299	15	no	no	INTJ
aji-155	299	16	.	.	NOUN
aji-155	299	17	1	1	NUM
aji-155	299	18	,	,	PUNCT
aji-155	299	19	pp	pp	ADJ
aji-155	299	20	.	.	PUNCT
aji-155	300	1	1	1	NUM
aji-155	300	2	-	-	SYM
aji-155	300	3	7	7	NUM
aji-155	300	4	,	,	PUNCT
aji-155	300	5	2025	2025	NUM
aji-155	300	6	;	;	PUNCT
aji-155	300	7	article	article	NOUN
aji-155	300	8	no.aji.129951	no.aji.129951	PROPN
aji-155	300	9	7	7	NUM
aji-155	300	10	available	available	ADJ
aji-155	300	11	:	:	PUNCT
aji-155	300	12	https://doi.org/10.1542	https://doi.org/10.1542	NOUN
aji-155	300	13	/	/	SYM
aji-155	300	14	peds.110	peds.110	NOUN
aji-155	300	15	.	.	PROPN
aji-155	300	16	4.820	4.820	NUM
aji-155	300	17	pradeu	pradeu	NOUN
aji-155	300	18	,	,	PUNCT
aji-155	300	19	t.	t.	PROPN
aji-155	300	20	,	,	PUNCT
aji-155	300	21	&	&	CCONJ
aji-155	300	22	carssella	carssella	PROPN
aji-155	300	23	,	,	PUNCT
aji-155	300	24	e.	e.	PROPN
aji-155	300	25	d.	d.	PROPN
aji-155	300	26	(	(	PUNCT
aji-155	300	27	2006	2006	NUM
aji-155	300	28	)	)	PUNCT
aji-155	300	29	.	.	PUNCT
aji-155	301	1	on	on	ADP
aji-155	301	2	the	the	DET
aji-155	301	3	definition	definition	NOUN
aji-155	301	4	of	of	ADP
aji-155	301	5	a	a	DET
aji-155	301	6	criterion	criterion	NOUN
aji-155	301	7	of	of	ADP
aji-155	301	8	immunogenicity	immunogenicity	NOUN
aji-155	301	9	.	.	PUNCT
aji-155	302	1	proceedings	proceeding	NOUN
aji-155	302	2	of	of	ADP
aji-155	302	3	the	the	DET
aji-155	302	4	national	national	PROPN
aji-155	302	5	academy	academy	PROPN
aji-155	302	6	of	of	ADP
aji-155	302	7	sciences	sciences	PROPN
aji-155	302	8	of	of	ADP
aji-155	302	9	the	the	DET
aji-155	302	10	united	united	PROPN
aji-155	302	11	states	states	PROPN
aji-155	302	12	of	of	ADP
aji-155	302	13	america	america	PROPN
aji-155	302	14	,	,	PUNCT
aji-155	302	15	103(47	103(47	NUM
aji-155	302	16	)	)	PUNCT
aji-155	302	17	,	,	PUNCT
aji-155	302	18	17858	17858	NUM
aji-155	302	19	-	-	SYM
aji-155	302	20	17861	17861	NUM
aji-155	302	21	.	.	PUNCT
aji-155	303	1	available	available	ADJ
aji-155	303	2	:	:	PUNCT
aji-155	303	3	https://doi.org/10.1073/pnas.0603497103	https://doi.org/10.1073/pnas.0603497103	ADJ
aji-155	303	4	santosham	santosham	NOUN
aji-155	303	5	,	,	PUNCT
aji-155	303	6	m.	m.	NOUN
aji-155	303	7	(	(	PUNCT
aji-155	303	8	1993	1993	NUM
aji-155	303	9	)	)	PUNCT
aji-155	303	10	.	.	PUNCT
aji-155	304	1	presentation	presentation	NOUN
aji-155	304	2	of	of	ADP
aji-155	304	3	hemophilus	hemophilus	ADJ
aji-155	304	4	influenzae	influenzae	ADJ
aji-155	304	5	type	type	NOUN
aji-155	304	6	b	b	PROPN
aji-155	304	7	disease	disease	NOUN
aji-155	304	8	.	.	PUNCT
aji-155	305	1	vaccine	vaccine	NOUN
aji-155	305	2	,	,	PUNCT
aji-155	305	3	11(51	11(51	NUM
aji-155	305	4	)	)	PUNCT
aji-155	305	5	,	,	PUNCT
aji-155	305	6	552	552	NUM
aji-155	305	7	-	-	SYM
aji-155	305	8	557	557	NUM
aji-155	305	9	.	.	PUNCT
aji-155	306	1	available	available	ADJ
aji-155	306	2	:	:	PUNCT
aji-155	306	3	https://doi.org/10.1016/0264410x(93)90273-4	https://doi.org/10.1016/0264410x(93)90273-4	PROPN
aji-155	306	4	shnawa	shnawa	PROPN
aji-155	306	5	,	,	PUNCT
aji-155	306	6	i.	i.	PROPN
aji-155	306	7	m.	m.	PROPN
aji-155	306	8	s.	s.	PROPN
aji-155	306	9	(	(	PUNCT
aji-155	306	10	2006	2006	NUM
aji-155	306	11	)	)	PUNCT
aji-155	306	12	.	.	PUNCT
aji-155	307	1	lapin	lapin	PROPN
aji-155	307	2	systemic	systemic	ADJ
aji-155	307	3	versus	versus	ADP
aji-155	307	4	mucosal	mucosal	ADJ
aji-155	307	5	humoral	humoral	ADJ
aji-155	307	6	responses	response	NOUN
aji-155	307	7	as	as	ADV
aji-155	307	8	well	well	ADV
aji-155	307	9	as	as	ADP
aji-155	307	10	cellular	cellular	ADJ
aji-155	307	11	immune	immune	ADJ
aji-155	307	12	responses	response	NOUN
aji-155	307	13	following	follow	VERB
aji-155	307	14	intravenous	intravenous	ADJ
aji-155	307	15	administration	administration	NOUN
aji-155	307	16	of	of	ADP
aji-155	307	17	c.	c.	PROPN
aji-155	307	18	fetus	fetus	PROPN
aji-155	307	19	heatkilled	heatkille	VERB
aji-155	307	20	bacterin	bacterin	PROPN
aji-155	307	21	:	:	PUNCT
aji-155	307	22	a	a	DET
aji-155	307	23	correlative	correlative	ADJ
aji-155	307	24	approach	approach	NOUN
aji-155	307	25	.	.	PUNCT
aji-155	308	1	al	al	PROPN
aji-155	308	2	qadysiah	qadysiah	PROPN
aji-155	308	3	veterinary	veterinary	ADJ
aji-155	308	4	medical	medical	ADJ
aji-155	308	5	science	science	NOUN
aji-155	308	6	,	,	PUNCT
aji-155	308	7	1(5	1(5	NUM
aji-155	308	8	)	)	PUNCT
aji-155	308	9	,	,	PUNCT
aji-155	308	10	47	47	NUM
aji-155	308	11	-	-	SYM
aji-155	308	12	51	51	NUM
aji-155	308	13	.	.	PUNCT
aji-155	309	1	shnawa	shnawa	PROPN
aji-155	309	2	,	,	PUNCT
aji-155	309	3	i.	i.	PROPN
aji-155	309	4	m.	m.	PROPN
aji-155	309	5	s.	s.	PROPN
aji-155	309	6	(	(	PUNCT
aji-155	309	7	2019	2019	NUM
aji-155	309	8	)	)	PUNCT
aji-155	309	9	.	.	PUNCT
aji-155	310	1	vaccine	vaccine	NOUN
aji-155	310	2	technology	technology	NOUN
aji-155	310	3	at	at	ADP
aji-155	310	4	a	a	DET
aji-155	310	5	glance	glance	NOUN
aji-155	310	6	.	.	PUNCT
aji-155	311	1	boffin	boffin	NOUN
aji-155	311	2	access	access	NOUN
aji-155	311	3	.	.	PUNCT
aji-155	312	1	shnawa	shnawa	PROPN
aji-155	312	2	,	,	PUNCT
aji-155	312	3	i.	i.	PROPN
aji-155	312	4	m.	m.	PROPN
aji-155	312	5	s.	s.	PROPN
aji-155	312	6	,	,	PUNCT
aji-155	312	7	&	&	CCONJ
aji-155	312	8	thewaini	thewaini	PROPN
aji-155	312	9	,	,	PUNCT
aji-155	312	10	q.	q.	PROPN
aji-155	312	11	n.	n.	PROPN
aji-155	312	12	a.	a.	PROPN
aji-155	312	13	(	(	PUNCT
aji-155	312	14	2002	2002	NUM
aji-155	312	15	)	)	PUNCT
aji-155	312	16	.	.	PUNCT
aji-155	313	1	lapin	lapin	PROPN
aji-155	313	2	mucosal	mucosal	NOUN
aji-155	313	3	versus	versus	ADP
aji-155	313	4	systemic	systemic	ADJ
aji-155	313	5	humoral	humoral	ADJ
aji-155	313	6	and	and	CCONJ
aji-155	313	7	cellular	cellular	ADJ
aji-155	313	8	immune	immune	ADJ
aji-155	313	9	responses	response	NOUN
aji-155	313	10	postintratesticular	postintratesticular	ADJ
aji-155	313	11	administration	administration	NOUN
aji-155	313	12	of	of	ADP
aji-155	313	13	heat	heat	NOUN
aji-155	313	14	-	-	PUNCT
aji-155	313	15	killed	kill	VERB
aji-155	313	16	c.	c.	NOUN
aji-155	313	17	fetus	fetus	NOUN
aji-155	313	18	.	.	PUNCT
aji-155	314	1	journal	journal	PROPN
aji-155	314	2	of	of	ADP
aji-155	314	3	baby	baby	PROPN
aji-155	314	4	university	university	PROPN
aji-155	314	5	,	,	PUNCT
aji-155	314	6	7(3	7(3	NUM
aji-155	314	7	)	)	PUNCT
aji-155	314	8	,	,	PUNCT
aji-155	314	9	538	538	NUM
aji-155	314	10	-	-	SYM
aji-155	314	11	543	543	NUM
aji-155	314	12	.	.	PUNCT
aji-155	315	1	sixt	sixt	ADJ
aji-155	315	2	,	,	PUNCT
aji-155	315	3	m.	m.	NOUN
aji-155	315	4	,	,	PUNCT
aji-155	315	5	&	&	CCONJ
aji-155	315	6	lammermann	lammermann	PROPN
aji-155	315	7	,	,	PUNCT
aji-155	315	8	t.	t.	PROPN
aji-155	315	9	(	(	PUNCT
aji-155	315	10	2011	2011	NUM
aji-155	315	11	)	)	PUNCT
aji-155	315	12	.	.	PUNCT
aji-155	316	1	in	in	ADP
aji-155	316	2	vitro	vitro	X
aji-155	316	3	analysis	analysis	NOUN
aji-155	316	4	of	of	ADP
aji-155	316	5	chemotactic	chemotactic	ADJ
aji-155	316	6	migration	migration	NOUN
aji-155	316	7	in	in	ADP
aji-155	316	8	3d	3d	NUM
aji-155	316	9	environments	environment	NOUN
aji-155	316	10	.	.	PUNCT
aji-155	317	1	in	in	ADP
aji-155	317	2	c.	c.	PROPN
aji-155	317	3	m.	m.	PROPN
aji-155	317	4	wells	wells	PROPN
aji-155	317	5	&	&	CCONJ
aji-155	317	6	m.	m.	PROPN
aji-155	317	7	parsons	parsons	PROPN
aji-155	317	8	(	(	PUNCT
aji-155	317	9	eds	ed	NOUN
aji-155	317	10	.	.	PUNCT
aji-155	317	11	)	)	PUNCT
aji-155	317	12	,	,	PUNCT
aji-155	317	13	cell	cell	NOUN
aji-155	317	14	migration	migration	NOUN
aji-155	317	15	:	:	PUNCT
aji-155	317	16	developmental	developmental	ADJ
aji-155	317	17	methods	method	NOUN
aji-155	317	18	and	and	CCONJ
aji-155	317	19	protocols	protocol	NOUN
aji-155	317	20	(	(	PUNCT
aji-155	317	21	vol	vol	NOUN
aji-155	317	22	.	.	PUNCT
aji-155	317	23	769	769	NUM
aji-155	317	24	,	,	PUNCT
aji-155	317	25	pp	pp	ADJ
aji-155	317	26	.	.	PUNCT
aji-155	317	27	113126	113126	NUM
aji-155	317	28	)	)	PUNCT
aji-155	317	29	.	.	PUNCT
aji-155	318	1	springer	springer	NOUN
aji-155	318	2	science	science	PROPN
aji-155	318	3	.	.	PUNCT
aji-155	319	1	available	available	ADJ
aji-155	319	2	:	:	PUNCT
aji-155	319	3	https://doi.org/10.1007/978-1-61779-2076_11	https://doi.org/10.1007/978-1-61779-2076_11	PROPN
aji-155	319	4	soberg	soberg	PROPN
aji-155	319	5	,	,	PUNCT
aji-155	319	6	m.	m.	NOUN
aji-155	319	7	(	(	PUNCT
aji-155	319	8	1969	1969	NUM
aji-155	319	9	)	)	PUNCT
aji-155	319	10	.	.	PUNCT
aji-155	320	1	interaction	interaction	NOUN
aji-155	320	2	of	of	ADP
aji-155	320	3	human	human	ADJ
aji-155	320	4	peripheral	peripheral	ADJ
aji-155	320	5	blood	blood	NOUN
aji-155	320	6	lymphocytes	lymphocyte	VERB
aji-155	320	7	and	and	CCONJ
aji-155	320	8	granulocytes	granulocyte	NOUN
aji-155	320	9	in	in	ADP
aji-155	320	10	the	the	DET
aji-155	320	11	migration	migration	NOUN
aji-155	320	12	inhibition	inhibition	NOUN
aji-155	320	13	reaction	reaction	NOUN
aji-155	320	14	.	.	PUNCT
aji-155	321	1	acta	acta	PROPN
aji-155	321	2	medica	medica	PROPN
aji-155	321	3	scandinavica	scandinavica	PROPN
aji-155	321	4	,	,	PUNCT
aji-155	321	5	185	185	NUM
aji-155	321	6	,	,	PUNCT
aji-155	321	7	221	221	NUM
aji-155	321	8	.	.	PUNCT
aji-155	322	1	thorley	thorley	PROPN
aji-155	322	2	,	,	PUNCT
aji-155	322	3	a.	a.	PROPN
aji-155	322	4	j.	j.	PROPN
aji-155	322	5	,	,	PUNCT
aji-155	322	6	ford	ford	PROPN
aji-155	322	7	,	,	PUNCT
aji-155	322	8	p.	p.	NOUN
aji-155	322	9	a.	a.	PROPN
aji-155	322	10	,	,	PUNCT
aji-155	322	11	gie	gie	NOUN
aji-155	322	12	,	,	PUNCT
aji-155	322	13	m.	m.	NOUN
aji-155	322	14	b.	b.	PROPN
aji-155	322	15	y.	y.	PROPN
aji-155	322	16	,	,	PUNCT
aji-155	322	17	goldstraw	goldstraw	NOUN
aji-155	322	18	,	,	PUNCT
aji-155	322	19	p.	p.	NOUN
aji-155	322	20	,	,	PUNCT
aji-155	322	21	young	young	ADJ
aji-155	322	22	,	,	PUNCT
aji-155	322	23	a.	a.	NOUN
aji-155	322	24	,	,	PUNCT
aji-155	322	25	&	&	CCONJ
aji-155	322	26	tetley	tetley	PROPN
aji-155	322	27	,	,	PUNCT
aji-155	322	28	t.	t.	PROPN
aji-155	322	29	d.	d.	PROPN
aji-155	322	30	(	(	PUNCT
aji-155	322	31	2007	2007	NUM
aji-155	322	32	)	)	PUNCT
aji-155	322	33	.	.	PUNCT
aji-155	323	1	differential	differential	ADJ
aji-155	323	2	regulation	regulation	NOUN
aji-155	323	3	of	of	ADP
aji-155	323	4	cytokine	cytokine	ADJ
aji-155	323	5	release	release	NOUN
aji-155	323	6	and	and	CCONJ
aji-155	323	7	leukocyte	leukocyte	NOUN
aji-155	323	8	migration	migration	NOUN
aji-155	323	9	by	by	ADP
aji-155	323	10	lipopolysaccharide	lipopolysaccharide	ADV
aji-155	323	11	-	-	PUNCT
aji-155	323	12	stimulated	stimulate	VERB
aji-155	323	13	primary	primary	ADJ
aji-155	323	14	human	human	ADJ
aji-155	323	15	lung	lung	NOUN
aji-155	323	16	alveolar	alveolar	ADJ
aji-155	323	17	type	type	NOUN
aji-155	323	18	ii	ii	NOUN
aji-155	323	19	epithelial	epithelial	ADJ
aji-155	323	20	cells	cell	NOUN
aji-155	323	21	and	and	CCONJ
aji-155	323	22	macrophages	macrophage	NOUN
aji-155	323	23	.	.	PUNCT
aji-155	324	1	journal	journal	NOUN
aji-155	324	2	of	of	ADP
aji-155	324	3	immunology	immunology	NOUN
aji-155	324	4	,	,	PUNCT
aji-155	324	5	178	178	NUM
aji-155	324	6	,	,	PUNCT
aji-155	324	7	463	463	NUM
aji-155	324	8	-	-	SYM
aji-155	324	9	472	472	NUM
aji-155	324	10	.	.	PUNCT
aji-155	325	1	available	available	ADJ
aji-155	325	2	:	:	PUNCT
aji-155	325	3	https://doi.org/10.4049/jimmunol.178.1.463	https://doi.org/10.4049/jimmunol.178.1.463	PROPN
aji-155	325	4	turgeon	turgeon	PROPN
aji-155	325	5	,	,	PUNCT
aji-155	325	6	m.	m.	NOUN
aji-155	325	7	l.	l.	PROPN
aji-155	325	8	(	(	PUNCT
aji-155	325	9	2020	2020	NUM
aji-155	325	10	)	)	PUNCT
aji-155	325	11	.	.	PUNCT
aji-155	326	1	immunology	immunology	NOUN
aji-155	326	2	and	and	CCONJ
aji-155	326	3	serology	serology	NOUN
aji-155	326	4	in	in	ADP
aji-155	326	5	laboratory	laboratory	NOUN
aji-155	326	6	medicine	medicine	NOUN
aji-155	326	7	.	.	PUNCT
aji-155	327	1	elsevier	elsevier	PROPN
aji-155	327	2	health	health	PROPN
aji-155	327	3	science	science	PROPN
aji-155	327	4	.	.	PUNCT
aji-155	328	1	venter	venter	PROPN
aji-155	328	2	,	,	PUNCT
aji-155	328	3	j.	j.	PROPN
aji-155	328	4	c.	c.	PROPN
aji-155	328	5	(	(	PUNCT
aji-155	328	6	1998	1998	NUM
aji-155	328	7	)	)	PUNCT
aji-155	328	8	.	.	PUNCT
aji-155	329	1	complete	complete	ADJ
aji-155	329	2	genome	genome	NOUN
aji-155	329	3	sequencing	sequencing	NOUN
aji-155	329	4	of	of	ADP
aji-155	329	5	hemophilus	hemophilus	ADJ
aji-155	329	6	influenzae	influenzae	NOUN
aji-155	329	7	.	.	PUNCT
aji-155	330	1	in	in	ADP
aji-155	330	2	r.	r.	PROPN
aji-155	330	3	f.	f.	PROPN
aji-155	330	4	doolittle	doolittle	PROPN
aji-155	330	5	(	(	PUNCT
aji-155	330	6	ed	ed	NOUN
aji-155	330	7	.	.	PUNCT
aji-155	330	8	)	)	PUNCT
aji-155	330	9	,	,	PUNCT
aji-155	330	10	microbial	microbial	ADJ
aji-155	330	11	genome	genome	NOUN
aji-155	330	12	opens	open	VERB
aji-155	330	13	up	up	ADP
aji-155	330	14	(	(	PUNCT
aji-155	330	15	pp	pp	ADJ
aji-155	330	16	.	.	PUNCT
aji-155	331	1	339	339	NUM
aji-155	331	2	-	-	SYM
aji-155	331	3	342	342	NUM
aji-155	331	4	)	)	PUNCT
aji-155	331	5	.	.	PUNCT
aji-155	332	1	nature	nature	NOUN
aji-155	332	2	.	.	PUNCT
aji-155	333	1	wisplwey	wisplwey	PROPN
aji-155	333	2	,	,	PUNCT
aji-155	333	3	b.	b.	PROPN
aji-155	333	4	,	,	PUNCT
aji-155	333	5	hansen	hansen	PROPN
aji-155	333	6	,	,	PUNCT
aji-155	333	7	e.	e.	PROPN
aji-155	333	8	,	,	PUNCT
aji-155	333	9	&	&	CCONJ
aji-155	333	10	scheld	scheld	PROPN
aji-155	333	11	,	,	PUNCT
aji-155	333	12	m.	m.	NOUN
aji-155	333	13	(	(	PUNCT
aji-155	333	14	1989	1989	NUM
aji-155	333	15	)	)	PUNCT
aji-155	333	16	.	.	PUNCT
aji-155	334	1	hemophilus	hemophilus	PROPN
aji-155	334	2	influenzae	influenzae	X
aji-155	334	3	omp	omp	PROPN
aji-155	334	4	-	-	PUNCT
aji-155	334	5	induced	induce	VERB
aji-155	334	6	bbb	bbb	NOUN
aji-155	334	7	permeability	permeability	NOUN
aji-155	334	8	during	during	ADP
aji-155	334	9	experimental	experimental	ADJ
aji-155	334	10	meningitis	meningiti	NOUN
aji-155	334	11	.	.	PUNCT
aji-155	335	1	infection	infection	NOUN
aji-155	335	2	and	and	CCONJ
aji-155	335	3	immunity	immunity	NOUN
aji-155	335	4	,	,	PUNCT
aji-155	335	5	57(18	57(18	NUM
aji-155	335	6	)	)	PUNCT
aji-155	335	7	,	,	PUNCT
aji-155	335	8	2559	2559	NUM
aji-155	335	9	-	-	SYM
aji-155	335	10	2562	2562	NUM
aji-155	335	11	.	.	PUNCT
aji-155	336	1	available	available	ADJ
aji-155	336	2	:	:	PUNCT
aji-155	336	3	https://doi.org/10.1128/iai.57.18.25592562.1989	https://doi.org/10.1128/iai.57.18.25592562.1989	PROPN
aji-155	336	4	zhao	zhao	NOUN
aji-155	336	5	,	,	PUNCT
aji-155	336	6	t.	t.	PROPN
aji-155	336	7	,	,	PUNCT
aji-155	336	8	cai	cai	PROPN
aji-155	336	9	,	,	PUNCT
aji-155	336	10	y.	y.	PROPN
aji-155	336	11	,	,	PUNCT
aji-155	336	12	jiang	jiang	PROPN
aji-155	336	13	,	,	PUNCT
aji-155	336	14	y.	y.	PROPN
aji-155	336	15	,	,	PUNCT
aji-155	336	16	et	et	PROPN
aji-155	336	17	al	al	PROPN
aji-155	336	18	.	.	PROPN
aji-155	336	19	(	(	PUNCT
aji-155	336	20	2023	2023	NUM
aji-155	336	21	)	)	PUNCT
aji-155	336	22	.	.	PUNCT
aji-155	337	1	vaccine	vaccine	NOUN
aji-155	337	2	adjuvants	adjuvant	NOUN
aji-155	337	3	,	,	PUNCT
aji-155	337	4	mechanisms	mechanism	NOUN
aji-155	337	5	,	,	PUNCT
aji-155	337	6	and	and	CCONJ
aji-155	337	7	platforms	platform	NOUN
aji-155	337	8	.	.	PUNCT
aji-155	338	1	signal	signal	ADJ
aji-155	338	2	transduction	transduction	NOUN
aji-155	338	3	and	and	CCONJ
aji-155	338	4	targeted	target	VERB
aji-155	338	5	therapy	therapy	NOUN
aji-155	338	6	,	,	PUNCT
aji-155	338	7	8	8	NUM
aji-155	338	8	,	,	PUNCT
aji-155	338	9	283	283	NUM
aji-155	338	10	.	.	PUNCT
aji-155	339	1	available	available	ADJ
aji-155	339	2	:	:	PUNCT
aji-155	339	3	https://doi.org/10.1038/s41392-0157-7	https://doi.org/10.1038/s41392-0157-7	ADJ
aji-155	339	4	disclaimer	disclaimer	ADJ
aji-155	339	5	/	/	SYM
aji-155	339	6	publisher	publisher	NOUN
aji-155	339	7	’s	’s	PART
aji-155	339	8	note	note	NOUN
aji-155	339	9	:	:	PUNCT
aji-155	339	10	the	the	DET
aji-155	339	11	statements	statement	NOUN
aji-155	339	12	,	,	PUNCT
aji-155	339	13	opinions	opinion	NOUN
aji-155	339	14	and	and	CCONJ
aji-155	339	15	data	datum	NOUN
aji-155	339	16	contained	contain	VERB
aji-155	339	17	in	in	ADP
aji-155	339	18	all	all	DET
aji-155	339	19	publications	publication	NOUN
aji-155	339	20	are	be	AUX
aji-155	339	21	solely	solely	ADV
aji-155	339	22	those	those	PRON
aji-155	339	23	of	of	ADP
aji-155	339	24	the	the	DET
aji-155	339	25	individual	individual	ADJ
aji-155	339	26	author(s	author(s	PROPN
aji-155	339	27	)	)	PUNCT
aji-155	339	28	and	and	CCONJ
aji-155	339	29	contributor(s	contributor(s	NOUN
aji-155	339	30	)	)	PUNCT
aji-155	339	31	and	and	CCONJ
aji-155	339	32	not	not	PART
aji-155	339	33	of	of	ADP
aji-155	339	34	the	the	DET
aji-155	339	35	publisher	publisher	NOUN
aji-155	339	36	and/or	and/or	CCONJ
aji-155	339	37	the	the	DET
aji-155	339	38	editor(s	editor(s	NOUN
aji-155	339	39	)	)	PUNCT
aji-155	339	40	.	.	PUNCT
aji-155	340	1	this	this	DET
aji-155	340	2	publisher	publisher	NOUN
aji-155	340	3	and/or	and/or	CCONJ
aji-155	340	4	the	the	DET
aji-155	340	5	editor(s	editor(s	NOUN
aji-155	340	6	)	)	PUNCT
aji-155	340	7	disclaim	disclaim	VERB
aji-155	340	8	responsibility	responsibility	NOUN
aji-155	340	9	for	for	ADP
aji-155	340	10	any	any	DET
aji-155	340	11	injury	injury	NOUN
aji-155	340	12	to	to	ADP
aji-155	340	13	people	people	NOUN
aji-155	340	14	or	or	CCONJ
aji-155	340	15	property	property	NOUN
aji-155	340	16	resulting	result	VERB
aji-155	340	17	from	from	ADP
aji-155	340	18	any	any	DET
aji-155	340	19	ideas	idea	NOUN
aji-155	340	20	,	,	PUNCT
aji-155	340	21	methods	method	NOUN
aji-155	340	22	,	,	PUNCT
aji-155	340	23	instructions	instruction	NOUN
aji-155	340	24	or	or	CCONJ
aji-155	340	25	products	product	NOUN
aji-155	340	26	referred	refer	VERB
aji-155	340	27	to	to	ADP
aji-155	340	28	in	in	ADP
aji-155	340	29	the	the	DET
aji-155	340	30	content	content	NOUN
aji-155	340	31	.	.	PUNCT
aji-155	341	1	_	_	PUNCT
aji-155	342	1	_	_	PUNCT
aji-155	343	1	_	_	PUNCT
aji-155	344	1	_	_	PUNCT
aji-155	345	1	_	_	PUNCT
aji-155	346	1	_	_	PUNCT
aji-155	347	1	_	_	PUNCT
aji-155	348	1	_	_	PUNCT
aji-155	349	1	_	_	PUNCT
aji-155	350	1	_	_	PUNCT
aji-155	351	1	_	_	PUNCT
aji-155	352	1	_	_	PUNCT
aji-155	353	1	_	_	PUNCT
aji-155	354	1	_	_	PUNCT
aji-155	355	1	_	_	PUNCT
aji-155	356	1	_	_	PUNCT
aji-155	357	1	_	_	PUNCT
aji-155	358	1	_	_	PUNCT
aji-155	359	1	_	_	PUNCT
aji-155	360	1	_	_	PUNCT
aji-155	361	1	_	_	PUNCT
aji-155	362	1	_	_	PUNCT
aji-155	363	1	_	_	PUNCT
aji-155	364	1	_	_	PUNCT
aji-155	365	1	_	_	PUNCT
aji-155	366	1	_	_	PUNCT
aji-155	367	1	_	_	PUNCT
aji-155	368	1	_	_	PUNCT
aji-155	369	1	_	_	PUNCT
aji-155	370	1	_	_	PUNCT
aji-155	371	1	_	_	PUNCT
aji-155	372	1	_	_	PUNCT
aji-155	373	1	_	_	PUNCT
aji-155	374	1	_	_	PUNCT
aji-155	375	1	_	_	PUNCT
aji-155	376	1	_	_	PUNCT
aji-155	377	1	_	_	PUNCT
aji-155	378	1	_	_	PUNCT
aji-155	379	1	_	_	PUNCT
aji-155	380	1	_	_	PUNCT
aji-155	381	1	_	_	PUNCT
aji-155	382	1	_	_	PUNCT
aji-155	383	1	_	_	PUNCT
aji-155	384	1	_	_	PUNCT
aji-155	385	1	_	_	PUNCT
aji-155	386	1	_	_	PUNCT
aji-155	387	1	_	_	PUNCT
aji-155	388	1	_	_	PUNCT
aji-155	389	1	_	_	PUNCT
aji-155	390	1	_	_	PUNCT
aji-155	391	1	_	_	PUNCT
aji-155	392	1	_	_	PUNCT
aji-155	393	1	_	_	PUNCT
aji-155	394	1	_	_	PUNCT
aji-155	395	1	_	_	PUNCT
aji-155	396	1	_	_	PUNCT
aji-155	397	1	_	_	PUNCT
aji-155	398	1	_	_	PUNCT
aji-155	399	1	_	_	PUNCT
aji-155	400	1	_	_	PUNCT
aji-155	401	1	_	_	PUNCT
aji-155	402	1	_	_	PUNCT
aji-155	403	1	_	_	PUNCT
aji-155	404	1	_	_	PUNCT
aji-155	405	1	_	_	PUNCT
aji-155	406	1	_	_	PUNCT
aji-155	407	1	_	_	PUNCT
aji-155	408	1	_	_	PUNCT
aji-155	409	1	_	_	PUNCT
aji-155	410	1	_	_	PUNCT
aji-155	411	1	_	_	PUNCT
aji-155	412	1	_	_	PUNCT
aji-155	413	1	_	_	PUNCT
aji-155	414	1	_	_	PUNCT
aji-155	415	1	_	_	PUNCT
aji-155	416	1	_	_	PUNCT
aji-155	417	1	_	_	PUNCT
aji-155	418	1	_	_	PUNCT
aji-155	419	1	_	_	PUNCT
aji-155	420	1	_	_	PUNCT
aji-155	421	1	_	_	PUNCT
aji-155	422	1	©	©	PRON
aji-155	422	2	copyright	copyright	NOUN
aji-155	422	3	(	(	PUNCT
aji-155	422	4	2025	2025	NUM
aji-155	422	5	):	):	PUNCT
aji-155	422	6	author(s	author(s	NOUN
aji-155	422	7	)	)	PUNCT
aji-155	422	8	.	.	PUNCT
aji-155	423	1	the	the	DET
aji-155	423	2	licensee	licensee	NOUN
aji-155	423	3	is	be	AUX
aji-155	423	4	the	the	DET
aji-155	423	5	journal	journal	PROPN
aji-155	423	6	publisher	publisher	NOUN
aji-155	423	7	.	.	PUNCT
aji-155	424	1	this	this	PRON
aji-155	424	2	is	be	AUX
aji-155	424	3	an	an	DET
aji-155	424	4	open	open	ADJ
aji-155	424	5	access	access	NOUN
aji-155	424	6	article	article	NOUN
aji-155	424	7	distributed	distribute	VERB
aji-155	424	8	under	under	ADP
aji-155	424	9	the	the	DET
aji-155	424	10	terms	term	NOUN
aji-155	424	11	of	of	ADP
aji-155	424	12	the	the	DET
aji-155	424	13	creative	creative	ADJ
aji-155	424	14	commons	common	NOUN
aji-155	424	15	attribution	attribution	NOUN
aji-155	424	16	license	license	NOUN
aji-155	424	17	(	(	PUNCT
aji-155	424	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-155	424	19	)	)	PUNCT
aji-155	424	20	,	,	PUNCT
aji-155	424	21	which	which	PRON
aji-155	424	22	permits	permit	VERB
aji-155	424	23	unrestricted	unrestricted	ADJ
aji-155	424	24	use	use	NOUN
aji-155	424	25	,	,	PUNCT
aji-155	424	26	distribution	distribution	NOUN
aji-155	424	27	,	,	PUNCT
aji-155	424	28	and	and	CCONJ
aji-155	424	29	reproduction	reproduction	NOUN
aji-155	424	30	in	in	ADP
aji-155	424	31	any	any	DET
aji-155	424	32	medium	medium	NOUN
aji-155	424	33	,	,	PUNCT
aji-155	424	34	provided	provide	VERB
aji-155	424	35	the	the	DET
aji-155	424	36	original	original	ADJ
aji-155	424	37	work	work	NOUN
aji-155	424	38	is	be	AUX
aji-155	424	39	properly	properly	ADV
aji-155	424	40	cited	cite	VERB
aji-155	424	41	.	.	PUNCT
aji-155	425	1	peer	peer	NOUN
aji-155	425	2	-	-	PUNCT
aji-155	425	3	review	review	NOUN
aji-155	425	4	history	history	NOUN
aji-155	425	5	:	:	PUNCT
aji-155	425	6	the	the	DET
aji-155	425	7	peer	peer	NOUN
aji-155	425	8	review	review	NOUN
aji-155	425	9	history	history	NOUN
aji-155	425	10	for	for	ADP
aji-155	425	11	this	this	DET
aji-155	425	12	paper	paper	NOUN
aji-155	425	13	can	can	AUX
aji-155	425	14	be	be	AUX
aji-155	425	15	accessed	access	VERB
aji-155	425	16	here	here	ADV
aji-155	425	17	:	:	PUNCT
aji-155	425	18	https://pr.sdiarticle5.com/review-history/129951	https://pr.sdiarticle5.com/review-history/129951	NOUN
aji-155	425	19	https://pr.sdiarticle5.com/review-history/129951	https://pr.sdiarticle5.com/review-history/129951	NOUN